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Abstract 
Tissue engineered heart valves (TEHV) will allow clinicians to have a high-
quality prosthesis for patients that could eliminate many drawbacks of currently available 
treatments. Although there is great promise for TEHV, the field is still in its infancy; 
proper scaffolding materials and dynamic culture regimens that produce TEHV suitable 
for implantation in the aortic valve (A V) position have not yet been identified. Novel 
systems to apply biomechanical stimuli to developing engineered tissues and materials 
development and characterization will be necessary to progress towards an aortic TEHV. 
This thesis work aimed to address these issues in a parallel manner. 
The thesis begins by describing the design and physical characterization of a 
bioreactor system capable of both AV organ culture and biomechanical conditioning of 
engineered A V tissues. This work demonstrated that the newly developed bioreactor 
system allows A V to be cultured dynamically in a simple system that scales to 
accommodate varying sample sizes. Evaluation of this bioreactor system showed that 
dynamic culture of A V maintained normal tissue phenotype for durations of up to seven 
days, which is to-date the longest ex vivo maintenance of normal A V tissue phenotype in 
a dynamic bioreactor system. 
This thesis work also investigated the suitability ofpoly(ethylene glycol) 
diacrylate hydro gels to be used as a TEHV scaffold. These studies showed that flexural 
stiffness of the resulting scaffolds could be modulated by varying the formulation 
parameters chosen, and that valvular interstitial cells embedded and cultured within these 
gels (also containing incorporated bioactive moieties) maintained expression of several 
characteristic phenotypic markers. The thesis also describes studies in which advanced 
iii 
hydrogel scaffolds were fabricated using anatomically-inspired composite strategies, 
resulting in scaffolds that possessed unique material properties (anisotropic behavior and 
altered bending stiffness) compared to standard single component hydrogels. These 
studies were the first to show a biphasic, trilayered quasilaminate structure in a 
photopolymerized system. Additionally, these studies demonstrated the development of 
new anatomically-inspired patterns of reinforcement that allow hydrogels material 
behavior to more closely mimic tissue. The thesis closes with a description of the 
implications of these studies on heart valve tissue engineering and potential future 
directions using these techniques. 
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Chapter 1: Introduction and Specific Aims 
1.1 Introduction 
Tissue engineering holds great promise for the repair or replacement of many 
diseased or damaged tissues, however, much work remains to be performed before 
suitable engineered tissues are a clinical reality. In particular, tissue engineered heart 
valves (TEHV) would allow clinicians to have a high-quality prosthesis for pediatric 
patients (whom frequently have malformed or diseased valves that require surgical 
intervention) that could eliminate many drawbacks of currently available treatments. 
Additionally, TEHV would give a higher quality option to adult patients who most 
commonly receive mechanical or bioprosthetic valves when they require valve 
replacement. Despite the promise, and the work over performed over the past 20 years by 
a few labs in this field, there has been limited clinical success of TEHV and even less 
when they are needed in the aortic position. Development of new systems to culture and 
study valves so that investigators can truly understand valve biology and stimulate tissue 
development will be necessary to realize progress towards a successful TEHV. Of equal 
importance will be the development of novel, advanced scaffolds capable of sufficient 
mechanical performance in the tissue's in vivo environment while supporting cells 
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exhibiting valve-like phenotypes. This thesis work aimed to address these issues 
simultaneously. The thesis begins by describing the design, physical, and phenotypic 
characterization of a bioreactor system capable both of aortic valve organ and 
biomechanical conditioning of engineered aortic valve tissues. The newly designed 
system will permit investigators to examine valve biology in a more controlled 
environment than in vivo large animal studies. Data collected and interpreted for the 
purpose of bioreactor validation is incorporated in the development and testing of poly 
(ethylene glycol) diacrylate (PEGDA) hydrogel compositions in order to evaluate their 
suitability for use in valvular tissue engineering. Following these studies, development 
and characterization of anatomically inspired advanced hydrogel scaffolds are described, 
which further incorporate valve-tissue specific concepts, while having general 
applicability to the engineering of a diverse range of tissues. 
The system designed and detailed in this thesis can be used to study valve disease 
states as provide dynamic mechanical stimulation to TEHV. The creation of a system that 
provides low-cost, scalable sterile culture of aortic valve tissues allowed for the 
determination of design criteria for engineered tissues (particularly flexure properties). 
Furthermore, this system has broad applicability for the study of valve biology and 
remodeling, as well as mechanical conditioning of tissue engineered heart valves. 
The testing of PEGDA gels with primary concern placed on their material 
properties and ability to support valve cells is unique. Material characterization of 
PEGDA hydrogels has been predominantly limited to compression and tension, while 
bending (used synonymously in this thesis with flexure) has largely been unexplored. 
This work is the first to investigate bending behavior of single-layer (referring to 
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formulation, standard in the literature) PEGDA hydrogels, which is of particular concern 
to TEHV. Additionally, this work investigated the mechanical consequences of adding 
heparin to hydrogel scaffolds. Novel methods for creating anatomically-inspired 
composite hydrogels were created. Quasilaminate structures and interpenetrating pattern 
reinforced composites that mimic the geometry of the native aortic valve leaflet were 
created, and allow for more biomimetic mechanical behavior of the resulting constructs. 
This research has been presented in this thesis in seven chapters. The first chapter 
set ups the ideas to be explored in this document and serves as a conceptual map for the 
thesis. Next, an in-depth review of pertinent literature and background information 
follows (Chapter 2) in order to describe the work that has enabled this research as well as 
to frame this work in the context of the field of heart valve tissue engineering. The first 
specific aim will be detailed in the subsequent two chapters (Chapters 3 and 4). The 
design, physical evaluation, and ability of the bioreactor system to provide a sterile 
medium-term culture environment will be detailed in the first of these chapters. Next, 
medium-term organ culture of native tissues in this system will be detailed. The 
following two chapters will detail the hydrogel investigation that comprises aims II and 
III. The composition optimization and bending evaluation of single layer hydrogels is 
detailed in Chapter 5. The following chapter describes the novel methods used for 
creating the anatomically-inspired structures that mimic native valve tissue. Finally, the 
thesis closes with a discussion that frames the global results achieved through this 
research and delineate the unique contribution of this work to valvular tissue engineering. 
Additionally, the thesis contains eight appendices that detail physical design of systems, 
new source code created in system design or image processing, and the doctoral 
candidate's contributions to projects outside the scope of this thesis. 
1.2 Motivation and Global Objectives 
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While TEHV have been researched in a variety of materials and dynamic culture 
conditions, the ideal material and dynamic culture regimen has yet to be realized. Low-
cost, scalable, simple systems to dynamically stimulate the valve will aid both 
investigation of native tissues, but also rapidly accelerate development of engineering 
tissues. The use of a hydrogel that can be extensively modified both biochemically and 
biomechanically, like PEGDA, is very attractive for applications such as TEHV. Despite 
the obvious potential benefits PEGDA has as a TEHV scaffold, it has not been 
extensively studied as a potential scaffold for heart valve tissue engineering, most likely 
due to initial reports that growing valvular interstitial cells on PEG surfaces was 
unsuccessful.[l] However, recent studies showed that by modifying PEGDA gels with 
methacrylated heparin, VIC growth and normal phenotype could be supported.[2] The 
objective of these studies was two-fold: (i) to develop a novel bioreactor that can be 
used for the ex vivo culture and dynamic conditioning of engineered and native 
heart valves and (ii) to develop composite PEGDA scaffolds with composition and 
architecture most suitable for tissue engineered aortic valve leaflets. The 
development of the novel bioreactor will enable application of dynamic biomechanical 
stimuli to engineered valves in the future. Exploration of PEGDA gels with primary 
concern placed on their bending properties will aid in the translation of hydrogels 
towards more biomimetic scaffold fabrication and realistic in vitro testing of hydrogel-
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based TEHV s. This objective has been realized through the investigation of the following 
specific aims. 
1.3 Specific Aims 
1.3.1 Specific Aim I: Design and evaluate a bioreactor capable of 
medium term culture of native and engineered aortic 
valves. 
Hypothesis: A system that cyclically opens and close an aortic valve will maintain 
the normal phenotype of aortic valve tissue for longer culture durations than will 
static culture. 
Approach: A simple, scalable system has been developed that provides a method 
to culture aortic valves under repeatable sterile conditions. The dynamically 
cultured valves have been compared with valves cultured under static conditions 
for the same duration and assessed for their mechanical, biochemical, and 
histological characteristics. 
Significance: This new system to maintain valves ex vivo has applications not 
only for development of tissue-engineered valves, but for also studying disease 
models in the aortic valve. Furthermore, this study developed the bending 
mechanics criteria for the following specific aim. 
1.3.2 Specific Aim II: Optimize the composition of PEGDA 
hydrogels to achieve most favorable bending mechanics 
for use in a tissue engineered aortic valve. 
Hypothesis: Altering the molecular weight and weight fraction of PEGDA chains 
used to develop hydrogels will significantly affect their material properties. Such 
parameters can be tuned to achieve bending properties similar to native aortic 
tissue. 
Approach: PEGDA hydrogels have been created with a range of compositions 
and the effect of each parameter on the bending mechanics of the hydrogel has 
been investigated with a custom designed bending tester. 
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Significance: While PEGDA hydrogels have been widely used in various 
applications, their bending behavior has not been reported. These studies augment 
the current understanding of PEG hydrogels as well as detail their suitability for 
use in tissue engineered heart valves. This characterization of bending behavior 
has applications in fields beyond heart valve tissue engineering, such as 
orthopedics. 
1.3.3 Specific Aim III: Create an anatomically-inspired composite 
hydrogel structure that emulates the natural structure of 
the aortic valve leaflet. 
Hypothesis: After characterizing bending properties of PEGDA hydrogels, 
layered and patterned structures can be created to mimic the natural structure of 
the aortic valve leaflet and exhibit unique bulk material properties when 
compared with standard hydrogel scaffolds. 
Approach: Quasilaminate structures and interpenetrating pattern-reinforced 
composites were created using a range of PEGDA hydrogel compositions. 
Photolithographic patterning and layering was used generate gels with material 
properties that were distinct from single component gels (exhibition of anisotropy 
and altered bending stiffness). 
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Significance: The developed layering techniques are novel for photopolymerized 
systems regardless of application, and both advanced scaffold fabrication 
techniques are unique in the field of heart valve tissue engineering. These 
methods allow the scaffold to more closely mimic the material properties of 
native tissue. Layering allows a very simple, quick way of controlling cell 
distribution throughout the construct, as well as control of the pericellular 
mechanical environment, without compromising overall scaffold material 
properties. Photolithographic patterning allows the creation of anisotropy in what 
is fundamentally an isotropic, elastic material. 
8 
Chapter 2: Background 
2.1 Aortic Valve 
2.1.1 Gross Anatomy 
The aortic valve is one of four valves in the heart, and is one of two 
arterioventricular valves. The aortic valve is composed of three semilunar leaflets and 
aortic sinuses and is located between the left ventricle and the aorta (Figure 2.1). It 
functions as a one-way valve, allowing oxygenated blood to flow from the left ventricle 
to the aorta. Each leaflet attaches to the sinus wall, thus creating the cavity between them, 
referred to as the sinuses of Valsalva. The walls of these sinuses become continuous with 
their respective leaflets at the fixed lower edge. The sinus wall is seen as a dilation of the 
aortic wall, and the left and right sinuses contain the ostia of their respective coronary 
arteries. The leaflets meet at the closing line, and overlap in the area 
of coaptation. [3] 
2.1.2 Aortic Valve Leaflets 
The shape of the leaflets have been determined to be cylindrical, which enables 
them to withstand more stress in the circumferential direction than the radial direction.[4] 
Additionally, during opening and closing of the valve, a cylindrical leaflet can undergo a 
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reversal of curvature more easily than could a multiply curved leaflet (Figure 2.2). The 
aortic valve experiences its maximal load during diastole, when the leaflets are fully 
pressurized and bulge back towards the heart. Maximum stress is found in two areas of 
the leaflet; the point of leaflet attachment and the line of leaflet coaptation. Maximum 
stress is due to flexion due to the high bending deformations at these areas. It is generally 
accepted that high local stresses lead to tissue damage and disease (calcification).[3 , 5-8] 
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Figure 2.1: Illustration of a dissected aortic root open to show the leaflets and coronary 
ostia. 
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The area where the leaflets join the aortic wall is called the commissure, and the 
peaks of these commissures are in the sinotubular junction. When the valve is open, the 
diameter of the opening is roughly equivalent to that of the sinotubular junction. While 
the valve is open, the length of the closing edge can be observed to be much greater than 
the straight-line distance between commissures. This is thought to be necessary for 
nonstenotic opening of the valve and nonregurgitant closure.[9] 
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Figure 2.2: Image showing the aortic valve in a closed (A) and open (8) position. When 
open, the leaflets undergo bending stresses while they experience a reversal of 
curvature.[9] 
2.1.3 Layered Structure of the Leaflet 
The aortic valve is composed of a layered structure, with the endothelium on the 
surface. Three distinct layers can be seen below the endothelium (Figure 2.3). They are, 
in order from the aortic to the ventricular side: 
1. Fibrosa - comprised of tightly packed collagen bundles 
2. Spongiosa -loose, GAG rich tissue 
3. Ventricularis - elastin rich layer 
Figure 2.3: Hematoxylin and eosin (H&E) stain of an aortic valve showing the layered 
structure of the leaflet. V, S, F denote ventricularis, spongiosa, and fibrosa 
respectively .[10] 
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These layers are present in both the coaptational and non-coaptational areas of the 
leaflet, however in the coaptational area there is a lower degree of organization. These 
layers give the tissue its strength, and the orientations of the elastic fibers and collagen 
bundles contribute to the anisotropic behavior of the leaflet. In the circumferential 
direction, the collagen bundles bear the brunt of the load, in contrast to the radial 
direction, where the elastic fibers bear the majority of the load.[II] The laminajibrosa is 
composed of parallel collagen fibers, oriented in the circumferential direction. 
Additionally, the increased extensibility of this layer is probably due to the "corrugated" 
nature of the collagen fibers in the relaxed state.[12] This structure bears the brunt of the 
stress experienced in diastole. The next layer up is called the lamina spongiosa, which is 
primarily composed of glycosaminoglycans and water. It has been hypothesized that this 
layer acts as a damper during leaflet closing. [11] The lamina ventricularis is found on the 
ventricular side of the spongiosa. The ventricularis is composed of both elastic and 
collagen fibers. The elastic fibers ensure that the collagen is organized into a folded 
contractile state.[12] This layer varies in thickness, and is considerably thicker at the 
transition between loaded and unloaded portions of the leaflet. [3] However, the mean 
thickness of this layer is roughly half that of the fibrosa. [12] 
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2.1.4 Comparison of Animal and Human Aortic Valves 
Various animal and human heart valves have been compared extensively, and in 
both dimension and anatomical characteristics (points of leaflet attachment), the porcine 
valve has been shown to be the most similar.[13] As a result, porcine valves have been 
long considered to be a suitable experimental model for human valves.[14] 
2.2 Aortic Valve Disease 
The most common incidences of aortic valve disease are congenital defects and 
aortic valve stenosis. [9] Congenital defects in valve formation are responsible for 
numerous types of valvular dysfunction, including regurgitation and valve stenosis. [15] A 
wide variety of causes for aortic valve stenosis have been proposed, but the root causes of 
this condition are not necessarily known. 
2.2.1 Aortic Valve Stenosis 
Aortic valve stenosis is fairly common, and affects patients with congenitally 
malformed valves as well as patients with normal valves.[16] It is a condition resulting in 
the hindrance of blood flow from the left ventricle to the aorta. In aortic valve stenosis, 
the valve orifice is frequently reduced to a small triangular opening that is not only 
stenotic, but may also be regurgitant (leaky).[9] Aortic valve stenosis can be divided into 
two classes, congenital and acquired. Congenital stenosis is uncommon (however when it 
does occur, it frequently is due to a bicuspid aortic valve), and when stenosis is seen 
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young patients it usually becomes symptomatic after birth. [15] [17]Acquired stenosis can 
be further subdivided into stenosis of a normally formed valve and stenosis of a 
malformed valve.[10] In normally formed valves, this pathology can be caused by 
rheumatic fever or calcific degeneration, as well as by congenital defects. 
Aortic stenosis that results from rheumatic fever is due to the formation of 
adhesions and the fusion of the commissures and cusps. In rheumatic fever, the tissue 
becomes fibrotic leading to stiffening.[9] Calcific degeneration of the valve tissue also is 
a significant cause of aortic stenosis. This calcification results from a variety of causes 
including osteogenic and inflammatory reactions, and may be linked to 
atherosclerosis.[18, 19] Congenital bicuspid valves, he most common malformed valve, 
produce turbulent flow patterns that also lead to fibrosis and increased calcification of the 
valve. [20] 
Regardless of the cause of aortic stenosis, the effect on the heart is the same. If 
untreated, this condition results in an increased after 10 ad for the heart. In tum, the heart 
compensates by increasing the muscle mass of the left ventricle. Ultimately, left 
ventricular hypertrophy leads to clinical heart failure. For this reason, a large number (> 
100,000) patients undergo valve replacement surgery each year. [9] 
Patients with normally formed tri-leaflet valves constitute the bulk of aortic valve 
stenosis cases in the 65+ age group. In these patients, calcific deposits are uniformly 
distributed across the cusp. The commissures are rarely fused; as such, it is uncommon 
for these patients to experience aortic valve regurgitation. 
As previously discussed, the bicuspid valve is the most common type of 
malformed aortic valve. In a retrospective study of aortic valve stenosis, the largest 
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percentage (47%) of patients aged 15-56 had bicuspid valves (Figure 2.4). In contrast, 
when patients over the age of 65 were studied, nearly all cases of stenosis were in normal 
tri-Ieaflet valves. [1 0] These results suggest that when aortic stenosis is seen in younger 
patients, the root cause is most likely some kind of malformed valve, but when it is 
observed in elderly patients, the cause is typically calcific degeneration. 
< 70 yr old (n-324) ~ 70 yr old (n&322) 
• Bicuspid 
• Post-inflammatory 
o Degenerative 
o Unicommissural 
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I [J Indeterminate 
Figure 2.4: Retrospective study examining sources of aortic stenosis. Figure adapted 
from Passik et al.[21] 
2.3 Clinical Relevance 
Cardiovascular disease and more specifically, valvular disease is very common in 
the United States. Roughly 95,000 people undergo some form of treatment each year for 
valvular disease, and over half of these patients have an aortic valve disorder. The 
mortality associated with aortic valve disorders is over 26,000 patients per year in the 
United States. [22] The most common treatment for valvular dysfunction is replacement, 
with either a mechanical or bioprosthetic valve. [8] Neither replacement option is ideal for 
pediatric patients. Mechanical valves require systemic anticoagulation, which can be 
dangerous in children. [23] In young patients bioprosthetic valves tend to calcify very 
quickly and require frequent replacement surgeries.[24] 
2.3.1 Valve Homografts 
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Mechanical and prosthetic valves are equally susceptible to endocarditis and 
nonstructural dysfunction.[8] Furthermore, since neither of these treatments have the 
ability to grow; they are not ideal for a pediatric patient. Additionally, pediatric patients 
experience much quicker degradation ofbioprosthetics than do elderly patients.[24, 25] 
As an alternative, the Ross procedure (pulmonary autograft and replacement of the 
pulmonary valve) is used commonly in pediatric patients in the hope that the transplanted 
valves may grow with the child. This has been used successfully for many years and is 
most successful when the pulmonary valve is replaced by a homograft.[26] Currently, the 
Ross procedure is the gold standard of care for suitable patients, and offers potential for 
valve growth in pediatric patients.[27, 28] However, in many cases the procedure proves 
to be too risky, since the operation more than doubles in complexity (one valve to two 
valve), there are a limited number of homo grafts, and an artificial valve is used. [27] 
2.3.2 Mechanical Valves 
While valve replacements have been successfully performed for many years, there 
is no "silver bullet" solution to treating valve dysfunction. A plethora of designs for the 
mechanical valve exist, and some have been used clinically for as long as 40 years. The 
most common mechanical valve used today is a bileaflet valve composed of two tilting 
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disks (Figure 2.5 A & B). These prostheses are very durable and have desirable central 
flow properties. The downside of mechanical valves is that they typically require the use 
of anticoagulant therapy for the remainder of the patient's life (regardless of the patient's 
age) , which puts the patient at risk for adverse hemorrhagic effects .[29] 
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Figure 2.5: Bileaflet mechanical (upper row), stented bioprosthetic (left, lower row) 
stentless bioprosthetic (right, lower row) aortic valves. Source: STS. 
2.3.3 Bioprosthetic Valves 
Bioprosthetic valves do not require systemic anticoagulation, but they are 
significantly less durable than mechanical prostheses. [24, 25] These valves are typically 
created by glutaraldehyde fixation of a porcine valve, which is then mounted to a stent for 
implantation (Figure 2.5 C & D). A major problem with bioprosthetic valves is the 
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durability. These valves are only expected to last 10-15 years after implantation due to 
structural valve degeneration, and are most commonly used in patients who are older than 
70.[25] This strategy is used because the patient is not expected to need a subsequent 
surgery, since the lifespan of the valve exceeds the patient's life expectancy.[30] When 
these valves are used in patients under the age of 65, they frequently need to be replaced 
(this replacement frequency increases with decreasing patient age).[25] The risk and 
trauma associated with multiple valve replacement surgeries further justifies the need for 
a tissue engineered valve. 
2.4 Valvular Tissue Engineering 
A tissue engineered heart valve offers a solution to the limitations of currently 
available treatments for aortic valve dysfunction. In addition, a tissue engineered heart 
valve could serve as a robust model to understand the mechanisms of valve biology and 
disease. An ideal tissue engineered valve would be able to grow and remodel as a 
pediatric patient grows. The ability to create a valve with a natural architecture will 
minimize the problems of hemolysis and incomplete closing associated with current vale 
prostheses. Valvular tissue engineering is emerging as an established field, and has been 
an active area of research for the past 20 years. 
2.4.1 Previous Tissue Engineered Heart Valve Paradigms 
There is no definitive solution to the problem of creating a tissue engineered 
valve, however, there are two main approaches being investigated: 
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i. decellularization of xenograft or human valve tissues and repopulation with the 
patient's own cells 
ii. population of engineered scaffolds with cells 
The promise of using the flrst method, a decellularized valve that would then be 
repopulated by the patient's own cells, was initially very popular due to the aortic valve's 
complex nature and our relative lack of knowledge about this process. [3 I] This method 
has yet to yield any success in a human model, and typically fails due to a severe 
inflammatory response and structural failure encapsulation.[32] The second method, 
population of engineered scaffolds with cells, is the more common "tissue engineering 
paradigm," which refers to the population of a 3D scaffold with cells then the subsequent 
application of biochemical and biomechanical cues to guide tissue formation. A variety 
of approaches to the second paradigm will be discussed below, however this chapter will 
focus primarily on the application of physical stimuli and scaffold material choice, since 
those conditions are of primary importance to this work. 
2.4.2 Current State-of-the-Art 
The current state-of-the-art tissue engineered valve has been detailed in the 
literature and has been developed in a number of collaborative labs.[33-54] The general 
technique employed by Hoerstrup et al.,[44] that yielded a functional tissue engineered 
valve was to create a valve-shaped mesh scaffold composed of polyglycolic 
acid/polylactic acid (PGAlPLLA) copolymer, which is then dip-coated in poly-4-
hydroxybutarate (P4HB). The valve was then seeded with human saphenous vein cells 
and mechanically conditioned in a bioreactor. Their method has yielded a layered 
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microstructure that mimics that of a native valve. However, this approach is not yet ideal, 
due to the compaction of the mesh scaffold. This compaction leads to the loss of 
coaptation of the valve leaflets, and leakage across the valve. Additionally, the 
degradation of this scaffold is uncontrolled and produces potentially cytotoxic acidic 
byproducts.[ 40] Finally, the created valve is not of a suitable strength for use in the aortic 
position. Other groups are investigating this approach with slight variation in the polymer 
or cell types used, but this approach is essentially the state-of-the-art. [38, 45-47, 50-54] 
2.4.3 Natural Scaffolds 
A variety of natural scaffold materials for use in a tissue engineered heart valve 
(TEHV) have been investigated. These range from gels comprised of fibrin, collagen, 
gelatin, hyaluronic acid and other glycosaminoglycans (GAG) to decellularized tissues. 
Collagen and fibrin gels exhibit compaction when seeded with mesodermal cells, and the 
compaction of the scaffold can be tuned by altering the matrix protein concentration.[55] 
Additionally, pure fibrin gels have been used to make bileaflet valve equivalents, which 
when cultured in a bioreactor in a valve shaped demonstrate anisotropy and show good 
cellularity through 5 weeks of culture. [56] While these scaffolds show promise for a 
clinical therapy, they suffer from leaflet thinning, are much less stiff than native tissues, 
and lack the intrinsic "bio-inertness" and customization potential of synthetic scaffolds. 
Modified gelatin has recently been investigated as a potential scaffold material for 
TEHV. This modified gelatin shows tunable mechanical properties, controllable porosity, 
biodegradability, and maintenance of valvular interstitial cell (VIC) phenotype 
throughout culture. Additionally, since the gelatin modified with methacrylate moieties 
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(gel-MA), it is possible to photopolymerize the scaffold. These gel-MA scaffolds, 
however are two orders of magnitude less stiff than native tissues.[57, 58] Hyaluronic 
acid based hydro gels have also been investigated as a potential scaffold material. These 
gels are similar in composition to the cardiac jelly present in heart development, can be 
photopolymerized, and have bioactive degradation products, but they too are significantly 
weaker than native tissue, and until recently, there was little control over the degree of 
modification required for crosslinking.[59] Decellularized valve tissues have also been 
explored as a natural TEHV scaffold and take advantage of significant industrial 
development of processing techniques used in the manufacture of bioprosthetic valves. 
Decellularized valve tissues can be fixed to stents, a common practice for bioprosthetic 
valves. These stented valves can easily be loaded into bioreactor systems and subjected to 
dynamic cell seeding environments. [31] Despite the advantages of dynamic seeding, it 
was shown by one group that when using human cells, cellularity in the TEHV remained 
less than half that of native tissues even after 8 weeks of culture. GAGs were deposited 
by the seeded cells; however, it has been difficult to ascertain the degree of matrix 
production by the reseeded cells that are retained in these constructs.[60] Furthermore, 
the decellularization process considerably weakens the construct, particularly in the radial 
direction. Cell seeding and dynamic culture for 16 days allows the recovery of tensile 
strength. [31] While constructs generated from decellularized natural tissues have shown 
in vitro success, they failed quickly and catastrophically when used in vivo in pediatric 
patients.[32] Three patients died (two suddenly), and one patient showed severe 
inflammation within 2 days of the implant. As a result, decellularized tissues are 
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undergoing more extensive laboratory testing to elucidate the root causes of the observed 
clinical failures. 
2.4.4 Polymer Scaffolds 
Biodegradable synthetic scaffolds are the other primary area of TEHV scaffold 
research, and they have been used extensively in a wide variety of applications. Many 
engineered tissues both in development and in clinical use employ this paradigm.[6l] The 
majority of these TEHV investigations have used non-woven fiber mesh or salt-leached 
foam scaffolds generated from polyglycolic acid, poly (lactic-co-g1ycolic acid), and 
po1yhydroxyalkanoates, to-date, hydroge1s have received far less attention for TEHV 
applications.[35, 37,40,51,53] The open structure of the mesh or foam allows cell 
migration throughout the scaffold, and their material properties can be engineered to be 
sufficient for the mechanical environment ofthe valve, which involves flexure, tension, 
compression, and shear varying throughout cardiac cycle. Additionally, these materials 
are degradable and have been FDA approved for many years. However, these materials 
have shown certain limitations, namely their high initial stiffnesses compared to native 
tissues and the substantial length of time required for the polymer to undergo hydrolysis-
governed degradation.[52] Polyhydroxyoctonoate (PHO), when cell seeded and subjected 
to physiologic flows results in functional flexible leaflets, with synchronous opening and 
closing, however, studies by Sodian et al. demonstrated that this material did not resorb 
completely over 4 months, and does not lead to full tissue development.[33, 35, 36, 62] 
Polyglycolic acid (PGA) meshes were also investigated as a TEHV scaffold, and when 
used alone, were far too stiff and thick for functional leaflet creation. [63] Constructs with 
22 
PGA meshes surrounding a nonporous PHO film were successfully implanted in the 
pulmonary position, and showed no thrombus formation when cell-seeded, although 
when acellular meshes were implanted, they constructs developed thrombi.[50] Both 
PGA and poly I-lactic acid (PLLA) have been modified by dip coating with poly 4-
hydroxybutyrate (P4HB) to improve the mechanical properties of these non-woven 
meshes. PGAlP4HB shows appropriate degradation kinetics, however in a study by 
Hoerstrup et al. the valves are regurgitant after 16 weeks of implantation. [34] 
PLLAlP4HB valves are of higher stiffness than leaflets and complete degradation can 
take longer than two years.[53, 64] Both of these materials were shown to have much 
quicker degradation when subjected to cyclic flexure.[53] Furthermore, these materials 
lack intrinsic biological functionalization, meaning that they do not present any 
functional biological moieties that could direct cell signaling, ECM production, or 
enzyme-governed degradation. These materials can be modified to present these motifs, 
however, there is no control over functional molecule localization, in contrast to the 
patterned localization achievable in hydrogels via photolithographic or two-photon 
adsorption methods (described in section 2.5 and Chapters 5 and 6).[65-67] 
Both non-woven fiber mesh and salt-leached foam scaffolds use cytotoxic 
processing conditions to generate their architecture. Since the polymer processing 
conditions are cytotoxic, cell seeding must be performed after the scaffold is fabricated. 
Cell seeding has been one of the most significant challenges in use of these scaffold 
materials. Seeding methods have often resulted in inhomogeneous cell distribution, low 
cell densities, and long seeding times before the scaffold was fully populated. Initially, 
cells were incubated atop the scaffolds under static conditions for up to 4 days in order to 
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allow cell migration into the interior of the scaffold.[34] Dynamic seeding methods were 
developed that yielded homogenous and slightly more efficient seeding, but the dynamic 
nature of the seeding environment was reported to cause small cracks in the scaffold 
material.[68] Encapsulation has been shown to be the most efficient and homogeneous 
method of cell seeding. For example, the use of a viscous fibrin "cell carrier" gel resulted 
in fast, high yield, homogenous seeding of valvular interstitial cells (VIes) into fiber 
matrices. The use of fibrin as the basis for the gel, however, alters the seeded cell's local 
biochemical and biomechanical environment. It does this both through its structure (cell-
substrate) as well changing the diffusivity of the cell's pericellular environment.[43, 69] 
While these previous mesh-based approaches hold promise, the ability to encapSUlate 
cells coupled with the customization potential of polymeric biomaterials makes 
photopolymerizable hydrogels very appealing as scaffold systems. 
2.5 Poly(ethylene glycol) Diacrylate Hydrogels 
Hydrogels are a class of polymer networks that are comprised of hydrophilic 
cross-linked polymer chains. Due to the hydrophilicity ofthe chains, these structures 
swell in the presence of water. Monomers that are in solution undergo anionic, cationic, 
or photoinitiated polymerization methods that yield a solution of uncross linked polymer 
chains. These polymer chains are then modified with a reactive group at the chain ends 
which enable crosslinking.[70] When hydrogels are created for tissue engineering 
purposes, the method of crosslinking a solution of polymer chains is most common, since 
most monomers are cytotoxic.[71] 
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The near infmite biochemical and biomechanical tunability of poly( ethylene 
glycol) diacrylate (PEGDA) hydrogels makes them very attractive potential scaffold 
materials for TEHV. PEGDA hydrogels are intrinsically biocompatible, since the base 
(unmodified) gels are biologically neutral, resist protein adsorption, do not release acidic 
products during their degradation and can be crosslinked with low cytotoxicity allowing 
for high density 3D cell encapsulation. Furthermore, these hydro gels can be modified by 
crosslinking a large number ofbioactive moieties (peptides, glycosaminoglycans, growth 
factors) to achieve a high degree of specific bioactivity.[2, 72, 73] Indeed, it is widely 
reported that peptides tethered to either the surface or bulk phase of PEGDA gels will 
retain their bioactivity after this modification.[74-76] Additionally, since these materials 
can be rapidly photopolymerized, spatial control of functional moieties is possible in both 
2D and 3D, due to the emerging field of two-photon stereolithographic fabrication 
techniques. [66] 
2.5.1 Photopolymerization of Hydrogels 
Photopolymerization exploits the use of a light-irradiated photoinitiator to 
produce a radical initiating species that can create crosslinked hydrogels. 
Photopolymerization has many advantages that establish its value for tissue engineered 
applications. This method offers spatial, temporal, and rate control ofpolymerization.[77] 
The spatial control of crosslinking allows for two and three dimensional patterning to be 
achieved in hydrogel structures with the use of photolithography patterning (PLP) and 
two photon adsorption (TPA).[65, 66, 78, 79] In addition to the high level of control 
realized via photopolymerization, this technique is desirable for use in vitro since 
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crosslinking can be completed quickly without the presence of monomers or organic 
solvents. Polymerization conditions that are sufficiently gentle to allow this procedure to 
be performed in the presence of cells have been achieved. [71] 
2.5.2 Previous Medical Applications of Poly(ethylene glycol) 
The very low toxicity ofpoly(ethylene glycol) (PEG) permitted it to become FDA 
approved, which has been a significant stumbling block for other biomaterials. As such, 
PEG has been used in a variety of medical applications, whose function can often be 
grouped into two major categories: 1) improvement ofbiocompatibility and 2) controlled 
release of a bioactive molecules. When used to improve biocompatibility, PEG is most 
often linked to the surface of another object. This technique is commonly referred to as 
PEGylation, which most typically refers to the tethering of single chains of PEG to a 
surface.[80] There are several commercially available products that use PEG to improve 
local biocompatibility. Vigilon is a hydrogel sheet that is used as a wound dressing to 
improve healing. The use of PEG as a mechanism for rate controlled drug delivery has 
been explored for many years. This schema has been successful in the delivery of both 
proteins and genes.[81, 82] Even though PEG has been used in other medical products, 
PEG hydrogels are only beginning to be explored for use as a TEHV scaffold. 
2.5.3 Mechanical Properties of PEGDA Hydrogels 
The tunable mechanics ofPEGDA hydrogels has been reported in the literature 
and it has been demonstrated that a wide range of material properties can be readily 
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achieved by varying the prepolymer composition. It has been shown that by varying the 
polymer chain's weight fraction, the modulus of elasticity can be altered 
significantly.[75, 83] In the 1 to 10% strain range, fully swelled PEGDA hydrogels have 
been shown to behave with near purely elastic behavior, and no significant difference 
between tensile and compressive moduli was shown.[75] Moreover, it has been 
hypothesized that the elasticity of PEG will enable more efficient transfer of dynamically 
applied mechanical loads to cells than current fiber based scaffolds. Molecular weight of 
the PEG chain is also a significant modifier of the modulus. At higher magnitudes of 
strain (up to 30% in compression), the behavior of hydro gels is nonlinear, and dependent 
on the molecular weight of PEG chains.[84] Although the tensile and compressive 
properties of PEG hydrogels have been investigated, there is little to no work that has 
been reported on the bending and fatigue characteristics of these hydrogels. 
The physical properties of PEGDA gels can be modified across a continuum of 
magnitudes that are biologically relevant in terms of recapitulating both tissue function 
and the pericellular environment. Hydrogel physical properties such as stiffness, degree 
of swelling and effective diffusivity can be controlled by manipulating the molecular 
weight of the macromer, the weight fraction of macro mer in solution and the crosslinking 
time.[85, 86] It has been further demonstrated that crosslinking density affects the strain 
experienced by the cell, and certain formulation parameters can translate nearly 100% of 
bulk strain to individual cells.[83] Cells seeded in fiber mesh scaffolds can be in contact 
with either a singular fiber, or many fibers, which may have varying degrees of 
displacement at the microstructure due to macrostructural strain. Thus, 
mechanotransduction in hydrogels appears to be more efficient than in fiber meshes. 
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2.5.4 VIC Adhesion to PEG 
Valvular interstitial cells are the primary cell type found in the heart valve. VICs 
are myofibroblasts that produce vast amounts of ECM and are contractile. Therefore, it is 
a natural choice to select this cell type when attempting to create a tissue engineered heart 
valve. The ability of PEG to be customized with particular functional groups is also 
desirable to ensure specific cell adhesion and retention. In one of the initial studies 
examining VIC seeding on PEG surfaces (Masters et al.), gels were created with 
covalently linked GRGDS and/or EILDV and VICs were seeded on these surfaces. These 
gels did not show much improvement with respect to adhesion over the unmodified 
PEGDA hydrogels.[l] In an effort to improve adhesion and cell morphology on 
hydrogels in a later work by Cushing et al., PEGDA gels were fabricated with both the 
RGD adhesive ligand as well as methacrylated heparin. VICs seeded on these gels did not 
show a significant increase in adhesion, however there were pronounced morphological 
and phenotype differences. The VICs seeded on heparinized gels had a more spread 
shape and significantly higher levels of uSMA expression. This behavior was shown to 
be specific to heparin and dose dependent.[2] Since these gels have been shown to 
support VIC adhesion and growth, as well as having high potential for mechanical and 
biochemical modification, they are a natural choice for investigation as a TEHV scaffold. 
Recent work investigating other hydrogel materials (including methacrylated gelatin and 
hyaluronic acid) has shown promise for the maintenance and proliferation of VICs, 
however these materials are not fundamentally inert (in contrast to PEG-based hydrogels) 
and therefore can influence cell behavior in unexpected ways. Additionally, it is more 
difficult to modify the material properties of these gels across a continuum, since the 
molecular weight of the prepolymer is not directly controllable.[57, 87] 
2.5.5 Advanced Hydrogel Structures and Strategies 
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In addition to being able to modify bulk PEGDA gels biochemically and 
biomechanically, the ability to photopolymerize these materials permits the fabrication of 
advanced structures. Since the prepolymer can be crosslinked via radical initiating 
species, patterns can be crafted in the gel with unique geometries. Photolithographic 
patterning, as described by Hahn et al. can be used to craft a variety of two dimensional 
patterns.[65, 78] Furthermore, using rapid prototyping methods (two-photon adsorption 
based stereolithography), 3D patterns can be created within the gel.[66] These structures 
can result in the creation of anisotropy in what is fundamentally a linearly elastic, 
isotropic material. Other groups are investigating inducement of anisotropy in hydrogels 
by application of strain while polymerizing (using freeze-thaw crosslinking)[88], control 
of secondary crosslinking by patterning [89], and direct embedding of fibers [90, 91], 
however, many of these methods prohibit the direct encapsulation of cells. 
Layered hydrogel structures have been investigated in a range of hydrogel 
materials, exploiting a variety of "lamination" strategies. Several groups have 
demonstrated the ability to create quasilaminate hydrogel structures where each layer is 
composed of the same material and formulation.[79, 92, 93] Temenoff et al. was the first 
to demonstrate the ability to laminate hydrogels with distinct formulations in each layer, 
and was able to demonstrate a strong interface by using thermal crosslinking.[85] While 
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quasilaminate hydrogels have been successfully fabricated by labs in the past, no one has 
demonstrated the ability to create a quasilaminate layered structure with distinct 
formulations in each layer in a photocrosslinked system. 
2.6 Bioreactors 
Tissue engineering has had limited success in attempts to regrow tissues that can 
withstand the mechanical demands of the in vivo environment.[94] This failure could be 
due to the original tissue engineering paradigm, which was the combination of cells, three 
dimensional scaffolds, and exogenous agents. Recently, studies have shown that 
mechanical stimuli playa very large role in the architecture of tissues.[95] As a result of 
these findings, various bioreactor systems have been designed to apply specific 
mechanical stimuli to constructs. These systems have a vast range of complexity and 
capability. Several bioreactor systems have been designed for heart valve tissue 
engineering. These include strain-based systems, flexure based systems, and flow loops. 
The majority of these systems are flow loops that approximate the behavior of the 
ventricle, and permit the engineered tissues to be cultured under a wide variety of 
conditions. 
2.6.1 Single Phenomena Systems 
A system to evaluate scaffold materials and their use in TEHV was designed by 
Englemayr et al. (Figure 2.6).[52] This system is a device that will apply dynamic three 
point bending to strips of scaffold material. The rationale for its design is that by isolating 
30 
a particular source of mechanical stimuli, a greater understanding of the effect can be 
achieved. This system has been used to test the fatigue properties of acellular PGAlP4HB 
and PGA:PLLAlP4HB. Substantial decreases in stiffness were observed for scaffolds that 
were dynamically flexed in comparison with controls. This fmding substantiates the 
hypothesis that fatigue may significantly accelerate weakening of the construct in a 
culture environment. This system is useful for preliminary material research, although, it 
cannot be used for valve shaped constructs. 
Figure 2.6: System to apply cyclic flexure to strips of scaffold material.[52] 
2.6.2 Complex Environment Systems 
The vast majority of bioreactors designed for use in heart valve tissue engineering 
have been flow loops. These systems (Figure 2.7) range from simple systems to 
approximate the pumping of the left ventricle to very complex setups that include 
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variable resistance and the ability to maintain long-term sterile culture.[33, 96-98] Flow 
loop systems, while robust, require complicated controls and do not easily scale to allow 
for higher sample size studies. 
Figure 2.7: Flow Loop systems for aortic valve culture. A) Simple flow loop with 
approximated left ventricle. B) Complex flow loop with automatic resistance control.[33, 
96] 
The last type of existing bioreactor for use in tissue engineered heart valves is the 
diastolic pulse duplicator (Figure 2.8). The aortic valve experiences maximum stresses 
during the diastolic phase, and this system was designed to replicate that phenomena. The 
system exploits the use of low flow rates (sub-physiologic) in the early stages of 
stimulation. It further develops the idea of strain based conditioning of TEHV constructs, 
and is modular for scalability. Ultimately, implementation of this system is complicated 
and setup is time consuming.[42] 
Figure 2.8: Diastolic pulse duplicator that allows high numbers of replicates per 
system.[42] 
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Tissue engineered heart valves have yet to be successful in the aortic position 
regardless of the methodology employed. The most appropriate material for TEHV has 
not been identified, due to the complex mechanical environment that these scaffolds must 
endure. Furthermore, the necessary biochemical and biomechanical cues for in vitro 
development of a TEHV are not yet fully known. We believe that since passive, inert 
prostheses have shown clinical success in valve replacement for over 40 years, and that 
structural valve degradation significantly reduces the useful life of inert bioprosthetics, 
the mechanical characteristics of the TEHV scaffold are of primary importance. Without 
adequate material properties, any TEHV will fail when implanted. Furthermore, it has 
been clearly demonstrated in the literature that biomechanical conditioning (with the goal 
of driving tissue formation) is necessary for any TEHV prior to implantation. In the 
following chapters, a system that can provide biomechanical stimuli to explanted tissue 
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or engineered aortic valves is detailed (Chapter 3), and the ex vivo culture of valves in 
this system is described (Chapter 4). Using criteria obtained from these studies, an 
optimization and characterization of the flexural properties of a range of PEGDA 
formulations is explained (Chapter 5). The flexural properties determined in those studies 
drove the interest in creating anatomically-inspired composite hydrogels, which are 
described in Chapter 6. 
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Chapter 3: Design and Physical Characterization of a 
Synchronous Multivalve Aortic Valve Culture System· 
For many tissues, cyclic mechanical stimulation is necessary to maintain the normal 
morphology in vitro. This need motivated the design of a simple, scalable aortic valve 
organ culture system capable of medium-term (more than 2 weeks) culture of native and 
engineered aortic valves. The system consists of three pistons in separate cylindrical 
chambers that are simultaneously driven through the culture medium by a crank and~ 
cam assembly. The faces of these pistons have unidirectional valves mounted in opposing 
orientations that permit flow from one side of the face to the other. A custom designed 
stent was employed to secure either native or engineered trileaflet valves to the pistons. 
Computational fluid dynamics and finite element modeling was used to assist selection of 
materials and components in the system. Finally, sterility testing using base culture 
medium was performed to verify the ability of the system to retain sterile conditions. The 
current design permits the cyclic opening and closing of three aortic valves, however this 
device can be modified to accommodate up to 12 valves simultaneously. This chapter 
• This majority of this chapter was published as: Durst CA, Grande-Allen KJ. Design and 
physical characterization of a synchronous multivalve aortic valve culture system. Annals 
of Biomedical Engineering, 2011 Jan; 7(1):75-82. 
will discuss the physical design and performance characterization of the system and 
effects of culture in this system will be discussed in Chapter 4. 
3.1 Introduction 
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The aortic valve consists of three leaflets continuous with three aortic sinus walls 
and is located between the left ventricle and the aorta. It functions as a one-way valve, 
allowing oxygenated blood to flow from the left ventricle to the aorta. The normal in vivo 
mechanical loading of aortic valves is responsible for varied biosynthetic responses of 
valvular cells and heterogeneous distribution of extracellular matrix throughout the 
leaflets.[99] For example, protein and glycosaminoglycan synthesis is greater at locations 
in the leaflet demonstrating the greatest functional stresses. [100] Furthermore, 
mechanical stimulation has been shown to be necessary for the maintenance of tissue 
phenotype as well as regulating matrix synthesis for a variety of tissues when cultured in 
vitro. [101-103] Cultured valve leaflets respond to hydrostatic pressure in a magnitude 
dependent manner by altering their sulfated glycosaminoglycan (sGAG), collagen, and 
DNA contents.[104] Similarly, engineered tissue surrogates containing valvular 
interstitial cells (VICs) react to cyclic stretch in a reversible manner by altering their 
GAG and proteoglycan production.[105] The need to improve our understanding of the 
true role that mechanical stimuli play on the extracellular matrix of the aortic valve has 
motivated the design and creation of the in vitro mechanical environment. The effects of 
varied mechanical stimuli on valves have only been studied in the past few years, and 
further investigations in this area will have far ranging impacts from advancing 
knowledge of basic valve biology to understanding valve disease progression. 
Mechanical stimulation culture systems have wide utility not only as systems to study 
models of valve disease and remodeling, but also for use in the development of tissue 
engineered heart valves. 
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A number of bioreactor systems have been designed to provide physical stimuli to 
engineered aortic valve tissues. These systems vary greatly in complexity, from very 
simple models that provide an isolated mechanical stimulus[52, 105] to very complex 
flow loops with automated resistance and feedback controls. [42, 96, 97, 106] Engelmayr 
et al. have detailed a system that allows the application of flexure thereby elucidating the 
effect of the mechanical stimulus.[52] In contrast, the flow loop described by Hildebrand 
et al. allows robust control over the physiologic environment, with control of both 
pressure and flow rates, which are achieved with computer controlled pumps and flow 
resistors.[96] Previously developed bioreactors and flow loops each serve a specific 
purpose and are well-characterized in the literature,[33, 42,52,96,97, 105, 106] 
however, these systems generally fail to address the need for a simple, scalable design. 
The newly developed bioreactor described here lacks the robust level of control achieved 
in the most complicated flow loops, but can be easily scaled to allow a large number of 
valves to be cultured in pseudo-physiologic conditions. The design objectives of this 
aortic valve culture system were simple operation, high efficiency multi valve culture, 
low-cost, and a sterile culture environment. 
3.2 Physical Design of Bioreactor System 
The custom designed bioreactor system provided mechanical stimulation to aortic 
valves through a cyclic opening and closing action (Figure 3.1). This action, caused by 
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fluid flow, was accomplished by raising and lowering a piston containing a securely 
mounted aortic root through culture medium. Motion was achieved using a Parker 
BE233FJ servo motor (Parker Compumotor, Rohnert Park, CA) coupled to a 25:1 
planetary gearbox (Parker Compumotor, Rohnert Park, CA), which in turn drove a cam-
crank (cam diameter 9.0 cm) assembly. The servo motor was chosen for its capacity for 
high torque (4.48 Nm) in a relatively small frame (5.7 x 5.7 x 14 cm, 1.9 kg). This servo 
provided sufficient torque to operate the system across a range of 0-11 0 equivalent BPM. 
The crank was attached to a cross-member (40 x 2.54 x 6.35 cm), which can slide in one 
dimension along two hardened steel alignment shafts. The drive components (cam, crank, 
cross-member) were made of 316L steel for high corrosion resistance as well as 
durability and low deformation under continuous load. The structural components of the 
bioreactor were made from anodized 6061 aluminum, chosen for its combination of low 
weight, strength and corrosion resistance. By varying the crank length and shaft speed of 
the motor, stroke volume (651 mL) and frequency (0-110 BPM) were controlled. For 
example, with the current cam and crank, a flow rate of 5 Llmin was be achieved with a 
cam speed of7.7 rpm. The system has been run at 5 rpm resulting in 3.3 Llmin of flow 
through the valves. These flow rates were comparable to the current state-of-the-art flow 
loop described by Hildebrand et at. [96] With a simple Pouiselle flow-based calculation, 
we determined that shear stress on the ventricular side of the leaflets was approximately 
0.249 dynes/cm2. With no modification to the system, it can deliver shear stresses of up 
to ~0.4 dynes/cm2. This is substantially lower than physiologic shear stresses (up to -80 
dynes/cm2 during systole), and ifit becomes apparent that application of physiologic 
shear stress is necessary for ex vivo maintenance, other strategies such as increasing the 
system viscosity with dextran could be used to increase imparted shear stresses. [1 07] 
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Motion of the three valve-containing pistons ensured that the valves open and 
close during each cycle (Figure 3.1). The piston formed a tight seal with the wall of the 
culture chamber to ensure all flow was through the valve. The piston faces were attached 
to the driven cross-member with steel shafts and a double seal was used at the 
air/chamber interface. The piston faces were machined from polycarbonate and were able 
to be autoclaved with the connecting shafts partially assembled. Each piston had one 
tissue valve mounted for flow in the positive z-direction, and one mechanical valve 
(Carbomedics, Austin, TX) mounted opposite to the tissue valve to allow flow in the 
negative z-direction. 
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Figure 3.1: A) Photograph of assembled prototype system. 8) Photograph of assembled 
final design, showing revised drive assembly. C) Computer model of system configuration 
for six valves. D) Computer model of system showing revision to allow culture of up to 
twelve valves. System width is approximately forty cm. 
A method of securing the aortic valve to the piston was established by adapting a 
concept put forth by Hildebrand et al. [96] An aortic root (prepared as described in the 
following paragraph) was sutured to a custom designed stent-like device (Figure 3.2), 
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which consists of three arms, each containing holes that allow a swaged suture needle to 
pass through. These holes were curved to match the radius of curvature of a 2-0 suture 
needle. Due to the complex geometry of the arms, this stent was fabricated using 
stereolithography (Laser Reproductions, Columbus, OH) from a high temperature 
nanoparticle filled polyurethane resin (Nanoform 15120, DSM Somos, Elgin, IL) to 
ensure both sufficient mechanical and thermal stability at high temperatures (autoclave 
121°C). The base of the stent contained a recess for a silicone rubber gasket (thickness 
0.125") that ensured a tight seal between the piston and aortic root. 
... 
ligated coronary artery 
Figure 3.2: A) Custom designed stent (left) and gasket (right) to secure the aortic root to 
the piston face (1.25 x 1.5 in dia x height) B) Porcine aortic root secured to stent with 
polypropylene sutures. 
The dissection and preparation of the aortic root allowed the tissue to be 
efficiently loaded into the organ culture system with minimal contamination for cyclic 
culture. First, the root was grossly dissected from porcine hearts obtained from a local 
abattoir. The root complete with valve was rinsed in PBS containing 2% 
antibiotic/antimycotic for 15 minutes. Next, the coronary arteries were ligated, and the 
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root is then sutured to the stent using 2-0 Prolene sutures (Ethicon, Cincinnati, OH). After 
the root had been secured to the stent, the ventricular annulus was sutured to the silicone 
gasket. The aortic valve/stent assembly was then locked into the piston face with spring 
clips (Figure 3.3). This valve was mounted to allow flow in an opposite direction to a 
permanently installed bileaflet mechanical valve (Carbomedics 19 mm aortic valve, 
Sulzer Carbomedics, Austin, TX). The oppositely oriented valves both function in one 
direction only, thereby ensuring that flow proceeded entirely through one valve per half 
revolution of the cam. During the first half of the cam revolution (the "downstroke"), 
culture medium was be present on both sides of the piston surface and flowed from the 
bottom portion of the culture vessel to the top. Once the second half of the revolution 
began (the "upstroke"), the mechanical valve opened, the tissue valve closed, and fluid 
flowed from the top portion of the culture vessel to the bottom. 
The pistons were located inside the cylindrical culture chambers, each of which 
was filled with 1.3 L of culture medium (Dulbecco's Modified Eagle's Medium (DMEM) 
supplemented with 2% antibiotic/antimycotic solution and 10% bovine growth serum 
(BOS); Mediatech, Manassas, VA and Thermo Scientific, Waltham, MA 
respectively).[108] The culture chambers were sealed by a rubber plug with an in-line 0.2 
Ilm syringe filter that allowed adequate gas exchange. Silicone o-rings were used to 
create a seal between sterile, fluid-filled areas and non-sterile areas of the bioreactor. 
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Figure 3.3: Assembled piston containing mechanical and porcine valves. 
3.3 Computational Analyses 
3.3.1 Computational Fluid Dynamics 
Computational models were used to investigate the forces due to fluids contained 
within the cylindrical culture chambers, which ultimately guided the selection of 
materials and the servo motor. Basic computational fluid dynamic (CFD) models of each 
direction of flow were performed using a simplified culture chamber in Floworks 
(Solidworks Corporation, Concord, MA), which will approximate solutions to Navier-
Stokes equations under specific boundary conditions and initial values. Models 
representing several states of the system were developed. In state I, an open 19 mm 
Carbomedics aortic valve was modeled, and the porcine valve was assumed to be 
completely closed, with no leakage between chambers. The flow was modeled as an 
internal flow (Q=O.193 Lis), with static pressure (761 mmHg) and flow rate input as 
43 
boundary conditions. This flow rate was chosen to be more than two times higher than 
physiologic or roughly 2.5 times what would be used experimentally[109] in order to 
generate a "safety factor" for load presented to the motor and to prevent material failure. 
Additionally, this state was modeled as an adiabatic system, and water was used as the 
test medium. Average transvalvular pressure was measured from areas on either side of 
the valve where laminar flow was observed (Figure 3.4A). In state 1 this value was 
approximately 61.658 mmHg. The highest normal force due to fluid resistance in state 1 
was 168.087 N. This system was recalculated in state 2 of the model-in which the 
porcine valve was open, and the mechanical valve was closed (Figure 3.4B) but 
conditions were otherwise identical to state 1. It was assumed that the orifice area of the 
porcine valve was identical to the aortic cross-sectional area, and the mechanical valve 
was completely closed with no leakage. Both average transvalvular pressure and normal 
force on the piston were lower in state 2 - 18.394 mmHg and 28.484 N respectively. 
Based on the calculated normal force exerted on the piston face, materials were selected 
to ensure consistent mechanical performance under load. An estimate of the maximum 
torque required to complete a stroke was calculated from the state 1 data, and was 
subsequently used in selection of the servo motor and gearbox. 
Dynamic 
Pressure 
(mmHg) 
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Figure 3.4: A) Pressure in the system calculated using a simplified model in Floworks 
(mechanical valve open, porcine valve closed). B) Pressure in the system calculated using 
a simplified model in Floworks (porcine valve open, mechanical valve closed). 
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3.4 Finite Element Analysis 
Results obtained from CFD studies were entered into a finite element analysis 
(FE A) of the behavior of the system under loaded conditions. The maximum calculated 
normal force on the disc was applied to a simplified internal model of the piston 
assembly. Material parameters for polycarbonate and steel were obtained from ASTM 
specifications provided by the supplier (McMaster-Carr, Atlanta, GA) and input into the 
model of the piston face and the connecting threaded shaft, respectively. The steel shaft 
was assumed to be fixed, which was used as a boundary condition. Von Mises stress and 
material deformations for these components were then calculated. Upon analysis of the 
von Mises stress resulting from a normal force on the piston face of 168.087 N, it was 
determined that the interface of the steel and polycarbonate threads resulted in an 
unacceptably high value, and would likely crack during loading. A design revision was 
made using a steel washer to distribute the load, and then fix the axial location of the disc 
with a steel nut. This revision was modeled and the system was recalculated. This 
revision minimized the von Mises stress to more than an order of magnitude below the 
yield strength ofp01ycarbonate (71-120 MPa, Figure 3.5). Deformation of the disk was 
also investigated since the alignment of the system is crucial to ensure no stiction 
between the circumferential surface of the piston and the inner wall of the culture 
chamber. There was no detectable bending deformation at modeled loads of the disc 
therefore the design was deemed acceptable. 
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Figure 3.5: Von Mises distribution of internal stresses in piston assembly demonstrating 
maximum stress is more than an order of magnitude under the yield stress of the material. 
Bearing lock-up was observed frequently when evaluating the prototype design 
(Figure 3.1A). In response to these problems, CosmosWorks (Dassault Systemes, 
Concord, MA) was used to analyze displacement and deformation of drive components 
using a finite element model of the system throughout a complete revolution of the cam. 
First, the peak torque required as a function of the stroke was calculated using a motion 
study with a 1 RPS shaft speed. The system was then virtually "assembled" in this 
configuration and deformation and displacement studies were performed. It was observed 
that purely due to the size of the link, placement of the cam, and location where these 
parts were pinned, there was a significant bending moment placed upon the sliding plate. 
The system was redesigned to increase the length:diameter ratio .spanned by the bearings 
on the alignment shaft. Additionally, the link was thickened from 0.25 to 0.5 inches and 
the location for pinning to the sliding plate was changed to be located in the center, rather 
than on the face of the part. Lastly, the cam' s diameter was reduced to decrease the force 
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exerted on the drive assembly. This new design (Figure 3.1B) was then subjected to the 
same analysis in Cosmos Works, where the maximum resultant displacement was 
observed to be reduced from 0.075 to ~0.035 mm (Figure 3.6). 
Figure 3.6: Resultant deformation plot produced (11 OOX magnification scale) by 
CosmosWorks, indicating peak deformation of ..... 20 11m in sliding components. Color scale 
is blue = 0 11m, green = 15 JIm, red = 30 11m. 
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3.5 Sterility Challenge 
The final design criterion was that the system provide a sterile culture environment 
for valves throughout the duration of stimulation. Thus, all developed components of the 
bioreactor are able to be steam sterilized. After all components of the bioreactor are 
removed from the autoclave, the system is assembled in a laminar flow hood using 
autoclaved tools and sterile gloves. The ability of the bioreactor system to provide a 
sterile culture environment was tested by filling the chambers with culture medium, 
placing the system in a humidified incubator (37° C with 5% C02), and enabling the 
drive. No valves were mounted in the system for the purposes of sterility evaluation. 
Medium samples were taken at one, two and four days and were plated on agar gels. Gels 
were inspected visually for colony formation at seven days post inoculation. No colony 
formation was observed indicating that no contamination of the culture environment 
occurred. Subsequently, the system has been run for up to 3 weeks (10 bpm, 4.2 Llmin) 
with porcine valves loaded, and no visible signs of contamination have been observed. 
3.6 Potential Directions and Future Studies 
Scalability was a major motivating factor in the design of this system; therefore, the 
described organ culture system can easily accommodate six tissue valves. In order to 
accommodate large sample sizes, the mechanical valve can be replaced with another 
tissue valve, wherein each culture chamber would have two biologic valves mounted in 
opposite directions, thus permitting cyclic stimulation of six valves per bioreactor (Figure 
3.1 C). Furthermore, with the addition of a twin-output gearbox and an additional three 
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culture chambers, this system will permit the culture of up to 12 tissue valves per run. 
This configuration has a small footprint (40 x 40 cm) for the number of samples, and 
even with a doubled number of culture chambers will still fit on a standard incubator 
shelf (Figure 3.1D). Furthermore, since the system is primarily composed of primarily 
two-dimensional parts, rapid fabrication of the components can be achieved using either 
waterjet or electrical discharge machining techniques at very low cost. Since its design, 
this system has been evaluated for its ability to maintain the normal state of valves ex 
vivo (described in Chapter 4). This system also will find utility for the study of tissue 
engineered heart valves, most likely at first with the fiber-mesh based technology 
employed by many labs pursuing TEHVs [33-37,41-48,50-54]; however, the design can 
be adapted to accommodate any current trileaflet TEHV scaffold, including the variety of 
hydrogel based scaffolds being pursued. [1 , 2,57,69,87,88,90, 110-113]) Finally, this 
system will fmd use as an organ culture system to elucidate the effects of specific 
biochemical agents on trileaflet valve biology and tissue remodeling, analogous to the 
studies on the mitral valve described in the thesis of Gheewala. [98] This wide range of 
bioreactor applications thus has implications for both the study of valve pathologies as 
well as the tissue engineering of heart valves. 
3.7 Conclusions 
The design of the system evolved as prototypes were fabricated and empirical 
results on system performance were obtained. The initial design of the system allowed 
the bearings to freeze, which ultimately resulted in sheared or bent parts. This failure was 
due to two design flaws. First, variability between the porcine valves meant that slightly 
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different forces were exerted on the sliding plate as a result of resistance in each culture 
chamber, resulting in an unbalanced load. Second, the prototype of the system did not 
have an optimal design to prevent bearing lockup in sliding and the pinning geometry 
contributed to an unbalanced bending moment. This failure was examined by studying 
the system using the CosmosWorks software package, thus leading to the redesign of the 
pinning geometry and location of alignment shaft bearings. After the new design was 
tested in the software package, the system was fabricated and run for 3 weeks, with no 
lockup problems observed. 
The design of a simple bioreactor system that can perform both organ culture and 
tissue engineering duties has yet to be realized. Many designs exist, but are inadequate 
for the design objectives listed here due to complicated mechanical designs, high 
implementation costs, lengthy setup times, low sample numbers, and complicated loading 
procedures. Flow loops offer the most precise control over culture conditions due to their 
use of pulsatile pumps and closed-loop feedback systems (both pressure and flow rate), 
however these systems require custom software to be created. These sorts of feedback 
systems require nontrivial software to both acquire and process signals before integrate 
them into meaningful changes in the pump's output. Furthermore, pulsatile pumps are 
more complicated than rotating shafts to design and maintain. Lastly, this system is the 
first to allow rapid loading of aortic valve roots due to the use ofthe spring-locked stent. 
This system can be pre-assembled and left under UV light in a BSC before dissection of 
the tissue. Since the system does not need to be completely disassembled to load the 
samples, it can be loaded and operational in minutes after tissue dissection. 
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The bioreactor presented here is simple to replicate, has the ability to scale to 
accommodate varying sample sizes, and uses very simple drive and control mechanisms. 
Limitations of this system include the lack of robust flow control and feedback systems, 
the requirement that all valves are subjected to the same stroke volume and flow rate, and 
imprecise waveform control. Improvements to controls could incorporate the inclusion of 
pressure or flow-based feedback sensors that would allow the servo to adjust the motion 
profile to achieve a desired physiologic condition. Furthermore, this system requires large 
volumes of media and an entire half-height incubator to run. Nonetheless, potential uses 
for a simple, scalable aortic valve organ culture system are wide ranging and the 
presented system will find many applications for study of valve biology and tissue 
engineering. In the subsequent chapter, the biological validation of this system will be 
described. Evaluation of the effect of the dynamic environment on porcine aortic valves 
cultured in this system helped determine if the imparted pseudophysiologic dynamic 
regimen was suitable for the ex vivo maintenance of aortic valve tissues. 
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Chapter 4: Phenotypic Evaluation of Aortic Valve 
Tissue Cultured in Synchronous Bioreactor System 
4.1 Introduction 
Mechanical stimulation has been shown to be necessary during in vitro culture to 
promote or maintain the normal phenotype of a variety oftissues.[114, 115] Furthermore, 
many engineered tissues show better functional, anatomical, or mechanical development 
when subjected to sub- or near-physiologic mechanical cues.[53, 54, 102, 105, 116-118] 
Organ culture systems (also frequently referred to as bioreactors) are one such method of 
imparting mechanical stimuli to both engineered and ex vivo native tissue. Organ culture 
has emerged as an exciting method for the study of tissue biology, since normal tissue 
architecture can be readily maintained as in an in vivo configuration, while having a 
culture environment that is more controlled than it would have been in an animal model. 
In contrast with monolayer or engineered tissue studies, organ cultures allow a 
much closer mimic of native tissue environment, since they enable 3D culture and the 
application various mechanical stimuli. Furthermore, the high cost, ethical concerns, and 
potential variability of animal studies can be substantially mitigated by the use of organ 
culture. Organ culture has been applied to a wide variety of cardiovascular tissues, 
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including mitral and aortic valves. [96, 98, 115, 119, 120] Most organ culture systems, 
however, have been used for short durations (usually 24,48, or 96 hours) or non-sterile 
investigations of tissue mechanics.[97, 103, 104, 109, 121-124] However, culture of 
portions of the valve leaflet has been performed for longer durations (up to fourteen 
days).[116] The system designed in the course of this research (as described in Chapter 3) 
has been shown to provide sterile culture well past the previous 48-hour mark and has 
scalability to accommodate large sample sizes with low cost and low experimental setup 
time. In the previous chapter, the design and physical characterization of a novel piston-
based bioreactor system for synchronous stimulation of aortic valves was described. In 
this chapter, the effect of cyclic mechanical stimulation on the tissue phenotype of aortic 
valves cultured in this system for up to fourteen days is detailed using mechanical, 
biochemical, and histological evaluations. 
4.2 Study Design and Statistical Methods 
In order to determine the effect of dynamic culture of porcine aortic valves in the 
designed bioreactor, three groups were prepared. Porcine valves were chosen due to their 
anatomic similarity to human valves and the relative ease of acquiring sufficient samples 
(in comparison with human valves). Two experimental groups, static culture and dynamic 
culture, were compared with a control group of freshly excised tissue. This setup allowed 
the establishment of "baseline" values of the experimentally measured parameters for 
native valve tissues that could be used to benchmark the effect of ex vivo aortic valve 
leaflet culture. Using these groups, pairwise comparisons elucidating the relative effect of 
static culture vs. dynamic culture could be determined as well as the changes from 
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nonnal tissue. One leaflet per aortic valve was retained for circumferential 0( ~ 
histology, leaving the other two leaflets for mechanical 
testing and biochemical evaluations. The leaflets used for 
mechanical testing were cut into circumferential strips and 
sUbjected to flexure testing or tensile testing. After 
Figure 4.1: illustration of 
leaflet showing direction 
of strips taken for 
mechanical testing. 
mechanical evaluation, the leaflet strips were enzymatically 
digested and subjected to biochemical evaluation of the ECM components. Sample sizes 
were calculated using an on-line statistical power calculator[125], with detectable change 
set at 40%, assumption of sample population standard deviation set at 25% (calculated 
from literature investigating flexural stiffness of bioprosthetic and native A V) and power 
threshold set at 80%.[126, 127] This level of detectable change was calculated from 
reported stiffness values from mechanical testing studies of aortic valve leaflets. [108] 
Statistical analyses of quantative and semi-quantative data were perfonned using JMP 
(SAS Software, Cary, NC). Where appropriate (flexural & tensile stiffness, biochemical 
analyses), either one- or two-factor ANOVA was perfonned and data was fit to a least 
squares model. Sample group means were compared with post-hoc Tukey-Kramer HSD 
(Honestly Significant Difference) or Dunnett's comparison with control where a=0.05. 
When significance was not seen, but the p value was less than 0.2, it was commented on 
as a trend. When data was non-nonnally distributed (semi-quantative IHC analyses), 
ordinal logistic regression was perfonned simultaneously to Kruskal-Wallis tests to verify 
the consistency of results obtained from Kruskal-Wallis tests. Ordinal logistic regression 
did not show differences from Kruskal-Wallis tests, therefore post-hoc means 
comparisons were carried out with Wilcoxon or Steel Methods (non-parametric pairwise 
means comparisons, all pairs or with control, respectively). When represented visually, 
data is expressed as mean ± standard error. 
4.3 Bending Tester Design 
One of the primary objectives of this thesis work was to evaluate the flexure 
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stiffness of hydrogel materials in comparison with native tissues in order to determine 
their suitability as a tissue engineered heart valve scaffold, since hydrogel flexure was 
unreported. In order to measure the flexure properties of native tissue and hydrogel 
samples, a three-point bending tester was designed. Before testing hydrogel materials 
(described in Chapter 5), native leaflets were tested to establish design criteria for the 
hydrogel scaffolds. For the organ culture phase of the research, the tester was also used to 
investigate the effect of the dynamic (bioreactor) culture environment on the bending 
properties of aortic valve leaflets. The design of the bending tester and general method of 
bending stiffness calculation is described here. 
A custom fabricated bending tester (design adapted from Gloeckner et at.) was 
used to conduct 3-point bending tests on tissue samples (Figure 4.2 and Figure 4.3).[126] 
The physical design of this system was performed in conjunction with two undergraduate 
students, Alex Brewer and Steve Xu. Further detail of the design evolution of this system 
can be found in Appendix I. This system consists of a stepper motor (Figure 4.2A) 
coupled to a micropositioner (Figure 4.2B, Newport SM-13), which was fixed to a linear 
stage (Figure 4.2C, Newport 460A) that together allowed 13 mm of total system linear 
displacement. Motion of the system was achieved through a custom LabView program 
that allowed control of the system displacement, acceleration, deceleration, and strain rate 
via RS-232 communication to the stepper controller (Figure 4.4). 
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The system was visualized with a varifocallens (Computar Ganz, Commack, NY) 
mounted to a CCD camera (DFC 320, Leica Microsystems, Bannockburn, IL) that 
captured images every 25 ms using Image-Pro Express (Media Cybernetics, Bethesda, 
MD). Optical tracking was used to detect sample deformation and the location of the 
loading and reference rod. Deformation tracking was achieved by sifting small graphite 
particles onto the top of the sample with a grid mesh, reference rod and a calibrated 
flexure bar (Figure 4.3).[52] Since the stiffness of the flexure bar was known, by 
calculating its displacement relative to a fixed reference point (reference rod) the force 
applied to the sample could be determined (Figure 4.5).[128-132] 
Bending stiffness of all samples was calculated by application of Bernouilli-Euler 
beam bending theory. This bending theory has been routinely used to measure the 
stiffness of heart valve prostheses and tissues.[52, 58, 126, 127, 133-139] The 
characteristic assumptions of Bernoulli-Euler beam bending theory include the following: 
1. The beam is in pure bending, with no shear force or torsional or axial loading. 
2. The material is isotropic and homogeneous. 
3. The material is linearly elastic. 
4. The beam is straight with a homogenous cross section. 
5. The beam has an axis of symmetry in the plane of bending. 
6. The proportions of the beam are such that it will fail by bending rather than 
crushing, wrinkling, or buckling. 
7. Cross sections of the beam remain in plane (no shear) during bending. [140] 
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While heart valve leaflets do not satisfy all of these characteristic assumptions 
(particularly number 2), this model has successfully been applied to aortic valve tissues 
and biomaterials.[52, 58, 126, 127, 133-139] Shearing of cross sections is neglected in 
Bernoulli-Euler theory, and Timoshenko theory would account for this shearing of beam 
cross-sections. Application of Timoshenko theory may ultimately be needed for thicker, 
laminate structures; however results would no longer be directly comparable with the 
literature if this analysis model is chosen. 
Figure 4.2: Isometric view of bending tester. Stepper motor (A) is coupled to a 
micropositioner (B), which is mounted to a linear stage (C) resulting in system linear 
displacement capability of 13 mm. Other loading rigs permitting various sample 
thicknesses and widths can be seen in the background. 
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Figure 4.3: Top-down view of AV leaflet loaded into bending tester. Letters denote (A) 
reference rod, (8) flexure bar, (C) loading posts. Leaflet is supported by loading posts and 
can freely slip, so rotation can occur (no tensile load applied). 
Input Controllers output Monitors 
Figure 4.4: Software interface for controlling bending tester. Total system displacement is 
input (in mm), along with shaft velocity (in counts per minute) and acceleration. 
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TOP 
reference 
Figure 4.5: Illustration showing the use of a calibrated steel bar to measure load applied to 
a sample in three point bending. The flexure bar bends and the relative displacement to 
the reference rod is recorded. 
A custom Matlab program, adapted from digital image correlation code by Chris 
Eberl et al., was used to track the locations of markers applied to the sample, flexure bar, 
and reference rod (data processing script available in Appendix VII). [141] After 
determining X -Y coordinates for the markers on the sample, a least -squares regression to 
a quadratic line was performed to quantify the deformation of the sample in each image. 
Equation 4.1: Quadratic line equation. . 
y = ax2 + bx + c 
U sing derivatives of this line, the curvature of the sample was calculated using the 
following equation: 
Equation 4.2: Curvature equation. Y is the quadratic fit. 
y" 
k=----~3 
[1 + (y')2]2 
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The deflection of the calibrated flexure bar was also determined from each image and 
used to calculate the force applied to bend the sample. The maximum radius of curvature 
used was 4 mm, which corresponded to a maximum applied force of -12 mN. It is 
important to note that in all samples (native tissue, single layered PEGDA, and 
quasilaminates), this resulted in large deformations, for which neither Bernouilli-Euler 
nor Timoshenko analysis account. The moment was then calculated using reaction forces 
at the arms: 
Equation 4.3: Moment equation. M Is moment, Fx and Fy are the x and y components of the 
applied load, respectively and x and yare the orthogonal distances from the pOint of 
applied force to the loading posts. 
Finally, the calculated moment and sample deformation were used in the Bernoulli-Euler 
moment curvature relationship, and the effective stiffness of the sample was calculated 
(Figure 4.6). 
Equation 4.4: Bernouilli-Euler moment curvature equation, where Eeff is stiffness, I is 
moment of inertia, and K is change In curvature (Equation 4.2). 
where the moment of inertia of a beam in bending is used (the thickness of the sample is 
greater than 111 oth of the length) 
Equation 4.5: Moment of Inertia equation, where t is sample thickness and w is height. 
Rearranging the above equations gives: 
Equation 4.6: Bernoullll-Euler equation rearranged to calculate stiffness. 
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Figure 4.6: Sample curve showing the moment-curvature relationship and the linear fit 
(from which the stiffness is calculated). 
4.4 Materials and Methods 
All chemicals were purchased from Sigma-Aldrich unless otherwise noted. 
4.4.1 Preparation of Tissue and Bioreactor Loading 
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The bioreactor system was preassembled in a biological safety cabinet using sterile 
tools and gloves before obtaining tissues. By preassembling the bioreactor into two main 
subassemblies (the base, motor support, and culture chambers on the bottom piece; the 
lid, alignment shafts, pistons, and cam-crank on the top) the system was ready for quick 
loading. After preassembly, the bioreactor was placed under UV light until the tissues 
were prepared for loading. Whole porcine hearts (from adult pigs) were obtained from a 
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local abattoir (Fisher Ham and Meat, Spring, TX). The hearts were sprayed superficially 
with 700/0 ethanol and then extensively rinsed with sterile PBS to remove any remaining 
blood clots. Whole aortic roots were dissected from the hearts using sterile instruments 
and aseptic technique. After the root was dissected, each root was rinsed extensively and 
soaked in a solution of sterile PBS supplemented with 10% penicillin-streptomycin-
amphotericin (Cellgro, Manassas, VA). For the "baseline" group, leaflets were then 
dissected out of the root and immediately subjected to the battery of tests and assays 
described in the sections 4.4.3, 4.4.4, and 4.4.5. For both the static culture and dynamic 
culture groups, the roots were sutured to the custom designed stent (described in section 
3.2) with 2-0 Prolene sutures (Ethicon, Minneapolis, MN) and a custom fabricated 
silicone gasket was sutured around the ventricular annulus of the root. Next the rootlstent 
assemblies (Figure 4.7) were either placed in culture flasks or snap-fit into the piston of 
the bioreactor system, respectively, depending on their culture group. At least 6 aortic 
roots were used for each group (n ~ 6 valves or 18 leaflets per group for all culture 
conditions ). 
Figure 4.7: Porcine aortic root sutured to custom designed stent and silicone gasket (not 
visible). 
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4.4.2 Static and Dynamic Culture 
Culture medium was prepared with DMEM supplemented with 10% bovine growth 
serum (BGS, Hyc1one, Logan, UT) and 2% penicillin-streptomycin-amphotericin B 
solution (Cellgro, Manassas, V A). The static culture specimens were placed in culture 
flasks containing 250 mL of culture medium; for this group, medium was changed every 
3-4 days. Dynamic culture specimens were placed in the bioreactor culture chambers, 
each of which was then filled with 600 mL of medium. For this group, medium was 
changed every seven days. After the bioreactor assembly was placed in the humidified 
incubator (37°C, 5% C02), the motor was enabled. The motor was controlled through a 
simple custom program that communicated with the servo drive via RS232 or Ethernet 
networking. A move profile was created with constant velocity and fixed acceleration and 
deceleration parameters. The software was set to produce a 2.1 rpm cam revolution, that 
when coupled with the 6.8 cm stroke length from the mechanical design of the system, 
corresponded to a ~ 1.5 Llmin flow rate through the valve. 
4.4.3 Mechanical Tests 
After completion of the culture period (7 or 14 days), the roots were removed 
from their respective culture chambers and the aortic valve leaflets were dissected from 
the aortic root. Baseline values were established from freshly dissected tissues. 
Mechanical characterization of the tissue was performed using uniaxial tensile testing as 
well as three-point bending. 
Uniaxial tensile testing was performed with a Bose Enduratec ELF 3200 system. 
A load cell (Honeywell Sensotec, Morristown, NJ) with capacity of ± 50 N was used to 
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acquire load data while displacement data was obtained from the crosshead position. Data 
was acquired at 1kHz. Samples were preconditioned for 25 cycles at 0.5 Hz, allowed to 
rest for 15 s, and cycled again for 3 cycles at the same rate. The samples were then pulled 
to the maximum displacement of the system (12 mm) at a strain rate of 0.1 mm1s and the 
Young's modulus of the tissue was measured from the linear region curve corresponding 
to the final crosshead extension. This preconditioning regimen allows for the aortic valve 
leaflet's material memory to reset and repeatable measurement of material 
properties.[142, 143] 
Flexural testing of the tissue was performed using the previously described three-
point bending apparatus (section 4.3) and digital image correlation to determine the 
instantaneous effective bending stiffness of the tissue. This apparatus was used to deform 
the sample by pulling the center of the sample against a flexure bar at a strain rate of 0.02 
mm1s to a displacement of 8 mm. Images of the sample deformation and graphite 
particles' movement were captured at 5 frames per second by a CCD camera (Leica 
DFC320) mounted over the apparatus. N ?: 5 for all flexure groups. After mechanical 
testing, samples were enzymatically digested for biochemical assays (described below). 
4.4.4 Biochemical Assays 
Samples used in biochemical assays were first assessed for wet weight, 
lyophilized for 48 hours and then assessed for dry weight. The samples were 
subsequently rehydrated with 100 mM ammonium acetate solution, minced, then digested 
with 100 uL of proteinase K solution (EMD Pharmaceutical, Durham, NC, 10 mglmL in 
100 roM ammonium acetate) for 16-48 hrs at 60°C. The enzyme solution was then 
deactivated by immersing the tubes in a 100 °C water bath for 5 minutes. After tissue 
digestion, quantative assays to determine hydoxyproline content and total 
glycosaminoglycan content were performed. 
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Collagen content was indirectly measured using a hydroxyproline assay, since 
hydroxyproline is a major component of the collagen triple helix.[144, 145] Significant 
variability observed with more modern biochemical collagen assays was observed, so a 
reliable hydroxyproline assay was chosen as a proxy for collagen content. It is known 
that in collagen type I heterotrimer ([Ul]z[UZ] 1), hydroxyproline constitutes roughly 
10.4% of total residues. In collagen type III ([ulh), hydroxyproline constitutes a slightly 
higher amount of total residues, -12.5%, therefore hydroxyproline content is a good 
proxy for total collagen content. [146, 147] Aliquots of proteinase K digested leaflets 
were hydrolyzed with 6 N HCI at 115 °C for 4 hours in glass vials sealed tightly with 
Teflon caps. After hydrolyzing the samples, the vials were removed from the heating 
block, allowed to cool, and uncapped, and then the HCI was boiled off at 115 °C for 2 
hours. The hydrolyzate was then dissolved in ddiHzO and samples and standards 
(prepared from a 1.0 mg/mL stock solution oftrans-4-hydroxy-L-proline in ddiHzO) were 
added to glass tubes in duplicate. Chloramine T (30 mM N-Chloro-p-toluenesulfonamide 
sodium salt hydrate, 10% v/v n-propanol in 0.16 M citric acid, 0.8 % glacial acetic acid, 
0.58 M sodium acetate, 0.4 M NaOH, 20% n-propanol) was added to samples at room 
temperature, vortexed, and incubated for 20 minutes. AldehydelPerchloric acid solution 
(1.17 M p-dimethyl-amino-benzaldehyde in 70% v/v n-propanol and 70% perchloric acid 
solution) was added to all samples and standards, vortexed until no schlieren were visible 
and incubated at 60 °C for 15 minutes. Samples and standards were then vortexed again, 
67 
aliquoted in triplicate into a 96-well plate and read on a spectrophotometer (Spectramax 
M2, Molecular Devices, Sunnyvale, CA) with absorbance read at 558 nm. Experimental 
absorbance measurements were compared with a standard curve derived from 
hydroxyproline standards, and were statistically analyzed to compare groups. 
Glycosaminoglycan (GAG) content was assessed using an uronic acid assay for 
total GAGs.[148] GAG content has been shown to be a good indicator of the leaflet's 
synthetic ability in response to mechanical stimuli.[104] The uronic acid assay was used 
to colorimetrically quantify GAG amounts. Aliquots of digested leaflets were added to 
sulfuric acid tetraborate (12.5 mM sodium tetraborate in concentrated sulfuric acid) at 4 
0c. This solution was then heated for 5 minutes at 100°C in a heating block. Samples 
were then cooled using a room temperature water bath for 5 minutes. 250 uL of solution 
was then removed from each sample to serve as a blank. The remainder of the solution 
was treated with 10 f!l ofhydroxyphenyl solution (0.15% m-hydroxyphenol in 0.5% 
NaOH). Blanks and samples were aliquoted in triplicate into a 96-well plate and read on a 
spectrophotometer (Spectramax M2, Molecular Devices, Sunnyvale, CA) with 
absorbance read at 532 nm and background subtraction performed at 750 nm. A standard 
curve of using known quantities of glucuronic acid was created and experimental sample 
concentration was back calculated from this curve. 
4.4.5 Histological Techniques 
Leaflets retained for histology and immunohistochemistry were fixed with 10% 
formalin, dehydrated through a series of graded alcohols and xylene (VWR, Radnor, PA), 
embedded in paraffin, and sectioned into 5 f!ID slices using a microtome. Sections were 
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affixed to glass slides for Movat pentachrome staining and immunohistochemistry (IHC). 
Movat pentachrome staining was accomplished using serial baths of Alcian Blue (1 % w/v 
Alcian Blue and 0.09% v/v acetic acid in ddiH20, Acros Organics, Geel, BE), alkaline 
alcohol (10% ammonium hydroxide, 4.5% ddiH20, 85.5% ethanol), Voerhoff's 
Hemotoxylin (5% w/v hemotoxylin in ethanol; 2% w/v iodine, 4% potassium iodide in 
ddiH20; 10% w/v ferric chloride hexahydrate in ddiH20; mixed 2: 1: 1 volumetrically, 
respectively), ferric chloride (2% w/v in ddiH20), aqueous sodium thiosulfate (5% w/v in 
ddiH20), Crocein Scarlet (0.1 % w/v Brilliant Crocein MOO and 0.5% v/v acetic acid in 
ddiH20; 0.1 % w/v acid fuschin and 0.5% v/v acetic acid in ddiH20; mixed 1: 1 
volumetrically; Acros Organics), 0.5% acetic acid, two changes of phospho tungsten tic 
acid (5% w/v in ddiH20), pure ethanol, Safran (6% w/v in ethanol, Poly Scientific, Bay 
Shore, NY), and pure ethanol. This protocol stains ECM components as follows: elastic 
fibers - black, collagen - yellow, GAG - blue, fibrin - red, muscle - red. Movat staining 
was used to identify the relative location ofECM components and layer structure of the 
leaflet. 
The presence of elastin and collagen type III was verified by 
immunohistochemistry. All samples were run concurrently for all semi-quantative IHC 
analyses to eliminate batch-to-batch variance in observed intensity. Antigen retrieval 
pretreatment was performed at 80°C for 30 minutes with citrate antigen decloaker 
solution (Biocare Medical, Concord, CA) for collagen type III or 0.1 % chymotrypsin and 
0.1 % CaCh (w/v) in diH20 for elastin. Peroxidases were then quenched with 3% H202 
(this step is unnecessary for elastin and was skipped) and the samples were blocked with 
0.1 % goat serum buffer for 1 hour at room temperature. Primary antibodies were added in 
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buffer with 0.1 % bovine serum albumin and incubated for 1 hour at 37 °C (collagen III: 
l:lO0 dilution Rb Anti-Col III; elastin: 1:150 Ms Anti-Elastin, Abcam, Cambridge, MA). 
Primary antibodies were removed with two PBS rinses and then biotinylated secondary 
antibodies were added at 37 °C for 1 hour (collagen III: l:lO00 Goat Anti-Rb; elastin: 
1:500 Goat Anti-Ms, Jackson ImmunoResearch Laboratories, West Grove, PA). A 
chromogen reaction showing antibody location was visualized using Elite Vectastain 
ABC and diaminobenzidine kits (Vector Laboratories, Burlingame, CA). A hematoxylin 
counterstain was performed after the chromogen reaction and slides were sealed with 
mounting media and a coverslip. Slides were then imaged on a Leica microscope and 
images acquired from a Leica DFC320 CCD in Image Pro Express (Media Cybernetics, 
Bethesda, MD). 
Image analysis was performed with a series of custom ImageJ scripts to eliminate 
the need for slide blinding and to mitigate potential viewer bias. First, slides were 
scanned with a Pathscan Enabler IV (Meyer Instruments, Houston, TX) at 7200 DPI in 
RGB color space. Semi-automated image processing and analysis was performed with 
ImageJ64. A brief description of the protocol follows, more detail can be found in 
Appendix VIII. First, background subtraction and color correction were performed using 
the built-in rolling ball method (pixel radius 50 mm, light background, sliding 
paraboloid). Next, the hematoxylin and DAB colors were deconvolved into separate 
images with only one color.[149, 150] Single-color images were converted to 8-bit 
greyscale images. Each image was then thresholded using with the upper bound of 
brightness from the on-slide negative control. A mask from the thresholded image was 
created and intensity (DAB) was measured within the mask area. These results were 
exported to Microsoft Excel, where the intensity was then binned into 5 bins across the 
dynamic range of intensities (e.g., if the darkest staining observed had a luminosity of 
100, the dynamic range was 255-100, or 155; which resulted in a bin width of 51 
intensity units). 
4.5 Results 
4.5.1 Mechanical Testing Results 
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At seven and fourteen days, there was no difference in tensile stiffness between 
the static and dynamic culture regimens (Figure 4.8, all mechanical testing was in the 
circumferential direction). However, at fourteen days, the statically cultured leaflets were 
significantly stiffer than either culture condition at seven days (p < 0.01). In addition, the 
stiffness values obtained here are much lower than recently published results (~1 0 MPa) 
by other groups, but test method and preconditioning can greatly affect the observed 
modulus.[58] 
Flexural stiffness of freshly excised (baseline) leaflets showed no difference from 
the samples cultured in the bioreactor at seven days (Figure 4.9). Statically cultured 
samples at seven days were significantly less stiff than baseline tissue and dynamic 
samples (p < 0.05 and p < 0.001, respectively). However, at fourteen days, both the 
dynamic and static culture regimens resulted in lower flexural stiffness than baseline 
samples (p < 0.05). Additionally, at this time point, stiffness in dynamic and statically 
cultured samples was no longer different. 
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Figure 4.8: Tensile stiffness of leaflets cultured for seven days. Statically cultured leaflets 
at day 14 were significantly stiffer than leaflets in either culture regimen at day 7 (p < 
0.01). N ~ 6 for all groups. 
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Figure 4.9: Flexural stiffness of porcine aortic valve leaflets in dynamic culture 
(bioreactor) or static culture in comparison with freshly excised (baseline) tissue. Day 7 
dynamic culture showed no difference from freshly excised tissue, and all other groups 
were significantly less stiff than freshly excised tissue. 
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4.5.2 Biochemical Results 
Hydroxyproline content (nonnalized to dry weight of sample) of valves in static 
culture for one week decreased in comparison to freshly excised valves (p < 0.05), 
however, valves exposed to dynamic culture showed no change in hydroxyproline 
content in comparison with freshly excised tissue (Figure 4.10). At two weeks, there was 
a trend showing that hydroxyproline content decreased in statically cultured samples 
compared with baseline values (p < 0.13). In contrast, samples cultured in the bioreactor 
(dynamic culture) showed significantly more hydroxyproline content at day fourteen than 
all other groups (p < 0.05). 
Total glycosaminoglycan content was unchanged in comparison with baseline for 
either culture condition at seven days (Figure 4.11). Both dynamic and static cultured 
samples showed higher total GAG content at day fourteen than at baseline and at day 
seven values (p < 0.001), although there was no difference between the statically and 
dynamically cultured samples. 
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Figure 4.10: Collagen content of porcine aortic valve leaflets, as measured by 
hydroxyproline content normalized to dry weight. In dynamic culture, the trend showed no 
change in hydroxyproline content at day seven and by day 14, hydroxyproline content 
was increased. There was virtually no change in the trend of collagen content across the 
duration of culture for statically cultured leaflets. * denotes statistically significant 
difference where p < 0.05. 
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Figure 4.11: Uronic acid content of porcine aortic valve leaflets, normalized to wet weight 
of the tissue. * denotes statistically significant difference with p<0.001. 
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4.5.3 Histological Characterization 
Movat staining was used to reveal the distribution of ECM components throughout 
the leaflet (Figure 4.12). Freshly excised tissue showed distinct collagen staining in the 
fibrosa (yellow), a GAG-rich spongiosa (blue), and distinct elastin banding in the fibrosa 
(black). During static culture, the leaflet showed collagen distributed throughout the 
layers at both seven and fourteen days. At both time points, the statically cultured leaflets 
maintained distinct staining for elastin (black) in the ventricularis. Statically cultured 
leaflets maintained GAG staining (blue) at day seven and fourteen, however it appeared 
less intense at day seven than fourteen. Both of these effects were noted by Barzilla et al. 
in static organ culture of mitral valve leaflet strips.[ 115} Additionally, GAG staining 
appeared primarily in the spongiosa of statically cultured leaflets. In the dynamically 
cultured leaflets, collagen was seen across all three layers of the leaflet at seven and 
fourteen days and it appeared to be mainly located in the fibrosa, however, the layered 
structure appeared less distinct at day fourteen. Furthermore, at day seven, it appeared 
that dynamic culture resulted in the appearance of elastin staining in the fibrosa, which 
did not appear to be maintained at day fourteen. Distinct blue GAG staining was seen in 
both day seven and fourteen dynamically cultured samples. Morphologically, the leaflets 
appeared to thin at day fourteen of either culture regimen, particularly in the cusp. 
Additionally, they appeared to be less intact than earlier time points. The location and 
abundance of elastin and collagen type III was further characterized by 
immunohistochemical techniques. 
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Figure 4.12: Movat pentachrome stain of porcine aortic valve leaflets. Black corresponds 
to elastin, yellow to collagen, greenlblue to proteoglycans and glycosaminoglycans, dark 
blue to cell nuclei, and red to muscle. Orientation of ventricularis, spongiosa, and fibrosa 
is the same across all samples (denoted by f , s, and v in high magnification inset). 
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Immunohistochemical staining revealed the presence of elastin across all layers of 
the valve during seven days of dynamic culture, however, at fourteen days of dynamic 
culture, it appeared to be localized to the ventricularis, where it is normally most 
abundant (Figure 4.14). Semi -quantitati ve analysis revealed that elastin staining intensity 
was significantly decreased at both seven and fourteen days in dynamic culture in 
comparison with baseline tissue (Figure 4.13). Static controls showed significantly lower 
elastin (by intensity) at day fourteen (p < 0.05 for all significant comparisons). The 
primary location of elastin in statically cultured samples appeared to be in the 
ventricularis. 
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Figure 4.13 - Relative intensity of elastin DAB staining in leaflets as a function of multiple 
days of culture. N~6 for all groups and * denotes significance with p < 0.05. 
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Figure 4.14: Immunohistochemical staining for elastin in leaflets cultured in static and 
dynamic conditions. Distinct elastin staining can be seen in the fibrosa of all leaflets, but 
it is more distinct in the fibrosa of dynamically cultured samples than statically cultured 
samples. Orientation of ventricularis, spongiosa, and fibrosa is the same across all 
samples. A representative staining control (2 0 antibody only) is included-all samples had 
on-slide staining controls. 
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Immunohistochemical staining revealed intense collagen type III staining across 
all layers of the valve during seven days of dynamic culture (Figure 4.16) and at fourteen 
days it appeared more diffuse. Staining appeared to be most intense in the fibrosa (where 
it is typically seen). Semi-quantitative analysis revealed that collagen type III staining 
intensity was significantly decreased at both seven and fourteen days in dynamic culture 
in comparison with baseline tissue (Figure 4.15). Static controls showed significantly 
more collagen III (by intensity) at day seven than baseline tissue, however at day 
fourteen, this difference was no longer observed. (p < 0.05 for all significant 
comparisons). Furthennore, at day seven, statically cultured samples showed significantly 
higher collagen III staining intensity than dynamically cultured samples. 
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Figure 4.15 - Relative intensity of collagen DAB staining in leaflets as a function of 
multiple days of culture. N~6 for all groups and * denotes significance with p < 0.05. 
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Figure 4.16: Immunohistochemical staining for collagen type III in leaflets cultured in 
static and dynamic conditions. Distinct collagen staining is observed in all leaflets. At day 
14 in statically cultured leaflets, it appears to be diffuse through the fibrosa and 
spongiosa and located mainly in the ventricularis. For dynamically cultured leaflets at day 
14, the staining appears to be diffuse throughout the leaflet. Orientation of ventricularis, 
spongiosa, and fibrosa is the same across all samples. A representative staining control 
(20 antibody only) is included-all samples had on-slide staining controls. 
80 
4.6 Discussion 
This newly developed organ culture system was evaluated for use to determine its 
applicability for future studies of aortic valve biology, remodeling, and disease as well as 
for evaluation of tissue engineered heart valve scaffolds. It can be concluded that 
compared to static cultures (no mechanical stimulation), bioreactor culture provides the 
superior culture environment for aortic valve tissue maintenance for durations up to one 
week. This conclusion is evidenced by the mechanical testing and biochemical results at 
seven days. The flexural stiffness of the leaflets at day seven in dynamic culture is 
maintained at baseline levels, as is both the hydroxyproline and uronic acid content of the 
leaflets. Both biochemical assays measured total quantity present, normalized to tissue 
weights. It is unknown if tissue weights were substantially changing as a function of 
culture duration, since a defined volumetric sample of tissue was not used at all 
timepoints - instead one half of a leaflet was measured. If the leaflets are changing in size 
significantly (and correspondingly, in weight), then the conclusions drawn from the 
biochemical data would not be valid. However, the tissues did not appear to be grossly 
changing in either size, thickness or weight (of one half a leaflet), therefore the trends 
interpreted from the biochemical assays provide likely insight as to remodeling and 
synthetic capacity of the leaflets. Statically cultured leaflets showed a significant decrease 
in hydroxyproline content (a proxy for collagen content) and a corresponding decrease in 
flexural stiffness at this time point (both in comparison with dynamic culture and baseline 
leaflets). However, it is important to note that at this time point, uronic acid (a proxy for 
total GAGs) was unchanged from baseline levels in both dynamically and statically 
cultured leaflets, and that tensile modulus of the dynamically and statically cultured 
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leaflets was identical. The discrepancy between measured hydroxyproline content and 
material properties could further investigated by examining the alignment of the collagen 
fibers with picrosirius red. For example, if the collagen network is becoming less aligned 
by day seven, that could explain why the tensile modulus is not significantly higher for 
the dynamically cultured leaflets, even though their hydroxyproline content is higher. 
Additionally, the extent of collagen crosslinks could be probed with IHC analysis of lysyl 
oxidase, since as crosslinking increases, stiffness of the tissue will increase 
correspondingly. 
The histological characterization provides further support that bioreactor culture 
is preferable to static culture for this one week duration. The leaflets appear to retain their 
layered structure more distinctly in the dynamically cultured leaflets (as shown by Movat 
staining). While leaflets appeared thinner at later time points, it is difficult to determine 
this purely from tissue sections, since section thickness depends on microtome technique 
and orientation of the tissue within the paraffin block. In the future, leaflet thickness 
should be quantified before beginning the fixation and dehydration process. While the 
overall amount of elastin is lower in the dynamically cultured leaflets compared to 
baseline levels (from both visual interpretation of images and semi-quantative IHC 
analyses), the distribution of elastin appears to be properly retained in the normal layer 
(ventricularis) at seven days. By semi-quantative analysis, collagen type III content at 
day seven was lower than both baseline and statically cultured leaflets in the bioreactor 
samples. Furthermore, the visual interpretation of the collagen type III distribution within 
the stained sections shows that it is more layer specific in bioreactor cultures than in 
static cultures. This distribution suggests that statically cultured leaflets are undergoing 
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remodeling in a manner that would generate more collagen III throughout the bulk of the 
leaflet. These findings could be investigated more quantitatively by using a fluorescently 
tagged secondary antibody, however, it is more difficult to visualize the whole sample 
when using fluorescence (microscope images must be tiled) and the stain could no longer 
be maintained for long term storage. 
Analysis of the data from all assays indicates that the benefit of dynamic culture 
in the bioreactor was less apparent by day fourteen. Tensile stiffness of samples cultured 
to day fourteen in this system show no significant difference from control, although they 
were less stiff than statically cultured leaflets at this time point. Furthermore, there was 
no difference in flexural stiffness between dynamically or statically cultured leaflets at 
day fourteen, and both of these culture regimens resulted in significantly less stiff leaflets 
than baseline controls. At day fourteen, hydroxyproline concentration in bioreactor 
samples significantly increased in comparison with baseline valves, as did uronic acid 
concentration in both dynamic and statically cultured leaflets. This overall pattern 
indicates that remodeling was occurring by day fourteen, and the leaflets' ECM 
composition was significantly changed from native tissue conditions. Histological 
analyses confirmed these observations. In contrast to day seven, the day fourteen samples 
that were subjected to static culture conditions show better retention of the layered 
structure than dynamically cultured leaflets. Furthermore, morphologically, the 
dynamically cultured leaflets appeared more degenerated than statically cultured leaflets. 
IHC analyses showed that elastin concentration significantly decreased in both 
dynamically and statically cultured leaflets at day fourteen, when compared with baseline 
elastin intensity. Elastin did appear to be retained in the ventricularis of leaflets exposed 
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to either culture regimen. Collagen III concentration at day fourteen was significantly 
lower in bioreactor samples than baseline values, and statically cultured samples showed 
a corresponding drop at this time point, although they were not significantly different 
than baseline controls, likely due to the spread of the data. Although the tensile and 
flexure moduli do not increase in dynamic culture at day fourteen, the data suggests that 
collagen type I content could be increased in bioreactor samples at day fourteen, since 
collagen III content decreased while hydroxyproline content increased. It may be that a 
mature, crosslinked, and oriented collagen network is not present at this time point. 
From the data exhibited in this chapter, one can conclude that the imparted 
dynamic culture regimen provides clear benefit to the culture of aortic valves for one 
week, but does not appear to be appropriate for durations exceeding one week. However, 
since the bioreactor can indeed provide extended-duration sterile culture of aortic valve 
leaflets in a pseudo-physiologic environment, it is expected medium to long term 
(fourteen days and beyond) ex vivo maintenance can be achieved with proper 
optimization of the imparted dynamic regimen. The dynamic environment can be 
controlled by varying flow rate and frequency with the software and physical design of 
the cam-link assembly. Other studies of ex vivo organ culture of whole aortic valves have 
been limited to 96 hours and they have only showed data from 48 time points.[97, 109]. 
These studies have demonstrated the necessity of a dynamic culture regimen to maintain 
VIC phenotype and proper ECM composition. Organ culture systems using portions of 
valve tissue (A V or mitral valve) have been performed to durations as long as fourteen 
days.[103, 116, 121, 133] These studies demonstrated the need for the appropriate 
mechanical culture regimen, as several cyclic stretch investigations have shown VIC 
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activation and degradation ofECM.[116, 133, 151, 152] Furthermore, altered shear 
stresses have been shown to have a profound effect on cells synthetic activity. The low 
shear stresses imparted in this system could be stimulating the cells to synthesis matrix 
metalloproteinases, of which increased synthesis could explain the decrease in tensile 
stiffness. As the system continues to be used for organ culture studies of valve biology, it 
will be important to characterize the collagen network for collagen quantity, alignment, 
and cross-linking. Additionally, since the system is clear, video analysis could be used to 
determine if valves remain competent during extended culture durations. Furthermore, 
the dynamic regimen could be optimized for tissue growth, since this system can also be 
used for the mechanical conditioning of a TEHV. Sub-physiologic flow rates have been 
shown to be very useful in these types of applications, and this system can easily generate 
these types of dynamic culture environments.[42] Lastly, the bulk bending stiffness of 
A V leaflets determined in this chapter serves as design criteria for the following chapters 
that deal with the optimization of hydrogel formulations for use in TEHV. 
4.7 Conclusions 
The dynamic culture regimen imparted by the bioreactor shows a clear benefit 
for ex vivo culture of aortic valves for one week when compared to static culture. At 
seven days, the flexural stiffness, hydroxyproline content and GAG content were 
unchanged from fresh tissue. Additionally, this culture regimen showed that when 
compared to statically cultured leaflets at the same time point, the dynamic regimen 
resulted in significantly better retention of flexural stiffness and hydroxyproline content. 
At durations longer than one week, this dynamic culture regimen does not appear to be 
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appropriate. Despite the unclear benefit of the imparted regimen for durations of fourteen 
days, this is the longest ex vivo organ culture of whole aortic valves to date. 
Histologically, leaflets cultured in the dynamic environment showed better retention of 
their characteristic layered structure, and proper distribution of collagen III and elastin at 
both time points. The bending stiffness of native A V leaflets determined in this chapter 
served as design criteria for investigations of PEGDA scaffold bending stiffness. 
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Chapter 5: Flexural Characterization of Cell-
Encapsulated PEGDA Hydrogels * 
5.1 Introduction 
The limitations of the current clinical options for valve replacements inspire 
development of enabling technologies to create a tissue engineered heart valve (TEHV). 
Poly(ethylene glycol) diacrylate (PEGDA) hydrogel scaffolds permit greater biological 
and biomechanical customization than do non-woven mesh scaffold technologies. 
However, the material characterization of PEGDA hydrogels has been predominantly 
limited to compression and tension, as opposed to bending. Since large flexural 
deformations result in points of maximum stress in native valves as well as TEHVs, it is 
crucial to evaluate any potential scaffold material in this mode. The effect of formulation 
parameters on the bending mechanics of cell-seeded PEGDA hydrogels were investigated 
with a custom designed bending tester. Three molecular weights (3.4, 6, or 8 kDa) and 
three weight fractions (5, 10, 15 %, w/v) were subjected to three-point bending tests and 
the flexural stiffness was calculated. Manipulating the composition of the hydrogels 
resulted in flexural stiffnesses comparable to native tissues (15-220 kPa) with varied 
• The majority of this chapter will be published as: Durst CA, Cuchiara MP, Mansfield 
EG, West JL, Grande-Allen KJ. Flexural Characterization of Cell Encapsulated PEGDA 
Hydrogels with Applications for Tissue Engineered Heart Valves. Acta Biomaterialia 
2011: in press. 
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mesh sizes and swelling ratios. Hydrogels containing encapsulated valve cells, 
methacrylated heparin (Hep-MA), or both were substantially less stiff than acellular 
hydrogeis. In conclusion, PEGDA hYdrogels are an attractive potential scaffold system 
for TEHVs because they are not only cytocompatible and modifiable but can also 
withstand bending deformations. These studies were the first to explore the encapsulation 
of valvular interstitial cells in pure PEGDA hydrogels as well as to investigate the 
bending properties of PEGDA gels. 
5.2 Background 
The near infinite biochemical and biomechanical tunability of hydrogels makes 
them very attractive potential scaffold materials for tissue engineered heart valves 
(TEHVs). HYdrogels have received far less attention than other scaffolding materials, 
with the majority ofTEHV investigations being performed using non-woven fiber mesh 
or salt-leached foam scaffolds generated from polyglycolic acid, poly(1actic-co-glycolic 
acid), and polyhydroxyalkanoates.[35, 37,40,51,53] Thus far, these materials have been 
used as scaffolds for the most successful TEHV to-date (in both in vitro and in vivo 
evaluation).[47] Their open structure allows cell migration throughout the scaffold, and 
their material properties can be engineered to be sufficient for the mechanical 
environment of the valve, which involves flexure, tension, compression, and shear 
varying throughout cardiac cycle. Additionally, these materials are degradable and have 
been FDA approved for many years. However, these materials have shown certain 
limitations, namely their high initial stiffnesses compared to native tissues and the 
substantial length of time required for the polymer to undergo hydrolysis-governed 
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degradation.[52] Furthermore, these materials lack intrinsic biological functionalization, 
meaning that they do not present any functional biological moieties that could direct cell 
signaling, ECM production, or enzyme-governed degradation. These materials can be 
modified to present these motifs, however, there is no control over functional molecule 
localization (in contrast to the patterned localization achievable in hydrogels via 
photolithographic or two-photon adsorption methods). [65-67] 
Both non-woven fiber mesh and salt-leached foam scaffolds use cytotoxic 
processing conditions to generate their architecture. Since the polymer processing 
conditions are cytotoxic, cell seeding must be performed after the scaffold is fabricated. 
Cell seeding has been one of the most significant challenges in use of these scaffold 
materials. Seeding methods resulted in inhomogeneous cell distribution, low densities, 
and long seeding times before the scaffold was populated. Initially, cells were incubated 
on the scaffolds under static conditions for up to 4 days in order to allow cell migration to 
the interior of the scaffold.[34] Dynamic seeding methods were developed that yielded 
homogenous and slightly more efficient seeding, but the dynamic nature of the seeding 
environment was reported to cause small cracks in the scaffold material. [68] 
Encapsulation has been shown to be the most efficient and homogeneous method of cell 
seeding. For example, the use of a viscous fibrin "cell carrier" gel resulted in fast, high 
yield, homogenous seeding of valvular interstitial cells (VICs) into fiber matrices. The 
use of fibrin as the basis for the gel, however, alters the cell's local biochemical 
environment through both its structure (cell-substrate) as well as retention ofbioactive 
molecules within the gel.[43, 69] While these previous approaches hold promise, we 
believe that the ability to encapsulate cells coupled with the customization potential of 
polymeric biomaterials makes hydro gels very appealing as scaffold systems. 
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Poly( ethylene glycol) diacrylate (PEGDA) hydrogels are intrinsically 
biocompatible, since the base (unmodified) gels are biologically neutral, resist protein 
adsorption, do not release acidic products during their degradation and can be crosslinked 
with low cytotoxicity allowing for high density 3D cell encapsulation. Furthermore, PEG 
hydro gels can be modified by crosslinking a large number of bioactive moieties 
(peptides, glycosaminoglycans, growth factors) to achieve a high degree of specific 
bioactivity.[2, 72, 73] Indeed, it is widely reported that peptides tethered to either the 
surface or bulk phase of PEGDA gels will retain their bioactivity after this 
modification.[74-76] Additionally, since these materials can be rapidly 
photopolymerized, spatial control of functional moieties is possible in both 2D and 3D, 
due to the emerging field of two-photon stereolithographic fabrication techniques.[66] 
The physical properties of PEGDA gels can be modified across a continuum of 
magnitudes that are biologically relevant in terms of recapitulating both tissue function 
and the pericellular environment. Hydrogel physical properties such as stiffness, degree 
of swelling and effective diffusivity can be controlled by manipulating the molecular 
weight of the macromer, the weight fraction of macro mer in solution and the crosslinking 
time.[85, 86] Stiffness was of primary interest in this study, and construct stiffness 
achieved ranged from very low (-5 kPa, similar to a 1 % HA gel[153], which could 
mimic the gelatinous spongiosa[154]) to several orders of magnitude higher (400 kPa, 
similar to bovine pericardium[127]). It has been further demonstrated that crosslinking 
density affects the strain experienced by the cell, and certain formulation parameters can 
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translate nearly 100% of bulk strain to individual cells.[83] Cells seeded in fiber mesh 
scaffolds can be in contact with either a singular fiber, or many fibers, which may have 
varying degrees of displacement at the microstructure due to macrostructural strain. Thus, 
mechanotransduction in hydrogels appears to be more efficient than in fiber meshes. 
While polymer hydro gels have been well studied in tension and compression, the 
flexural properties of these gels have yet to be investigated. Since flexure represents a 
major mode of deformation of heart valve leaflets, the purpose of this study was to 
investigate the behavior of these gels in three-point bending. We hypothesized that cell 
encapsulated PEGDA gels could be formulated to approximate the flexural stiffness of 
fresh porcine aortic valve leaflets, and that these gels would support short-term 
maintenance of the VIC phenotype and ECM synthesis. This exploration ofPEGDA gels 
with respect to their capacity for the mechanical requirements of engineered heart valve 
leaflets will aid in the translation of hydrogels towards more biomimetic scaffold 
fabrication and realistic in vitro testing of hydrogel-based TEHVs. 
5.3 Materials and Methods 
All chemicals were purchased from Sigma unless otherwise noted. 
5.3.1 Study Design 
The primary concern of this study was to investigate the effect of hydrogel 
formulation parameters on flexure properties of TEHV scaffolds. As a result, the 
experiment employed a full factorial design for the flexural testing and 
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immunofluorescence studies of cell seeded gels, and flexural, compression and network 
property characterization of acellular gels (Figure 5.1). 
Figure 5.1: Diagram of experimental design. A full factorial design was chosen to 
investigate the effect of varied formulation parameters (molecular weight, weight fraction) 
on cell phenotype and hydrogel network and mechanical properties. Sample sizes were 
chosen from prospective power calculations. 
Sample sizes were chosen based on prospective statistical power calculations. 
Using two-way ANOYA comparison of the row*col means, where detectable contrast is 
set at 0.4, standard deviation at 0.15 (on the upper bound of what is reported in hydrogel 
compression testing [83, 84]), and n=5, statistical power was observed to be 0.8. As the 
study was underway, it became evident that heparin altered the gels' properties in an 
unexpected way, and subgroups were added to attempt to address the effect of heparin 
incorporation on gel mechanical properties (Figure 5.2). These subgroups were tested 
using lower sample sizes than the samples used in the primary focus of the chapter. 
Compression 
Testing 
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Figure 5.2: Diagram showing sub-studies investigating the effect of heparin inclusion on 
gels. 
5.3.2 Cell Culture 
Primary cultures of valvular interstitial cells (VICs) were isolated from aortic 
valve leaflets from 6-month-old pigs obtained from a local abattoir (Fisher Ham and 
Meat, Spring, TX) within 6 hours of slaughter. The valve leaflets were dissected using 
sterile technique and rinsed with sterile phosphate-buffered saline (PBS) supplemented 
with 5% antibiotic-antimycotic solution (ABAM, Cellgro, Manassas, VA). The leaflets 
were then placed in a flask containing serum-free DMEM (Cellgro) supplemented with 2 
mg/mL of collagenase type II (Worthington, Lakewood, NJ) and 2.50/0 ABAM. The flask 
was incubated at 37°C in an incubated shaker for 30 minutes. Next, the leaflets were 
removed from solution and the endothelial cells were removed by rubbing the surface of 
the valve with a cotton swab. The leaflets were then minced using a #10 scalpel and 
digested using 2 mg/mL of collagenase type III, 0.1 mg/mL testicular hyaluronidase 
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(Worthington), 2 mglmL protease, 2.5 % (v/v) HEPES, and 2.5% (v/v) ABAM in serum-
free DMEM for 4 hours on an incubated shaker (150 rpm). The cell suspension was 
filtered using a 70 ~m pore size cell strainer (BD Falcon, Franklin Lakes, NJ), pelleted, 
and cultured on TCPS in DMEM supplemented with 10% bovine growth serum (BGS, 
Hyclone, Logan, UT) and 1 % ABAM. VICs were maintained in a humidified incubator at 
37°C with 5% C02. Medium was changed every 2 days. All experiments were performed 
using cells between passages 4 and 8. 
5.3.3 PEGDA Synthesis 
PEGDA was prepared using previously described methods. [73] Briefly, 0.1 mM 
dry poly( ethylene glycol) with molecular weight of either 3400, 6000, or 8000 Da was 
combined with 0.4 mM acryloyl chloride, 0.2 mM triethyl amine, in anhydrous 
dichloromethane. The reaction was stirred proceed overnight under argon at 22°C. The 
solution was washed with 2 M K2C03 in order to remove HCl. Gravity-based phase 
separation was used to separate the solution into an aqueous and organic phase. The 
organic (PEGDA containing) phase was removed the next day and dried with anhydrous 
MgS04. PEGDA was then precipitated with cold diethyl ether, filtered, and dried under 
vacuum. IH-NMR was used to verify acrylation of the PEG chains by the presence of 
peaks at 3 ppm. MALDI-TOF was used to verify molecular weight of the synthesized 
PEGDA. PEGDA was stored at -20°C under argon until use. 
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5.3.4 Methacrylation of Heparin 
Heparin was methacrylated using previously described methods for the 
methacrylation of polysaccharides. [2, 155] In short, the procedure involved dissolving 
heparin in ddH20 at 2% (w/v), reacting the solution with a 20 times molar excess of 
methacrylic anhydride, and adjusting the pH to 7.5 using 4N NaOH. This solution was 
stirred on ice for 24 hours while maintaining pH at 7.5. The methacrylated heparin (Hep-
MA) was precipitated from solution with 4 °C ethanol, then dialyzed for 48 h using a 
1000 Da MWCO filter (Spectrum Laboratories, Rancho Dominguez, CA). The solution 
was then dialyzed and the powder was stored under argon at -20°C until use. lH-NMR 
was used to determine methacrylation per disaccharide repeat unit. 
5.3.5 Hydrogel Polymerization 
In order to test the effects of a wide range of hydrogel formulation parameters on 
bending mechanics, a full factorial design was employed. Because molecular weight and 
weight fraction of the macromer are known to affect the material behavior of the resulting 
hydrogels,[85] three different molecular weights (3.4, 6, or 8 kDa) and three weight 
fractions (5, 10, or 15%, w/v) were investigated in a combinatorial study (nine 
permutations). For each permutation, a specific molecular weight ofPEGDA was 
dissolved in PBS to a specific weight fraction, after which Hep-MA was added to obtain 
a final concentration of 0.5 mM Hep-MA in the prepolymer solution. The photoinitiator 
2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone was dissolved in ethanol at 
10% (w/v) and added to the prepolymer solution at 3% (v/v). The resulting solution was 
sterile filtered and VICs were added to the solution at a concentration of22 x 106 
cells/mL. All cellularized gels used Hep-MA since it had previously been shown to be 
necessary for the maintenance of VIC phenotype when VICs were seeded on PEGDA 
gels (in 2D studies).[2] 
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Prior to polymerization, the prepolymer solution was poured into custom molds. 
The molds were created from glass slides separated by comb-shaped polycarbonate 
spacers, resulting in seven 6 x 44 x 0.8 mm (width x height x thickness) wells per mold 
assembly. Prior to molding, the glass slides and polycarbonate spacers were coated with 
Sigmacote (Sigma-Aldrich, St. Louis, MO) to ease removal of the crosslinked hydrogels 
from the molds. The molds were steam sterilized assembled and after cooling, the 
prepolymer was loaded into the molds. Subsequently the gels were crosslinked with 
longwave UV light (365 nm, 10 W/cm2) for 10 minutes. The hydrogels were removed 
from the molds and cultured separately in well plates for 48 hours in a humidified 
incubator before mechanical testing. 
To determine the impact of cell inclusions on hydrogel bending behavior, 
acellular gels were created in the same manner as above for all nine permutations of 
molecular weight and weight fraction. In order to elucidate the effect ofmethacrylated 
heparin subsets of hydrogel formulations were created in the same manner as above, 
except that either (i) the heparin used was not methacrylated (10% WF for all MW plus 
15% for 8 kDa) or (ii) the concentration of Hep-MA was varied (10% WF for all MW). 
An additional control set of "base" PEGDA hydrogels (all nine permutations ofMW and 
WF) was prepared without any Hep-MA. 
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5.3.6 Mechanical Testing 
The hydrogel strips were loaded into a custom built bending tester (design adapted 
from [126]) and subjected to 3-point bending tests. The general method of flexure testing 
is the same as described in section 4.3, and the methods will be briefly summarized here. 
Optical tracking of hydrogel deformation was achieved by sifting small graphite particles 
over the hydrogel test strip, the reference rod, and a calibrated flexure bar (Figure 
5.3).[52] 
Figure 5.3: Photograph with annotations depicting the method of operation of the bending 
apparatus. The linear motion of the bending tester stage pulls the hydrogel strip (secured 
against the loading posts (c» against the flexure bar (b). Displacement of the flexure bar is 
determined relative to the immobile reference bar (a). Graphite particles (d) are visible 
atop the hydrogel strip. Arrow indicates the direction of motion. 
The sample was deformed at a rate of 1.5 mm1min until a maximum change in 
curvature (~K) of 0.3 mm- 1 was achieved. Images of the sample deformation and 
graphite particles movement were captured at 5 frames per second by a CCD camera 
(Leica DFC320) mounted over the apparatus. Calculation of stiffness was identical to the 
method presented in Chapter 4. Sample size for all flexure groups was 3-6 per hydrogel 
permutation. After flexure testing, the cellularized gels were retained for 
immunocytochemical staining. 
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In order to verify stiffness results obtained from bending, several additional sets 
ofPEGOA hydro gels were tested in compression. PEGOA slabs with initial thickness of 
3 mm were created (as in section 2.4, with the exception of using 3 mm spacer), punched 
with a 3 mm biopsy punch, swollen in medium, and compressed. The gels were 
compressed to 50% strain at 0.1 mmls between stainless steel platens in a Bose-Enduratec 
ELF3200 (Bose Electroforce, Eden Prairie, MN). After converting load-displacement 
data to stress-strain data, stiffness was measured from the linear portion of the stress-
strain curve at 15-30% strain. Compression testing was also performed to determine 
whether there was an influence of Hep-MA concentration (0.5 or 1.0 mM) on hydrogel 
stiffness. All compressive testing groups had a sample size of 5-6 for each hydrogel 
formulation. 
5.3.7 Cellular Analyses 
To assess the viability of the VICs following encapsulation, freshly prepared cell-
seeded hydrogels were stained with a LivelDead kit (Molecular Probes, Carlsbad, CA). 
After staining for 30 minutes, the hydrogels were imaged using a Zeiss LSM 510 
confocal microscope (Carl Zeiss Microimaging, Thornwood, NY) to assess the 
abundance and location of live cells (green calcien AM) or dead cells (red ethidium 
homodimer-1 ). 
To assess the VIC phenotype and capacity for collagen synthesis, the gels were 
cultured for 2 days in static culture (using same medium and conditions as 20 culture 
explained in 5.3.2) and then stained with rabbit anti-a-smooth muscle actin (Abcam, 
Cambridge, MA) and mouse anti-prolyl-4-hydroxylase (Chemicon, Billerica, MA).[2, 
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156] Primary antibodies were used at 1: 100 dilution in 0.1 % (w/v) BSA in PBS and 
allowed to diffuse into the hydrogel for 16 hours at 4°C on a rocker table at room 
temperature. Gels were then washed with 0.1 % BSA in PBS for 4 hours on a rocker table. 
After washing, gels were incubated simultaneously for 16 hours with fluorescently tagged 
secondary antibodies (AF-488 conjugated donkey anti-mouse, AF-633 conjugated goat 
anti-rabbit secondary, Molecular Probes, Carlsbad, CA) at 4° C on a rocker table. 
Secondary antibodies were used at 1: 1000 dilution in 0.1 % BSA in PBS. Finally, gels 
were washed with 0.1 % BSA in PBS for 4 hours on a rocker table and subsequently 
imaged. 
The proportion of aSMA and P4H positive cells was determined in order to 
assess the maintenance of the myofibroblast phenotype. First, the channels from the 
confocal images were separated in ImageJ. Next, the background was subtracted using a 
rolling ball method with radius of 25 pixels. The images were thresholded from with 
values above the background intensity obtained from secondary-only controls. Lastly, the 
analyze particles algorithm was used to count cells with particle size greater than 5 !-.Im2 
and circularity ranging from 0.5-1.0. The total count for aSMA or P4H positive cells was 
normalized to the total cell count (from DAPI) in each frame and at least five images 
were used for each group. 
5.3.8 Hydrogel Network Characterization 
The hydrogel network was characterized using Flory-Rehner theory. The wet 
mass of the gels was measured after cellular analyses and mechanical testing. After the 
gels were lyophilized for 48 hours, their dry mass was measured. From this information 
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and the formulation parameters the number of effective chains per unit volume (Equation 
5.1), molecular weight between crosslinks (Equation 5.2), average end-to-end distance of 
the unperturbed state (Equation 5.3), crosslink density (Equation 5.4), mesh size 
(Equation 5.5), and mass swelling ratio were calculated as previously described by Cruise 
et a/.[157] The number of effective chains per unit volume, Ye, used in calculation of 
molecular weight between crosslinks, was calculated using the equation below (Equation 
5.1) 
Equation 5.1: Number of effective chains per unit volume, where v Is the specific volume 
of the bulk PEG in amorphous state, V, Is the molar volume of water, V2,rand V2,. are the 
polymer volume fraction In the relaxed and swollen state respectively, and u is the Flory-
Huggins solvent Interaction parameter. 
After the number of effective chains per unit volume was solved, molecular weight 
between crosslinks was calculated using the equation below (Equation 5.2) 
Equation 5.2: Molecular weight between crossllnks equation, where Ve Is number of 
effective chains per unit volume, u Is the specific volume of PEG in the amorphous state, 
and Mn is the number average molecular weight of the starting polymer. 
( 2 )-1 Ve+--
Mn(O) 
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Equation 5.3: Average end-to-end distance of polymer in unperturbed state. Me Is the 
number average molecular weight between crosslinks, Mr is the molecular weight of the 
repeat unit, and Cn is the characteristic ratio for PEG. 
Equation 5.4: Crosslink density calculation, where Me is the number average molecular 
weight between crossllnks and u is the specific volume of PEG in the amorphous state. 
1 
Equation 5.5: Mesh size equation, where where ro is average end-to-end distance of the 
polymer, and V2,& Is the polymer volume fraction in the swollen state. 
5.3.9 Statistical Analysis 
Statistical analyses of stiffnesses and network parameters were performed using 
JMP (SAS Software, Cary, NC). Where appropriate, either one- or two-factor ANOVA 
was performed and fit to a least squares model. Subgroup means were compared with 
post-hoc Tukey's HSD testing with an a=0.05. When represented visually, data is 
expressed as mean ± standard error. Significance is denoted in figures with letters. 
Groups are significantly different if they do not share a letter. 
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5.4 Results 
5.4.1 Characterization and Verification of Polymer Products 
The molecular weight of the synthesized PEGDA was verified by mass 
spectrometry to be within 150 Da of the specified MW of the precursor (PEG) for all 
MW of PEG. The polydispersity index was calculated to be 1.053, 1.007, and 1.0574 for 
3400, 6000, and 8000 Da PEGDA, respectively. Acrylation efficiency was verified by the 
presence of peaks at 3 ppm with NMR for all PEGDA samples. Percent methacrylation 
for heparin was 6.8% (spectra in Appendix 11).[158] 
5.4.2 Hydrogel Material Properties 
As expected, decreasing the molecular weight of the PEGDA in unmodified, 
acellular hydrogels (containing no Hep-MA) resulted in stiffer gels in flexure (Figure 
5.4). For equivalent weight fractions, gels in compression (Figure 5.5) showed similar 
modulus to that of gels in flexure, so it was concluded that the stiffnesses measured by 
the flexure device were valid. Compressive stiffness of the unmodified, acellular 
hydrogels was observed to increase with increasing weight fraction and to decrease with 
increasing molecular weight. 
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Figure 5.4: Flexural stiffness of base PEGDA hydrogels (unmodified; containing no Hep-
MA). Hydrogels were all 10% PEGDA by weight. Samples marked with different letters are 
significantly different at 0=0.05. N=6 for all sample groups. 
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Figure 5.5: Compressive stiffness of base PEGDA hydrogels. Flexural stiffnesses are on 
the same order of magnitude as compressive stiffnesses for the 10% weight fraction 
hydrogels. Samples marked with different letters are significantly different at 0=0.05. N=6 
for all sample groups. 
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Since heparin is a charged molecule, inclusion of heparin was expected to alter 
the swelling properties of the gel, although it was unknown what impact there would be 
on the material properties. In acellular gels containing 0.5 mM Hep-MA (Figure 5.6), 
stiffness again showed the pattern of being significantly increased with increasing weight 
fraction within each molecular weight (p < 0.05). 
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Figure 5.6: Flexural stiffness of acellular gels containing 0.5 mM of Hep-MA. N=3-6 for all 
groups and samples marked with different letters are significantly different at a=0.05. 
Interestingly, there was either no change in stiffness or a trend of increasing 
stiffness with increasing molecular weight, which was opposite from what was expected 
given the data patterns from testing of unmodified PEGDA hydrogels (Figure 5.4 and 
Figure 5.5) . To evaluate whether this deviation from the expected pattern was due to the 
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methacrylation of heparin, PEGDA hydrogels containing unmodified heparin (0.5 mM) 
were tested in flexure (Figure 5.7). 
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Figure 5.7: Flexural stiffness of representative groups of PEGDA hydrogels containing 0.5 
mM unmodified heparin. N=3-6 for all groups and samples marked with different letters 
are Significantly different at a=0.05. 
Although there was no difference in hydrogel flexural stiffness between entangled 
unmodified heparin and Hep-MA for the lower molecular weights of PEG, stiffness of 
the 8 kDa PEGDA hydrogels was significantly lower for the unmodified heparin case, at 
PEGDA weight fractions of both 10% (Figure 5.7, p < 0.01) and 15% (70 kPa for 
unmodified heparin vs. 209.7 kPa for Hep-MA, results not shown on figure, p < 0.01). To 
determine whether Hep-MA interfered with stiffness in a concentration-dependent 
manner, hydrogels containing either 0.5 or 1.0 mM Hep-MA were tested in compression. 
The 3.4 kDa PEGDA hydrogels with greater Hep-MA concentration were less stiff 
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(Figure 5.8), but there was no significant effect of Hep-MA concentration at the higher 
molecular weights of PEGDA. 
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Figure 5.8: Compressive stiffness of PEGDA discs with containing Hep-MA at 
concentrations of either 0.5 or 1.0 mM. N=3-6 for all groups and samples marked with 
different letters are significantly different at 0=0.05. 
It was also noteworthy that for these hydrogels tested in compression, the inverse 
relationship between stiffness and molecular weight was again present, i.e., the addition 
of heparin to PEGDA hydrogels affected the flexural characteristics more than the 
compressive behavior. 
Finally, cell seeded PEGDA gels with 0.5 mM Hep-MA were tested in flexure 
(Figure 5.9). These samples demonstrated trends that were very similar to the flexural 
stiffnesses of acellular hydrogels containing Hep-MA (Figure 5.6). 
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Figure 5.9: Flexural stiffness of cell-seeded gels. N=3-6 for all samples. Samples marked 
with different letters are significantly different at a=0.05. 
Within each molecular weight, stiffness increased with increasing weight fraction 
(p<0.05). Additionally, stiffness was either unaffected or generally increased with 
increasing molecular weight, in contrast to the patterns shown in Figure 5.5 and Figure 
5.8. It was also evident that the inclusion of cells reduced the hydrogel stiffness for all 
formulations compared with the acellular gels (p<0.05). 
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5.4.3 Network Properties of Acellular Hydrogels 
The network properties of the gel were investigated to verify observed mechanical 
phenomena, and to ensure that diffusional properties were sufficient for cell viability and 
immunostaining. For hydrogels prepared without heparin, molecular weight between 
crosslinks decreased with increasing weight fraction and increased with increasing MW, 
as expected (Table 5.1). Adding Hep-MA to these gels resulted in a similar pattern at 3.4 
and 6 kDa, however this trend was lost at the highest molecular weight (8 kDa). 
Decreasing molecular weight between crosslinks typically results in a stiffer gel, so these 
results were consistent with the material behavior of the unmodified (base) hydrogels. 
For the hydrogels containing Hep-MA, this relationship between molecular weight 
between crosslinks and stiffness was only evident for the lowest molecular weight 
PEGDA hydrogels (3.4 kDa). As shown in the table, mesh sizes in the base and 
heparinized hydrogels demonstrated the same data patterns, or lack thereof, as found with 
molecular weight between crosslinks. Swelling ratios for the various hydrogel 
formulations slightly increased with PEG molecular weight, but this effect was much less 
pronounced than for the other network properties. Swelling ratios decreased with 
increasing weight fraction of PEGDA. Finally, the overall magnitude of mesh sizes, and 
swelling ratios were lower for the heparinized hydro gels compared with the base 
hydrogels. However, molecular weight between crosslinks was only significantly lower 
in the heparinized gels than the base gels within at the 6000 kDa, 5% and 8000 kDa, 5% 
formulations. The impact of formulation on network parameters described in is 
illustrated visually with three figures along with omitted network property data in 
Appendix II. 
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positive cells were sparse in all gels, and were not seen at all in the 15% w/v, 6000 and 
8000 Da gels (Figure 5.10). 
Table 5.2: Percentage of cells expressing alpha smooth muscle actin (top Item) and prolyl-
4-hydroxylase (bottom Item) In each composition of gel. NitS for all samples. 
Weight Percentage of cells expressing 
Molecular Fraction marker:t standard error 
Weight (Oa) (%) cxSMA P4H 
5 0.68 ± 0.06 0.01 ± 0.02 
3400 10 0.70 ± 0.06 0.14 ± 0.02 
15 0.71 ± 0.05 0.02 ± 0.01 
5 0.90 ± 0.05 0.06 ± 0.01 
6000 10 0.47 ± 0.06 0.00 ± 0.02 
15 0.72 ± 0.05 0.03 ± 0.01 
5 0.56 ± 0.06 0.02 ± 0.01 
8000 10 0.12±0.06 0.00 ± 0.02 
15 0.11 ± 0.06 0.00 ± 0.02 
10 0/ 0 15 % 
6000 Da 
8000 Da 
3400 Da 
6000 Da 
8000Da 
Figure 5.10: Representative immunostaining of (A) alpha smooth muscle actin and (8) 
prolyl-4-hydroxylase in cell-encapsulated hydrogels for each composition of hydrogel. 
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5.5 Discussion 
Hydrogels are rapidly garnering interest within the valve community as potential 
scaffolds for TEHVs, but further investigation is needed about the ability of hydro gels to 
support the culture of VICs and about their material behavior, particularly in flexure. In 
contrast to the large body of information about TEHV s generated using polymer meshes 
or foams, the study of VIC encapsulation within hydrogels is in the nascent stage, with 
only three studies currently published, albeit with some differences to the hydrogels 
materials presented in this chapter.[57, 69, 112] The function ofVICs encapsulated in 
PEG hydrogels was investigated in a recent paper by Benton et al. [87] Although previous 
work has focused on the important characteristics of cell phenotype and function, it is just 
as relevant to examine material properties, due to both the mechanical demands of the in 
vivo environment as well as the impact of pericellular substrate stiffness on cell function. 
Furthermore, since flexure constitutes a major mode of deformation for heart valves, and 
it is reported that maximum sites of stress are due to flexure in the in vivo 
environment[3], it is prudent that any potential TEHV scaffold undergoes flexural 
characterization in vitro. It has been reported that the incorporation of heparin into 
hydrogels is necessary to maintain the normal phenotype ofVICs (in 20 culture), 
however, recently published data has demonstrated methods to preserve VIC phenotype 
by careful choice of gel formulations.[2, 87] This data was the motivation for the use of 
methacrylated heparin in this manuscript. By methacrylating heparin, it can be covalently 
bonded to the hydrogel bulk and its bioactivity can be retained. The tests performed in 
this study demonstrated that functionalizing the gels with immobilized heparin caused 
flexural stiffness to decrease. However, the resulting range of flexural moduli (up to 400 
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kPa), even in the hydrogels containing Hep-MA (up to 200 kPa) and encapsulated cells 
(up to 160 kPa), while lower than that of native tissue (703.05 kPa against curvature, 
491.69 kPa with curvature[133]; we perfonned 3-point bending on a limited number of 
A V leaflets with our tester and obtained results on the same order of magnitude), was on 
the order of magnitude of both bovine pericardium (400 kPa cross fiber [127], commonly 
used in bioprosthetic valves) and virgin PGAIPLLA meshes (-250 kPa [53], commonly 
used for valvular tissue engineering). 
The network properties, which were calculated to characterize these hydrogels 
further, suggested that the incorporation of Hep-MA disrupted network fonnation by the 
crosslinked PEGDA. For example, it was expected that lower values for molecular 
weight between crosslinks would correspond to stiffer gels. Indeed, when considering 
each hydrogel class (i.e., heparinized) separately, molecular weight between crosslinks 
followed the expected trends of decreasing with increasing weight fraction and increasing 
with increasing molecular weight. When comparing gels with and without heparin, the 
incorporation of heparin did not statistically impact the molecular weight between 
crosslinks of the resulting gels (with the exception of6 kDa, 5% and 8 kDa, 5%). This 
result indicates that there are additional phenomena that govern gel stiffness when 
heparin is immobilized within the network. One potential explanation is that the negative 
charge or size of the heparin molecule could be interfering with network fonnation, thus 
inhibiting complete crosslinking of the PEGDA gel. This explanation was tested by 
varying the concentration of Hep-MA in gels in compression and it was confinned that 
gels containing 1.0 mM Hep-MA were less stiff than gels containing 0.5 mM Hep-MA 
(Figure 5.8). To investigate whether this was a size dependent phenomena, gels were 
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doped with unmodified heparin. Gels doped with 0.5 mM heparin were less stiff than gels 
functionalized with the same concentration of Hep-MA, suggesting that the potential 
multiple crosslinking sites per heparin molecule increase stiffuess, and that chain 
entanglement is not the only means of retaining the heparin molecule. Collectively, these 
studies indicate that the negative charge of the heparin molecule is likely inhibiting the 
formation of radical polymerization sites, and that incomplete crosslinking is obtained 
when either Heparin or Hep-MA is included. The number of potential reactive sites per 
heparin-MA chain was calculated to be 2.5. This inhibition of complete crosslinking, 
however, appears to be mitigated by the inclusion of Hep-MA due to its ability to 
crosslink with PEGDA (through the reactive sites on the molecule). The other network 
properties (swelling ratio, mesh size) showed trends that were comparable with molecular 
weight between crosslinks. Mesh size was additionally investigated to ensure that 
molecules could diffuse through the gel. Mesh size ranged from ~50-l80 A, which is 
sufficiently large enough to allow the diffusion of molecules such as IgG.[159] 
The finding that the addition of heparin or Hep-MA reduced the flexural stiffness 
of PEGDA hydro gels was in contrast to the results of Beamish et aI., who reported that 
the incorporation of PEGylated moieties into the gel actually increased the bulk material 
stiffness.[160] Their finding was also surprising, given that it was expected that these 
additions would decrease the stiffness due to network interruption. Together, these works 
emphasize the importance of investigating the mechanical consequences of adding 
monoacrylated PEG or other functional sequences (peptides, glycosaminoglycans) to 
these hydro gels, in addition to the effects of these biofunctional moiety inclusion on cell 
phenotype and synthetic ability, which has received far more attention. The effect of 
bioactive moiety incorporation on hydrogel mechanics is important, and significant 
enough to merit its own study. 
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The incorporation of cells into the hydrogels profoundly decreased flexural 
stiffness, which was most likely caused by their cytoskeletal stiffness and total volume 
fraction. [161] This decrease in stiffness seen in cellularized gels could also be due to the 
high cell concentrations causing UV scattering, thereby decreasing crosslinking 
efficiency. It is unlikely that cells are either degrading or synthesizing matrix in the 
amount of time between encapsulation and mechanical testing (48 hours). Because the 
concentrations of cells typically used in TEHVs are rather high, it is necessary to plan for 
their effects on hydrogel mechanics. [87, 112] Furthermore, the impact of hydrogel 
swelling on cells has been understudied. Gel swelling could potentially "prestrain" the 
encapsulated cells, however, for compositions chosen in this chapter, this effect of 
swelling was likely modest due to both the small volumetric swelling (the resulting strain 
is substantially lower than what is typically imparted in a mechanical conditioning study) 
exhibited by the chosen formulations and the immaturity of adhesions between embedded 
ligands and cells during the swelling period. Gel formulations with very high molecular 
weight (20 and 35 kDa, results unpublished) demonstrate very high volumetric swelling 
and it will be necessary to characterize the mechanical forces imparted due to the cells by 
swelling phenomena. 
The concentration of cells used in this study (22 million cells/ml) is representative 
of the range of cell concentrations employed in other hydrogel studies.[43, 57, 87, 112] In 
the future, it will be of interest to evaluate the impact of cell encapsulation on hydrogel 
mechanics in a concentration-dependent manner. Furthermore, the immunofluorescence 
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showed that as gel stiffness increased, the proportion of cells positive for aSMA 
decreased. The stiffest gel compositions tested (15% w/v with 6000 and 8000 Da 
PEGDA, 100 and 150 kPa respectively) showed the lowest proportion of cells expressing 
aSMA. P4H expression was low throughout all gel compositions, which potentially was 
due to the short culture duration. 
In conclusion, since bending is a major mode of deformation for valves, it is 
crucial to investigate the flexural properties of the materials being considered as TEHV 
scaffolds. This study is the first to examine flexure of cell-seeded hydrogels. 
Understanding the bending behavior of cell-seeded, homogeneous hydrogels will permit 
the creation and characterization of scaffolds with more complicated architectures in the 
drive to mimic heart valve tissue mechanics more closely. It is important to note that the 
hydrogels used in this study lacked any cell-degradable motifs, however these 
incorporations will be necessary to include as the scaffold architecture becomes more 
complex to enable the cells to synthesize matrix, migrate, and remodel the scaffold prior 
to implantation. Furthermore, this work adds to the recent publication by Beamish et 
al. [160] in demonstrating that the addition of other crosslinkable groups to PEGDA can 
radically change the mechanical behavior of the hydrogel. It will be important to 
consider and account for all of these effects in the design of more complex biomaterials. 
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Chapter 6: Fabrication and Mechanical Evaluation of 
Anatomically-Inspired Advanced Hydrogel 
Structures * 
6.1 Introduction 
As described in the previous chapter, many traditional hydrogel materials are 
being investigated for use in heart valve tissue engineering. These materials include 
natural gel materials such as fibrin, collagen, and hyaluronic acid as well as synthetic 
materials, such as poly (ethylene glycol) diacrylate (PEGDA). The synthetic class of 
materials is particularly interesting because they are intrinsically biologically compatible 
and permit the rapid encapsulation of cells in a cytocompatible environment. 
Furthermore, synthetic hydrogels can be modified extensively to tune their biochemical 
and biomechanical characteristics. However, generally these hydrogels do not yet possess 
sufficient mechanical strength for use in animal models or clinical applications of heart 
valve replacement. Furthermore, PEGDA hydrogels are fundamentally elastic, isotropic 
materials, whereas heart valve leaflets are layered, viscoelastic, and demonstrate 
anisotropic material behavior. These unique material characteristics of the valve leaflet 
allow the valve to undergo many loading-unloading cycles and a complete reversal of 
• The majority of this chapter is being prepared for submission to Advanced Materials 
and will be published as: Durst CA, Cuchiara MP, Lin CJ, West JL, Grande-Allen KJ. 
Fabrication and Mechanical Evaluation of Anatomically-Inspired Advanced Hydrogel 
Structures. 
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curvature upon opening. [3, 9] Moreover, the layered structure of the leaflet is believed to 
aid in shielding the cells in the interior layer from high stresses.[134] This chapter will 
discuss newly developed methods to fabricate quasilaminate structures with each layer 
having distinct cellularity and material properties. The resulting gels have different bulk 
material properties than single-component, single-layer (slab) gels. Additionally, this 
chapter will discuss the incorporation of valve anatomy-inspired patterns of 
reinforcement into hydrogel slabs. This work forms the basis for fabrication of truly 
advanced leaflet scaffolds that could address the current physical limitations of basic 
hydrogels when applied as scaffolds for valve leaflet engineering. 
6.2 Background 
Anisotropy, which refers to something having different properties depending on 
the direction of measurement, is widely observed in biological tissues, and arises due to 
the specific mechanical demands placed on the tissue. It is commonly seen in load 
bearing tissues such as heart valve leaflets, aortic tissue, intervertebral discs, cartilage, 
and connective tissue (e.g. tendons and ligaments). Most tissues exhibiting anisotropy 
behave in a similar manner as soft fiber-reinforced composites, in which the fiber and 
matrix can dissipate energy by large inelastic deformations[162]. The anisotropy of 
valve leaflets allows them to withstand the complex mechanical environment imparted by 
the heart. During the cardiac cycle, leaflets are exposed to shear, tension, compression, 
flexure, or a combination of any of these phenomena. The valve undergoes large radial 
elongations and a complete reversal of curvature during opening and closing, and the 
layered, anisotropic nature of the leaflet permits this movement.[9] In the aorta, the high 
119 
circumferential strength of the tissue is governed by the preferential orientation of fibers 
and multiple lamina, permitting the aorta to withstand high pressure without failure. [163] 
Intervertebral discs are comprised of the annulus fibrosus (fibrocartilage) which 
surrounds the nucleus pulposus (gelatinous).[164] The annulus fibrosus is anisotropic and 
comprised of concentric layers of aligned co llagen fibers and proteoglycans. [165] The 
gelatinous nature of the nucleus pulposus gives resistance to compression (dissipation of 
energy hydrostatically).[166] This geometry yields a tissue that is able to distribute and 
absorb the large complex loading (a combination of tension, shear, compression, and 
bending) imparted by the spine. [164, 167] In general, native tissues demonstrate 
anisotropy as part of a unique material behavior that allows the tissue to maintain proper 
function in its in vivo mechanical environment. 
The aortic valve is a multilayered structure, with each layer possessing distinct 
ECM components (described in Section 2.1.3). The orientation and mechanical 
characteristics of these components gives each layer unique material properties, in 
addition to giving the overall leaflet anisotropic, viscoelastic behavior. For example, the 
corrugations found in fibrosa layer give the leaflet its characteristic high extensibility 
when strained in the radial direction, while the circumferential orientation of crimped 
collagen fibers allows for some extension (while the collagen is uncrimping) before the 
load is primarily borne by the collagen fibers. [167 -169] Crimp period and amplitude 
corresponds to the degree of circumferential extensibility exhibited by the leaflet. [170] 
Furthermore, since each layer has distinct ECM components, the stiffness of each layer is 
distinct.[12] The varying stiffness found in the valve (with the center layer, the spongiosa 
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exhibiting the lowest stiffness) is thought to shield the cells within from the majority of 
the significant stresses generated during valve opening and closure. [134] 
Furthermore, the highly hydrated nature of the spongiosa (due to its rich 
proteoglycan content), gives the valve its compressive load-bearing ability.[154] These 
layer-specific properties allow the valve to undergo many cyclic loading-unloading 
cycles during the cardiac cycle. The purpose of this study was to implement methods for 
generating (i) a range ofbio-mimetic anisotropic features and (ii) layered structure within 
poly(ethylene glycol) diacrylate hydrogels. We hypothesized that developing methods to 
mimic these microstructural features would create an improved scaffold for valve tissue 
engineering, as well as having broad applicability to engineering of other layered or 
anisotropic tissues. 
Anisotropic tissues have been modeled as soft fiber-reinforced composites. [162, 
167, 171, 172] In this case, we have assumed that the essential anisotropic aspects of the 
valve behavior are generated by collagen embedded within a softer matrix, which 
inspired our experimental hydrogel architecture. We hypothesized that the bulk 
anisotropic behavior of valve leaflets could be mimicked by the combination of a soft 
hydrogel matrix (8 kDa MW, 5% w/v) with stiff hydrogel reinforcements (3.4 kDa MW, 
15% w/v). The reinforcements were designed to replicate collagen fibers, with 
reinforcement thicknesses of either 88 or 176 Ilm, a crimp period of 10 mm, and a crimp 
amplitude of 2 mm. [173] This reinforcement was accomplished using 2D 
photolithographic patterning (PLP) techniques that were initially developed for 
semiconductor fabrication and recently applied to soft hydrogels in Dr. Jennifer West's 
laboratory.[65, 78] Other potential ways of creating true fiber reinforcements could 
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include directly embedding polycaprolactone (peL) fibers in hydrogels, which our group 
is also beginning to pursue. While this latter approach will yield a true fiber-reinforced 
soft material, it employs electrospinning. Electrospinning permits the fabrication of 
anisotropic meshes, but is highly sensitive to operating parameters. [I 74] In addition, 
electro spinning operating conditions can be damaging to cells, so cells must be seeded 
post-fabrication. [118, 174, 175] Other groups are investigating inducement of anisotropy 
in hydrogels by application of strain while polymerizing (using freeze-thaw 
crosslinking)[88], control of secondary crosslinking by patterning [89], and direct 
embedding of fibers [90, 91], however, many of these methods prohibit the direct 
encapsulation of cells. 
In contrast, PLP is an inexpensive, fast method that can control spatial diffusion 
of a secondary interpenetrating polymer network within a hydrogel. This patterning 
technique has been previously used to create high fidelity patterns with distinct edges in 
hydrated PEGDA gels.[78] This technique employs the use ofa photomask, which is 
printed on acetate from a traditional high-resolution printer. The mask is then laid on a 
hydrogel soaked in the unpolymerized secondary polymer solution, and re-exposed to UV 
light. In the previous study, a variety of complex geometries with high fidelity were 
achieved, with minimum feature size of --40 f.lm.[78] This technique was originally used 
for creation of distinct patterns of bioactivity, but has since been used to create distinct 
patterns of elasticity. [65] Nemir et al. showed that significant differences in bulk 
modulus could be achieved between the reinforcement direction and the lateral direction 
(00 and 900 to pattern direction, respectively). The PLP technique was similarly 
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employed in this work to generate anisotropic patterns generally mimicking those found 
in heart valve leaflets. 
Layered hydrogel structures have been reported infrequently in the literature over 
the previous 15 years, exploiting a variety of "lamination" strategies. Lu et al. 
demonstrated a multilayer fabrication technique using poly(hydroxyethyl methacrylate) 
and diethylene glycol methacrylate that allowed photocrosslinking of multilayered 
hydrogel structures where each layer had the same formulation.[92, 93] These studies 
were performed to characterize a drug delivery technology, where material properties 
were not a primary concern. As a result, no mechanical data was available from these 
initial reports. The studies performed by Lu et al. informed the design of the serial 
layering method described in Section 6.3.5.1. The first (and to our knowledge, only) 
published study demonstrating hydrogel layering where each layer had distinct 
composition was performed by Temenoff et al. using a oligo(PEG fumarate) with 
molecular weights of 860, 3900 and 8900 Da chemically crosslinked with PEGDA 
(molecular weight of 575 Da).[85] The 1 sl OPF:PEGDA mixture was injected into a 
mold, allowed to crosslink for 15 minutes at 22°C, and then the second layer was added 
and crosslinking was completed at 60°C for an additional 15 minutes. Temenoff et al. 
showed that a strong interface between layers with different compositions could be 
achieved. Furthermore, these studies showed that differential swelling as a result of using 
varying formulations in each layer was a significant problem that needed to be accounted 
for, since it frequently resulted in gel tearing. More recently, Cuchiara et al. demonstrated 
that PEGDA could be serially molded with PDMS to produce microfluidic channels. This 
method demonstrated that PEGDA of the same composition could be self-layered using a 
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photocrosslinking method. The method used in this chapter is analogous to the sandwich 
layering method described in Section 6.3.5.2 and was developed in parallel with the 
methods published in the manuscript by Cuchiara et al.[79] These methods served as the 
foundation for both the developed serial and sandwich layering techniques described in 
this chapter. While these studies served as a guide for the work performed in our studies, 
the research presented in this chapter represents the first successful efforts to: (i) fabricate 
trilayer composite hydrogels, (ii) rigorously test the interface strength of multilayer 
photopolymerized hydrogel structures, (iii) mechanically characterize multilayer PEGDA 
scaffolds with layer-specific composition. 
6.3 Materials and Methods 
6.3.1 Study Design and Statistical Analysis 
The objective of this study was to apply advanced hydrogel fabrication techniques 
to mimic the anatomic features of the aortic valve that promote the unique material 
behavior of the leaflets. We believe that by incorporating properties that allow the 
hydrogel to approximate more closely the behavior of the native tissue, a superior TEHV 
scaffold will be realized. Furthermore, development of these techniques will have 
applicability to diverse tissues, such as those listed in Section 6.2. 
For an overview of the research design, this work was divided into two studies: 
layering and patterning. First, the layering method was evaluated by preparing hydrogels 
with layers of distinct composition (quasilaminate gels). These gels were then subjected 
to interfacial failure testing to find the optimal formulation for a quasilaminate gel. The 
124 
"stiff-soft-stiff' quasilaminate gels were prepared both with and without cells, tested in 
flexure, and compared with acellular and cellular single layer controls. Additionally, cells 
encapsulated in quasilaminates were imaged with a confocal microscope to verify that 
viable cells remained after the layering procedure. Second, patterned gels were prepared 
across a sample space that contained a variety of feature thicknesses, while holding fixed 
the total amount of patterned material. These gels were then subjected to uniaxial tensile 
testing to determine the presence of anisotropy and the relative contribution of the pattern 
to the material behavior. Sample sizes were chosen based on prospective statistical power 
calculations. Using two-way ANOV A comparison ofthe row*col means, where 
detectable contrast was set at 0.4, standard deviation was set at 0.2 [83, 84], and n=10, 
statistical power was observed to be 0.9296. 
Statistical analyses of stiffness and interface strength were performed using JMP 
(SAS Software, Cary, NC). Where appropriate, either one- or two-factor ANOVA was 
performed and fit to a least squares model. Sample group means were compared with 
post-hoc Tukey-Kramer HSD and a=0.05. When represented visually, data was 
expressed as mean ± standard error. 
6.3.2 Polymer SyntheSiS 
PEGDA was prepared using previously described methods (Section 5.3.3). Gels 
were polymerized from pure PEGDA and did not contain any additional bioactive 
moieties. The photo initiator 2-Hydroxy-4' -(2-hydroxyethoxy)-2-methylpropiophenone 
was dissolved in ethanol at 10% (w/v) and added to the prepolymer solution at 3% (v/v). 
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The resulting solution was sterile filtered before use and polymerized as described below 
(Sections 6.3.5.1,6.3.5.2, and 6.3.6). 
6.3.3 Cell Culture 
Cell culture was performed in the same manner as in Section 5.3.2. 
6.3.4 Interface Strength Testing 
To ensure that the layering technique yielded robust interfaces that would remain 
bonded during handling and culture, the strength of the interface was tested. Additionally, 
it was necessary to investigate what "soft" formulation would yield the strongest bond. 
For the purposes of this chapter, the higher stiffness polymer formulation will be referred 
to as prepolymer A, and the lower stiffness hydrogel formulation will be referred to as 
prepolymer B. Prepolymer A was selected to have a molecular weight of 3.4 kDa and a 
weight fraction of 12.5%. Previous experiments (Table 5.1) showed that this formulation 
swells compatibly with a range of other PEGDA formulations. Prepolymer B was either 6 
kDa, 10% (w/v) or 8 kDa, 5% (w/v). Layered gels were prepared by filling a I" x 3" 
mold halfway with prepolymer A, exposing for 4.5 minutes, and then filling completely 
with prepolymer B and re-exposing for 10 minutes. The resulting gels were swollen for 
48 hours in cresyl violet acetate in PBS (0.4 mglmL) to visualize the stiffer (top) layer 
(Figure 6.1). The gels were punched into a dogbone shape for uniaxial tensile testing 
where the interface was placed at the center of the dogbone (Figure 6.2). The punched 
dogbone-shaped strips were then glued to 1 x 1 cm pieces of paper with Loctite 401 
126 
(Loctite, Dusseldorf, Germany). The pieces of paper were then loaded into the grips of an 
Instron Model 3340 (Instron, Norwood, MA) uniaxial mechanical tester and pulled to 
failure at a rate of 6 mmlmin. The maximum stress of the 5 samples acquired by the 
software prior to failure was averaged to obtain the failure stress value for each hydrogel 
specimen. All experiments were recorded with high-speed videos, which were later 
analyzed to ensure that the samples did not fail at the layer interface. 
Figure 6.1 : Dogbone punched hydrogel strips loaded in mechanical tester for interface 
strength determination. The stiff layer can be seen in purple at the top, and the soft layer 
has the faint violet tint at the bottom. 
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6.3.5 Layering 
Trilayer quasilaminate gels were fabricated with A-B-A architecture, where the A 
layers were of different composition than the B layer. The A layers were of higher 
stiffness due to their lower molecular weight and higher weight fraction than the B layer. 
A was composed of 12.5% (w/v) 3400 kDa PEGDA and B was composed of 10% (w/v) 
6000 kDa PEGDA. Single layer controls were prepared for both the A and B 
formulations. Since the B layer was the only layer to be cellularized in the quasilaminate, 
acellular and cellular single layer controls were prepared for this formulation to elucidate 
the effect of cell encapsulation on stiffness. 
6.3.5.1 Serial Layering 
Quasilaminate gels were prepared using a serial layering technique when desired 
layer thickness was greater than 1.0 mm (Figure 6.3). First, molds were prepared by 
coating 3" x 2" glass slides with Sigmacote (Sigma, St. Louis, MO), a silicone surface-
coating lubricant in heptane, yielding glass slides with a tough, slick coating. The slides 
and PTFE spacers were then steam sterilized in an autoclave. Spacers with desired strip 
geometry and thickness were placed between two coated slides. The resulting well was 
filled with the first prepolymer solution and exposed to UV light for 7 minutes. One slide 
was removed, an additional spacer was added, and the slide was replaced. The resulting 
space was filled with the next prepolymer solution, which was allowed to diffuse into the 
gel for a minimum of 4 hours. The next layer was fully crosslinked with UV exposure for 
7 minutes. This process can be iterated stepwise to achieve the desired number of layers. 
Serial layering to fabricate quasi-laminate scaffolds with variable composition 
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6.3.5.2 Sandwich Layering 
When desired layer thickness was below 1.0 mm, a sandwich layering technique 
was used to ensure reliable bonding between layers. Again, molds were prepared by 
coating 3" x 2" glass slides with Sigmacote (Sigma, St. Louis, MO), a silicone surface-
coating lubricant in heptane, yielding glass slides with a tough, slick coating. The slides 
and PTFE spacers were then sterilized in an autoclave. Spacers with the desired strip 
geometry and thickness were sandwiched between one untreated slide and one slide 
coated with Sigmacote (Figure 6.4). Prepolymer solution A was pipetted into the molds 
and two filled molds were exposed to longwave UV light at the same time. The untreated 
slide was placed closest to the illumination source for 4.5 minutes. Following exposure, 
the slide coated with Sigmacote was removed; resulting in an underexposed (gelatinous) 
slab remaining adhered to the untreated slide. Next, another PTFE spacer was added and 
the two slides with underexposed gels were brought together (yielding an A-empty-A 
assembly, 3 spacers used total). This technique is shown in Figure 6.4. Prepolymer B was 
added to the void between slab gels and the assembly was exposed to UV irradiation for 
10 minutes, rotating 1800 about the length and width of the slide at 5 minutes. 
6.3.6 Photolithographic Patterning 
Photolithographic patterning was used to impart regions of stiffness to hydrogel 
scaffolds. Pilot studies to investigate feasibility of various pattern geometries and 
contribution of reinforcement to bulk stiffness were performed. Masks used in pilot 
studies were created from custom MA TLAB code to generate biologically inspired 
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patterns including linear reinforcement, "skewed" reinforcement (random linear stripes 
with ± 25 0 from the long axis of the mask), and sinusoidal reinforcement. Pilot data 
suggested that stripe and sinusoidal patterns were the most likely to demonstrate 
anisotropic tensile behavior, so these were tested more rigorously while holding total 
coverage fixed. For final PLP studies, patterns were created using Adobe Illustrator. 
Parameters that were varied for both linear and sinusoidal patterns were stripe thickness, 
stripe spacing (as a function of total coverage). Negative (inverted polarity) versions of 
these patterns were then transferred to acetate sheets by CADI Art Services (Bandon, OR) 
at 10,000 dpi, resulting in high-resolution photomasks (Figure 6.5). 
To create pattern-reinforced gels, slab gels were generated by pipetting polymer B 
(5% wlv, 8 kDa) into a mold comprised of two slides coated with Sigmacote separated by 
a 0.5 mm PTFE spacer. This was exposed to UV light for 7 minutes, rotating 1800 about 
the length and width of the slide at 3.5 minutes. These slabs were then swelled in a 
solution of pre polymer A (15% wlv, 3.4 kDa) supplemented with initiator under argon at 
22 °C on a shaker table overnight. To pattern, molds were prepared by taping either a 
pure black strip or patterned piece of acetate (both 1" x 3") emulsion side up to a plain 
slide to give a black background and the patterned mask. A PTFE spacer with the 
thickness of the swollen gel was placed on top of the black background, the slab gel 
positioned inside the spacer (trimmed to fit), and the patterned slide was then laid on this 
assembly with the patterned acetate in direct contact with the hydrogel (Figure 6.6). This 
assembly was then exposed to UV light for 10 minutes, rotating 1800 about the length 
and width of the slide at 5 minutes. The uncrosslinked prepolymer was diffused out by 
placing the patterned gel in PBS on a rocker table for 48 hours (changes of PBS at 1, 2, 
12, and 24 hours). Patterns were visualized by soaking the gels in a solution of cresyl 
violet acetate (0.2 mg/mL, Sigma, St. Louis, MO) in PBS for 4 hours. 
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Figure 6.5: Photomask patterns tested for generating anisotropic gels. The first four linear 
patterns have the same level of total coverage, while varying the thickness of the 
patterned stripes (number shown in microns); as a result, spacing between stripes 
changes. The sinusoidal patterns have the same amplitude and period, but thickness of 
the pattern is varied. 
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6.3.7 Modeling of Photolithographically Patterned Gels 
Since the potential number of parameters that could be varied for the PLP gels 
was quite high, particularly the sinusoidally patterned gels, simple finite element 
modeling with COSMOSWorks (Dassault Systemes, Concord, MA) was performed in an 
attempt to predict bulk material behavior. Known material properties for PEGDA 
hydrogel formulations were input to SolidWorks as custom materials. Sinusoidal 
amplitude, spacing, and number of features was varied. The gels were then set with fixed 
geometry on the left edge, and a planar boundary on the right that could translate in one-
dimension (similar to a uniaxial mechanical tester). Von Mises stress was used to probe 
the stress distribution throughout the gel. Additionally, "simulated mechanical testing" 
was performed by running a series of simulations with applied loads ranging from 9.81 x 
10-3 to 3.924 N and then calculating the bulk strain in the gel. The applied stress was 
calculated and the simulated stiffness of the bulk was calculated. This simulated testing 
was performed to determine if the sinusoidally patterned gels deformed in a non-linear 
manner. 
6.3.8 Flexure Testing of Quasilaminates 
Flexure tests of the quasilaminates were preformed as in Section 5.2.5. To briefly 
summarize, samples were loaded in a custom 3-point bending tester and deformed at a 
rate of 1.5 mmlmin to a maximum linear deformation of 6 mm. Sample deformation was 
tracked optically with a Canon Rebel T2i recording high definition video at 60 frames per 
second. The resulting video was demultiplexed into 24-bit TIFF images and analyzed 
with parallel Matlab code that performed digital image correlation similar to what was 
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described in Chapter 5. Because these calculations were extremely computationally 
demanding, they were performed using the distributed computing feature of Matlab on 
SUG@R (Shared University Grid @ Rice). 
6.3.9 Mechanical Testing of Photolithographically Patterned 
Gels 
Uniaxial tensile testing was performed as above (Section 6.3.4) with the following 
modification. Patterned gels were punched with the dogbone punch at either 0° (along the 
length of the I" x 3" slab, hereby referred to as "with" direction) or 90° (along the width 
of the slab, hereby referred to as "perp" direction). These gels were then loaded into the 
tensile testing system as described in section 6.3.4 and tested in the same fashion. 
6.4 Results 
6.4.1 Layering Results 
Pilot studies using the serial layering method yielded quasilaminates that were 
strongly adherent at layer thicknesses that were greater than 1.0 mm (Figure 6.7), 
however, when this was scaled down to a thickness that was appropriate for flexure 
testing, spontaneous delamination of one or more layers was commonly observed. 
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Figure 6.7: Quasiaminates formed with serial layering method. Bilayer and trilayer 
quasilaminates could be formed with this method, however, they could not be formed with 
layers under 1.0 mm in thickness. "a" a higher molecular weight polymer, and "b" is a 
lower molecular weight polymer. Preferential cresyl violet staining can be seen in the 
higher stiffness layers. The top gel was formed in a steel mold, and the curving interface 
was a result of surface tension. 
Regardless of the formulation chosen for the "soft" layer (prepolymer B), gels did 
not fail at the layer interface when prepared using the sandwich layering method (Figure 
6.8A) Since the gels with soft layers having low molecular weight and high weight 
fraction (6 kDa/l 0%) showed a much higher failure stress than the gels with high 
molecular weight and low weight fraction (8 kDa/5%), the low molecular weight with 
high weight fraction (6 kDaJI0%) formulation was chosen for layering studies (Figure 
6.8B). The higher failure stress could be accounted for by the increased stiffness shown 
by the low molecular weight-high weight fraction gels, resulting in a higher stress at 
analogous deformations. 
A 
B 
50000 
40000 
V) 30000 
I'd 
u 
V) 
I'd 
a... 20000 
10000 
* 
o -""'---- 6k/10% 8k/5% 
Soft Component Composition 
(MW (Da) IWF (w Iv» 
. Failure Stress 
. Stiffness 
138 
Figure 6.8: A) Representative images of tensile interface strength test demonstrating that 
failure does not occur at the interface between layers. The interface between layers is 
highlighted with the red arrow in the far right panel. B) Mean failure stress and bulk 
modulus for uniaxial tensile testing of quasilaminates. N~1 0 for all samples. * denotes 
significance with p < 0.0001. 
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Quasilaminates prepared with the sandwich layering method were significantly 
stiffer than both of the single-layer, single component gels (Figure 6.9). Since the inner 
layer of the quasilaminates was the only PEGDA formulation that was to be cellularized 
(in the experimental design), single layer controls were prepared both with cells and 
acellularly. In doing so, the effect of encapsulated cells on the flexural stiffness could be 
probed. Since the outer layer of the quasilaminates was not to be cellularized, this step 
was omitted for a single layer control. The encapsulation of cells at the concentrations 
used in this study did not significantly alter stiffness of the gels, so the acellular and 
cellular samples were pooled for comparisons of means. At cell densities above 10 * 106 
cells/mL, cell encapsulation significantly impacts scaffold modulus, but at lower cell 
densities this appears to not be significant (as evidenced by Chou et al. and confirmed in 
data presented in Chapter 5 and here).[176] Additionally, PEGDA can not be remodeled 
by the cells, and the culture durations were too short (2 days) for significant ECM 
synthesis to occur. Quasilaminates swelled to a mean thickness of 1.93 mm (1.5 mm 
original thickness, 128% of original), 3.4k112.5% single layer controls swelled to a 
thickness of 1.0288 mm (1.0 mm original thickness, 103% of original), and 6k11 0% 
single layer controls swelled to a thickness of 1.1053 mm (1.0 mm original thickness, 
111 % of original). 
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Figure 6.9: Flexure testing of quasilaminate hydrogels. The bulk flexural modulus of 
trilayer gels was higher than for the single layer bulk slab gels. The inclusion of cells did 
not significantly affect scaffold stiffness for either the softer single layer gels or the 
quasilaminate gels (in which cells were embedded in the softer inner layer only). 
Quasilaminates were significantly stiffer than both single layer gels and * denotes p < 
0.05. 
6.4.2 Behavior of Modeled Photolithographic Patterned Gels 
Internal stress analysis demonstrated that because of the vast difference in 
stiffness between the matrix (soft component) and the "fiber" (stiffer pattern), the 
reinforcement bore most of the stress due to bulk applied load (Figure 6.10). As the 
number of patterned reinforcement elements was increased, the matrix bore nearly zero 
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load. It is important to note that the model assumed that there was no slip between the 
reinforcement and the bulk matrix . 
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Figure 6.10: Simplified finite element analysis of scaffold deformation when reinforced 
with sinusoidal patterns of increased stiffness. The patterned regions bear the majority of 
the load applied to the bulk. 
Simulated mechanical testing showed that the sinusoidally patterned gel models 
showed linearly elastic behavior over the range of loads applied (Figure 6.11), in contrast 
to the desired nonlinear behavior. This behavior was confirmed when actual uniaxial 
tensile testing was performed on pattern-reinforced hydrogels, where the physical gels 
demonstrated linear-elastic behavior from 0-100% strain (as shown in the following 
section). 
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Figure 6.11: Simulated loads ranging from 9.81 x 10-3 to 3.92 N were applied to a FEA 
model of sinusoidally reinforced hydrogel. Bulk strain was calculated and the resulting 
stress-strain curve was plotted. In contrast to expected results, no nonlinear behavior was 
observed (linear fit r2=0.99981). 
6.4.3 Mechanical Properties of Photolithographically Patterned 
Gels 
Pilot studies were performed to investigate the feasibility of fabricating desired 
patterns (particularly sinusoidal patterns, Figure 6.12) at the feature size desired and to 
gain insight as to what parameters were most influential parameters on bulk stiffness. The 
patterns were imaged with cresyl violet acetate, which preferentially remains in the 
patterned (interpenetrating network) part of the gel. Initial samples showed that patterns 
of desired geometry and size yielded a range of stiffnesses in the bulk material (Figure 
6.13). 
Figure 6.12: Patterns used to investigate feature size and geometry. Pattern on right 
("skewed fibers") was highlighted with red lines to aid in visualization. Patterns were 
generated with custom MATLAB code available in Appendix VII. Dark purple indicates 
regions of pattern reinforcement and light purple is unpatterned gel. 
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Figure 6.13: Stress strain curves for a variety of patterns used in pilot study to investigate 
feasibility of desired feature size and geometry. 
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Patterned gels tended to be stiffer as pattern thickness increased while holding the 
total amount of pattern coverage fixed (Figure 6.14A). For gels patterned with stripes, the 
353 J.1m pattern showed the highest stiffness (significantly stiffer than all other stripe 
groups except 264 J.1m, where anisotropy was observed). For gels patterned with 
sinusoidal patterns, stiffness also significantly increased with increasing feature thickness 
(p < 0.0001). Anisotropy was demonstrated in the 264 J.1m stripe patterned group, where 
the "with reinforcement" direction was stiffer than in the perpendicular direction. 
Additionally, the unpatterned controls (black mask) and fully reinforced (clear film) 
controls were significantly less and more stiff than all samples, respectively (p < 0.0001). 
The relative contribution of pattern to stiffness could be observed when stiffness was 
normalized to the unpatterned control (Figure 6.14B). Generally, the trend of increased 
stiffness with pattern thickness was observed, regardless of sine or stripe patterning. 
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Figure 6.14: A) Tensile modulus of patterned gels. "Perp" indicates the samples were punched across (perpendicular) to the direction of 
the patterned features. "With" indicates samples were punched in the direction (0° to the long axis of the pattern) of the patterns. 
Anisotropy was observed in the 264 JIm stripe group. All patterned groups were significantly stiffer than the unpatterned control (black 
mask) and significantly less stiff than the fully reinforced control (clear mask). * denotes significance with a p < 0.001 and samples 
marked with different letters are significantly different with p < 0.05. N ~ 12 for all groups (Subgroups, which are the directional group 
within each feature type, have n ~ 6). B) Modulus normalized to stiffness of unpatterned slab gel. Reinforcement significantly increases 
the modulus in comparison with control, and relative stiffening contribution as a function of pattern can be seen. Statistical significance 
is identical to A. 
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6.5 Discussion 
The methods developed and implemented in the studies described in this chapter 
are the first to demonstrate strongly-bonded photocrosslinked multiphase hydrogels that 
remain well adhered after swelling. These methods allowed the development of a 
biphasic, trilayered composite hydrogel with distinct layers of stiffness and cellularity. 
Through empirical testing, a "swelling envelope" was determined that allowed the 
successful layering of hydrogel formulations with different material properties. 
Additionally, new patterns of reinforcement that demonstrate bulk anisotropic behavior in 
a fundamentally elastic, isotropic material were developed. 
6.5.1 Interface Testing 
In developing and optimizing the layering strategy, interface strength testing was 
performed to determine if different hydrogel formulations could indeed be successfully 
bonded in a serial or sandwich fashion. This study allowed the author to determine the 
formulations most likely to remain bonded after composite swelling. Since the 6k/10% 
formulation showed higher mean failure strength than the 8k/5% formulation, the 6k/lO% 
formulation was selected for the quasilaminate flexure studies. Additionally, the bulk 
stiffness of this composition was higher than that of the 8k/5% as expected. This data 
demonstrated that biphasic layered hydro gels could reliably be fabricated using standard 
photopolymerization methods, and that strong interfacial bonding was retained even post-
swelling. 
6.5.2 Development of Serial and Sandwich Layering Methods 
and Practical Setbacks 
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Development of the layering methods had several practical setbacks due to 
unexpected phenomena. The serial layering method was used to create gels with thick 
spacers (1.0 mm or greater) in order to refme the methods using hydrogel geometries that 
were easy to handle. This method was presumed to use interpenetration of the polymer 
chains. Studies performed in Chapter 5 demonstrated that the mesh size increases with 
increasing molecular weight of the polymer. Also, Flory-Rehner theory shows that lower 
molecular weight polymers have lower effective hydrodynamic radii. Therefore, to 
achieve layer-layer bonding with this methodology, a layer with high molecular weight 
was first polymerized. The next layer to be added, with lower molecular weight was 
added to the polymerized high molecular weight "slab" gel and allowed to diffuse in. 
This was repeated on the other side to yield the desired "stiff-soft-stiff' quasilaminate. 
These gels were ultimately too thick to test using the 3-point bending apparatus in our 
laboratory, and they had to be reduced in thickness to test the bending properties. When 
thinner spacers were machined and the gels were prepared according to the serial layering 
method, many gels "delaminated" after swelling. It was observed in a pilot study (data 
not shown) that when preparing gels for interface strength testing (where the gels are 
exposed "in cross-section" as described in section 6.3.4) very low diffusion times «30 
minutes) for interpenetration were needed to obtain firmly adhered layers. Diffusion time 
of the interpenetrating layer did not appear to have a significant effect on adhesion at the 
times measured. This may be because interpenetration occurs so quickly that it is difficult 
to measure or that interpenetration was not the main factor that governed delamination of 
148 
the quasilaminates prepared with the serial method. Results published by Cuchiara et al. 
showed that molecules with similar diffusivity to formulations tested in this chapter can 
penetrate more than 100 Jlm at times as low as 60 minutes.[79] Deep interpenetration of 
hydrogel prepolymer may not be necessary to achieve entanglement, and this may be why 
biphasic gels prepared in the serial manner showed adequate interface strength. Due to 
the strong adhesion that was apparent independent of interpenetration time and the 
difference in exposure profile (cross-sectionally vs. through the layer) for interface 
testing it was concluded that chain entanglement was not the actual cause of strong layer-
layer adhesion. It was then speculated that if scattering of UV irradiation was occurring 
in thicker quasilaminates at the side opposite the UV lamp, many unreacted acrylates 
could remain. Therefore, the sandwich layering method was tested to determine 
empirically ifunreacted acrylates could be used as a method to achieve strong layer-layer 
adhesion. This method yielded strong adhesion for the range of thicknesses tested (total 
initial thickness 0.75-1.5 mm) with no "delamination" of A-B-A quasilaminates. Another 
important factor in successful development of the quasilaminates was matching the 
swelling of the different layers. It was empirically observed that the mass swelling ratios 
for the formulations chosen needed to be within 5 (±2.5) of one another to ensure that the 
quasilaminates did not curl. This need to match swelling limited the potential 
formulations that could be used to form layers, although recently published work by Cha 
et al. has shown that material properties can be decoupled from swelling by incorporation 
of methacrylated alginate. [177] In the future, such decoupling methods should enable a 
vast range of potential formulations to be used with the layering techniques described in 
this work. 
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6.5.3 Interpretation of Quasilaminate Stiffness 
Although it was expected that the quasilaminates would have a bending stiffness 
between that of the single layer controls, the quasilaminates were actually stiffer than 
single layer gels. There are several possible explanations for this finding. The first 
explanation considers the effects of differential swelling on the sample geometry. We 
observed that the B layer ("soft", 6k110% formulation) swelled to 111 % of original 
thickness and the A layer ("stiff', 3.4k112.5% formulation) swelled to 103% of original 
thickness in single layer samples. If we assume that the swelling was similar in the 
quasilaminates, it follows that the two stiffer outer layers were located further from the 
neutral axis of bending than if all layers swelled equally, which could increase the 
"effective stiffness" of the composite. However, in a homogenous beam in bending this 
should be accounted for by the moment of inertia calculation in the Bernouilli-Euler 
equation (Equation 4.4). It is important to note that using an additive formula laminate 
composite moment of inertia yields the same moment of inertia as the standard equation 
for a rectangular cross section in bending.[178] These layered structures do have an axis 
of symmetry about the plane of bending, due to their A-B-A construction. Ifa layered 
structure with an asymmetric (i.e. A-A-B, A-B-B, A-B-C, etc.) layering scheme was to be 
tested, Bernoulli-Euler analysis may no longer be appropriate. However, these 
quasilaminates to have a uniform cross-section, and do not thin after deformation (both 
prerequisites for Timoshenko analysis). Additionally, since the layers in this system are 
covalently bonded, there probably is not free slip between layers. As a result, it is likely 
that there are shear deformations of the layers in addition to bending deformations. 
Timoshenko beam bending theory could be used to include the effect of layer shear on 
bulk stiffness, however this would have obfuscated comparisons with fresh tissue and 
single layer gels (in Chapters 4 and 5, respectively). 
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A more likely explanation of how thickness impacts stiffness in the quasilaminate 
composites follows. The thickness of the quasilaminate composite was higher than that of 
the single layer controls, which even when accounting for moment of inertia, will cause 
Eeff to increase since the imparted moment changes with thickness. Additionally, the 
quasilaminates swelled to a greater degree than their single layer controls, which could 
affect stiffness in two ways: (i) the actual physical increase in thickness will increase the 
measured stiffness since the load applied with the bending tester varies with thickness 
(described in Appendix II) and (ii) the changes in swelling pressure affect the polymer 
network (discussed below). 
6.5.3.1 Consideration of Swelling on State of the Hydrogel Network and 
Other Potential Causes of Increased Stiffness in Quasilaminates 
The second explanation above considers the effect of swelling on the hydrogel 
network. The quasilaminates swelled to 122% of the predicted value, based on the 
swelling of single layer controls (mean thickness 1.92 mm instead of 1.582 mm). This 
unexpected increase in one-dimensional swelling can be explained as follows. The B 
layer undergoes confined swelling due to the strong layer adhesions and lower stiffness 
of B layer when compared to the A layer. This B layer has been planarly confined to only 
swell across the thickness of the scaffold since the A layers (layered on top and bottom of 
the B layer) restrict its swelling in the length and width directions. This explanation is 
confirmed by the literature, where increased one-dimensional swelling is seen in thin 
hydrogel films when surface-coupled rather than free swelling.[179] In the hydrogel 
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systems described in that work, the degree of linear swelling in surface-constrained 
hydrogels consistently exceeds the linear swelling of free hydrogels. If one considers the 
Flory expression for free energy, where the network is subjected to the opposing forces of 
thermodynamic mixing (favoring swelling) and the retractile force of the network 
(opposing swelling),[180] by restricting swelling to one dimension, the osmotic swelling 
pressure is increased, and must be opposed by higher elastic free energy. We speculate 
that increased swelling in quasilaminates (in comparison to single layer controls) causes a 
tensile "prestrain" of the hydrogel polymer mesh. This prestrain causes the 
quasilaminates to demonstrate higher stiffness than their single layer controls. Further 
characterization of layer-specific swelling will be necessary to determine the underlying 
cause of increased stiffness in quasilaminates. Moreover, it has been shown that a 2-fold 
change in volumetric swelling ratio can increase hydrogel modulus by two orders of 
magnitude.[IIO] 
Another possibility that could explain the increased quasilaminate stiffness is the 
fabrication method. In the quasilaminates tested, each layer created had an initial 
thickness of 0.5 mm, whereas the single layer controls were 1.0 mm. The intent in the 
sandwich layer formulation approaches was to leverage UV scattering, resulting in one 
side of the layer having unreacted acrylates or a "sticky" gel. It may be that the UV light 
scattering in the central region of the single layer controls causes there to be an 
undercrosslinked central region. It has been shown that lowered crosslink density results 
in higher degree of swelling in hydrogels, which could account for the increased swelling 
of quasilaminates.[89] However, since PEGDA is highly transparent, it is unlikely that 
UV scattering is occurring at depths of 0.5 mm, therefore making this explanation the 
least likely proposed here. 
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Regardless of the underlying cause of increased stiffness in quasilaminates, these 
methods allow scaffolds with distinct layers with specific cellularity and material 
properties to be fabricated. As shown by the flexure data, using these methods the cells' 
pericellular mechanical environment can be engineered to be of a lower stiffness than the 
overall scaffold (since the stiffness of the 6 kDa single layer controls is substantially 
lower than the bulk stiffness of the quasilaminate.) It has been demonstrated that VICs 
respond to their substrate stiffness where higher stiffness substrates accelerate calcific 
nodule formation, therefore the ability to culture VICs in an engineered tissue where the 
bulk stiffness and pericellular stiffness can be controlled will potentially result in 
healthier engineered tissues.[69, 113] Furthermore, when these scaffolds are flexed, a 
larger proportion of stress is imparted to the stiffer layers, further shielding cells from the 
high stresses resulting from large bending deformations, which have been correlated to 
sites of valve calcification. [3] 
6.5.4 Interpretation of Modeled Behavior in PLP Hydrogels 
Modeling of sinusoidally patterned gels was performed to attempt to identify the 
parameters with the most significant influence on bulk gel behavior. Modeled gels 
showed that the majority of applied load was borne by the reinforced areas, which was 
expected. However, sinusoidally patterned simulated gels showed no nonlinear behavior, 
regardless of period or amplitude of the sinusoid. This finding is in contrast to tissues, 
where collagen fiber crimp period and amplitude significantly affect tissue 
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extensibility.[8, 168, 181] This discrepancy between model results and native valve 
tissues could be due to the model's use of no-slip boundary conditions between the 
reinforcements and the matrix, although these are likely accurate representations of these 
reinforcement conditions in the actual gels, they are not indicative of what happens in 
vivo. It is known that collagen and elastin fibers are able to slip through the ECM in a 
native aortic valve leaflet when stress is applied.[3, 182] It is likely that true fiber 
reinforcements that can slip within the hydrogel bulk will be necessary to achieve 
nonlinear behavior at strains under 100%. Our group is currently investigating the 
potential to replicate non-linear (tissue-like) toe regions in PEGDA hydrogels using 
electrospun fiber reinforcements. 
6.5.5 PLP Increases Bulk Stiffness and Allows Anisotropic 
Behavior 
The major finding in the patterning study was that patterned hydrogels 
demonstrated stiffness increased approximately 1.5-2 times over the stiffness of 
unpatterned controls. While holding total coverage fixed, as pattern feature thickness 
increased, the bulk stiffness increased. Only one pattern (the 2641lm stripe) resulted in 
anisotropy, in which the gels were stiffer along the direction length of the patterned 
feature (along the stripe). However, the 1761lm sinusoid pattern showed a trend of 
anisotropy (p < 0.09, Tukey-Kramer HSD; P < 0.02, paired t-test). The initial results 
showing inducement of anisotropy in photolithographic ally patterned hydrogels 
published by Nemir et al. did not report any effect of pattern feature width.[65] That 
research investigated material behavior in relation to a range of total pattern coverages (0, 
25,33,50, and 100% coverage), and gels with total pattern coverage of25 and 33% were 
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the only to demonstrate anisotropy. This was the rationale for holding total pattern 
coverage fixed in this study and also informed the choice of probing other parameters 
(feature thickness, non-linear patterns) while holding total pattern coverage fixed at 20%. 
Further optimization of this patterning scheme, potentially employing approaches that 
permit fiber reinforcement "slip", it is anticipated that sinusoidal patterning will be able 
to generate a hydrogel with anisotropic, nonlinear stress-strain behavior. Although this 
work has employed patterning to create anisotropy in a material that is fundamentally 
isotropic and linearly elastic, a limitation of the PLP technique is that it only allows the 
creation of 2D patterns of reinforcement. This limitation could be overcome through two-
photon adsorption methods, which allow 3D patterns to be created since there is minimal 
scattering due to the focal cone of the laser employed. It should be noted that two-photon 
adsorption methods are significantly more complex to implement and require longer 
patterning times [66] than the PLP strategy employed in this work. PLP of a reinforcing, 
interpenetrating polymer network is not the only method available to yield anisotropic 
material behavior in a fundamentally linearly elastic, isotropic hydrogel. Recently Zawko 
et al. demonstrated that photopatterning of secondary cross links in a chemically 
crosslinked gel yielded anisotropic swelling and viscoelastic bulk behavior.[89] The PLP 
methods described in this chapter could be used in an analogous method to enable 
patterning of secondary crosslinks that would yield differential swelling and potentially 
exhibit anisotropic behavior in photopolymerizable hydrogel materials. Applications of 
hydrogel patterning are rapidly expanding, and are not limited to purely mechanically 
inspired uses. Several applications of hydrogel patterning (both using PLP and soft 
lithography) currently under investigation include biosensors, cell-substrate studies, 
control of scaffold porosity, and microfluidic channels.[79, 183-187] 
6.5.6 Applications and Utility of Layering and PLP Methods 
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The methods described in this chapter allow the fabrication of increasingly 
complex architectures in hydrogel scaffolds. These methods will likely find their first 
utility in tissue engineering, where layered, anisotropic structures are difficult or 
impossible to create with existing synthetic hydrogel fabrication techniques. The most 
obvious application is to recapitulate the layered, anisotropic structure of a heart valve, 
from which the studies described in this chapter derived their inspiration. By controlling 
the prepolymer formulation, bioactivity of each layer and the direct encapsulation of a 
specific cell type is possible. The result is a fabrication technique that allows simple, 
simultaneous control of mechanical properties, bioactivity, and cell type, and potentially 
the control of permeability (if the recently described methods of Cha et al. can easily be 
translated to this process.) In the future, an ideal hydrogel-based TEHV could be 
comprised of layers with varying bulk stiffness, cellularity, and tethered biochemical 
functionalization. The layers could also be patterned with layer-specific reinforcements 
(such as recapitulating collagen fiber orientation in the fibrosa) derived from new studies 
detailing layer specific ECM orientation. [188] This would allow regions of stiffness 
across the engineered leaflet that best mimicked native tissue. Furthermore, these 
methods can be translated to controlled release applications, since pericellular stiffness 
could be designed to be appropriate for the desired cell type, while the surface could 
modified by adherence of a high stiffness, low diffusivity layer. These methods permit 
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the mimicry of tissue-specific anatomical features in hydrogels, which can in tum yield 
superior performance of resulting scaffolds and may enable diverse functional engineered 
tissues to be created. 
6.6 Conclusions 
Interface testing showed that strong layer bonding in mixed composition 
photopolymerized hydrogels was achieved by using the sandwich layering method. This 
study is the first to demonstrate this phenomena in PEGDA and more generally using 
photopolymerization to provide crosslinking. These studies showed that using the 
developed layering methods, a "stiff-soft-stiff' quasilaminate architecture yielded higher 
flexural stiffness than its constituent components separately. Photolithographic patterning 
with anatomically inspired patterns resulted in anisotropic tensile behavior. Additionally, 
all tested patterns served to reinforce the material and increase the bulk tensile modulus. 
This is in agreement with results published by Nemir et al. and these studies establish 
new patterns that can be used for reinforcement and the inducement of anisotropic 
behavior in hydrogel scaffolds.[65] 
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Chapter 7: Conclusions and Future Directions 
7.1 Thesis Summary 
The promise of a tissue engineered heart valve has yet to be realized. A living 
engineered valve that grows with the patient and is able to remodel in response to the in 
vivo environment would sidestep the current problems associated with clinical therapies -
especially the limited supply and durability concerns of homografts, drawbacks arising 
from the use of systemic anticoagulation with mechanical valves, degeneration of 
bioprosthetics, and sizing and reoperation concerns for pediatric patients regardless of the 
prosthetic used. While many groups are pursuing a diversity of strategies to generate a 
TEHV, no one has had clinical success in the aortic position. This work took a ground-up 
approach to the tissue engineered heart valve, and tools and techniques for the creation of 
a TEHV were investigated. The design and evaluation of a system that is capable of 
providing necessary mechanical stimuli to developing tissues was detailed in Chapters 3 
and 4. This system also has utility outside of purely tissue engineering of heart valves, 
and can be used for ex vivo organ culture of whole aortic roots, as it was in the studies in 
Chapter 4. This application will allow researchers to study valve biology in a more 
controlled and less costly fashion than large animal experiments. Information about aortic 
valve tissues obtained in the studies in Chapter 4 also served as design criteria for the 
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ground-up hydrogel scaffold applications executed in Chapters 5 and 6. The hydrogel 
studies were the first to investigate the flexure behavior of PEGDA hydrogels in both 
single layer and quasilaminate structures. Furthermore, the studies in Chapter 6 were the 
first to show quasilaminate structures with well-adhered layers having different 
compositions in a photopolymerized system. The studies described in this thesis form the 
basis for fabricating and mechanically conditioning advanced hydrogel-based TEHV 
scaffolds with anatomically-inspired architectures that will address some of the 
mechanical shortcomings of existing approaches. 
7.2 Conclusions 
The design of the first simple, scalable bioreactor system that can perform both 
organ culture of native A V tissue and mechanical conditioning of engineered A V s is 
detailed in Chapter 3. Many A V bioreactor designs exist and have been reported in the 
literature, but did not satisfy the design goal of allowing low-cost, high-replicate culture 
with simple control systems. Another novel feature of our bioreactor is that it was the 
first to allow rapid loading of aortic valve roots since it employs a spring-locked stent. 
The bioreactor system can be pre-assembled into two main subassemblies and left under 
UV light in a biological safety cabinet (to preserve sterility) before dissection of the 
tissue. This feature allowed tissues to be loaded rapidly after dissection, since it did not 
need to be completely disassembled to load the samples. 
The evaluation of medium-term (up to 14 days) organ culture of porcine aortic 
valves in the novel bioreactor is described in Chapter 4. The primary fmdings were that 
the tissue appeared to be best maintained to day 7 (in comparison with fresh tissue) and 
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that optimization of the imparted dynamic culture regimen should be performed for 
dynamic ex vivo organ culture with durations longer than 7 days. At seven days, the 
flexural stiffness, hydroxyproline content and GAG content was unchanged from fresh 
tissue. Additionally, this culture regimen showed that when compared to statically 
cultured leaflets at the same time point, the dynamic regimen resulted in significantly 
better retention of flexural stiffness and hydroxyproline content. Histologically, leaflets 
cultured in the dynamic environment showed better retention of their characteristic 
layered structure, and proper distribution of collagen III and elastin. The benefits of the 
dynamic culture regimen were less obvious at day 14, and further optimization of the 
culture regimen needs to be performed before attempting cultures with this duration. 
Increased shear stresses and optimization of the imparted flow regimen will be necessary 
for long term ex vivo cultures. It is important to note that the bioreactor proved capable of 
maintaining A V organ cultures for 14 days in a sterile environment, which to our 
knowledge is the longest ex vivo organ culture of A V leaflets in a bioreactor system 
(published studies on whole AV organ culture have yet to extend past 96 hours).[109] 
Additionally, this system can certainly provide the subphysiologic forces that are thought 
to yield better tissue development in engineered tissues. The flexural properties of native 
A V leaflets that were determined in these studies served as design criteria for the flexural 
hydrogel work performed in Chapter 5. 
The first study investigating the flexural stiffness of PEGDA hydrogels was 
described in Chapter 5. A variety of formulations were tested and compared with the 
more widely-reported compressive moduli of these formulations. Additionally, these 
studies demonstrated the effect of hydrogel formulation on encapsulated VIC phenotype 
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within the gel using two well-known phenotypic markers. Much work has been 
performed characterizing VICs within the more prevalent mesh or foam-based TEHV 
scaffolds, but to-date only 7 other papers have been published detailing work with VICs 
and synthetic hydrogels.[l, 57, 69, 87, 112, 113, 189] Therefore, the studies in Chapter 5 
significantly contribute to the nascent study of hydrogel scaffold applications for TEHV. 
Additionally, since flexural deformations are large in native valves and can frequently be 
the source of the maximum stress present in the valve[3], it is necessary to characterize 
this behavior for any potential TEHV scaffold. The effect of methacrylated heparin 
incorporation on gel material properties was another novel finding in this study. Recently 
published studies showed that PEGylated bioactive moieties increased gel stiffness rather 
than decreased it as expected.[160] The studies in Chapter 5 demonstrated the opposite 
effect with the bioactive moiety tested (Hep-MA). These results indicate that the effect of 
bioactive molecule incorporation on material properties may be difficult to predict due to 
differences in chemical structural and available crosslinking sites on the molecule of 
interest. The characterization of flexural stiffness and analysis of encapsulated VIC 
behavior in Chapter 5 underpinned the development of more complex hydrogel based 
TEHV constructs in Chapter 6. 
Advanced hydrogel scaffolds with unique material properties inspired by native 
valve tissues were fabricated and tested in Chapter 6. These studies were the first to 
demonstrate a quasilaminate layered scaffold with strong layer-layer adhesion where each 
layer had distinct composition and cellularity in a photopolymerized system. 
Additionally, these studies tested the bending stiffness of "stiff-soft-stiff' quasilaminates 
inspired by native A V layer properties. Lastly these studies uncovered new patterns of 
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reinforcement yielding anisotropy, and investigated the relative contribution of various 
experimenter-controllable parameters on bulk stiffness, adding to the growing body of 
literature on patterned regions of stiffness in hydrogels. 
7.3 Future Directions 
The bioreactor presented in Chapters 3 and 4 is simple to replicate, can scale 
easily to accommodate varying sample sizes, and uses very simple and durable drive and 
control systems. This system will allow experimenters to study A V tissue behavior in an 
environment that is far more controllable than an in vivo study, while simultaneously 
being much lower cost than a large animal study. Furthermore, the use of organ cultures 
sidesteps ethical concerns regarding experimental animal studies. In addition to organ 
culture of native A V tissue, the newly developed bioreactor also can be used for the in 
vitro development of TEHV. This system can readily generate pseUdo-physiologic and 
subphysiologic flow rates and pressures. Since the system scales to readily accommodate 
large numbers of native AVs, it will be useful for mechanical conditioning of many 
TEHV constructs in parallel. This system could also be used to perform accelerated 
fatigue testing by rapidly cycling TEHV to investigate the failure modes of diverse 
TEHV scaffold materials. The novel bioreactor described in this thesis has wide ranging 
applications in the study of aortic valve biology and engineering, and will likely find 
multiple uses in our lab and others. 
The hydrogel studies described in Chapters 5 and 6 serve to expand our 
fundamental understanding of hydrogel behavior in mechanical modes that are very 
relevant for valve tissues. These studies form a basis for heart valve tissue engineering in 
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hydrogel scaffolds when added to the few existing papers from labs at University of 
Wisconsin, University of Colorado, and University of West em Ontario. [1 , 2,69,87,90, 
111, 112, 190, 191] Bending of hydrogel structures is novel, and will need to continue to 
be analyzed. Currently, there is no model for bending analysis of these structures that 
allows for large deformations (similar to the complete reversal of curvature seen during 
leaflet opening and closing). Development of a model that accounts for large 
deformations both single layer and advanced structures would increase the analytical 
rigor of mechanical evaluation of native and engineered tissues. Additionally, the 
development of the advanced fabrication techniques allow the creation of hydrogel 
constructs that more closely mimic the material properties of a diverse range of native 
tissues. It is likely these methods will find utility in both tissue engineering applications 
and controlled release. Specifically for tissue engineering applications, these constructs 
will need to incorporate cell-degradable motifs to enable the seeded cells to synthesize 
matrix, migrate, and remodel the scaffold prior to implantation. Further characterization 
of the effects of incorporating these motifs on material properties will be necessary, 
although the developed methods should be able to be generalized to work with any 
photopolymerizable hydrogel system. Future studies with cell-degradable polymer 
scaffolds in an anisotropic, layered configuration could be evaluated in vivo in a sheep 
model to characterize their performance relative to the current state-of-the-art. The work 
performed here will allow better mimicry of native tissue behavior, which will in turn 
yield better performance of engineered tissues, and allow a diversity of new engineered 
tissues to be created by future investigators. 
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Appendix I: Design Evolution of Bioreactor and 
Bending Tester 
A.1 Bioreactor Design Evolution 
The designed bioreactor system and bending tester underwent a series of revisions 
as prototypes were fabricated and new discoveries regarding their performance were 
made. First, a crude bench top system with a sliding disk in a tub was made (Figure 
A 1.1). This disk was aligned by 4 stainless steel wires, and motion of the disk was 
generated by a pulley, weights, and a strong closing spring. Mechanical valves were 
loaded into this system, it was filled with water, and the system was used to validate the 
"sliding piston" idea for valve opening and closure. In particular, this model system was 
evaluated to determine if changing direction caused significant "fluttering" or repeated 
opening and closing of the valve. This was not seen, so a simple system using a brass 
rack and pinion that slid on a Teflon track was fabricated to test the sliding disk within 
the culture chamber (Figure A1.2). The doctoral candidate used this prototype to ensure 
that no "water-hammer" effect was present by enclosing the sliding disk in a chamber, 
and that valve opening and closing proceeded as was observed in the first prototype. 
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Figure A 1.1: First bench top prototype to investigate sliding piston/disk design for valve 
opening and closure. 
The first full bioreactor system can be seen in Figure AI .3, where the parts were 
initially fabricated to test fit and general system performance. Fluid resistance was 
similar to modeled behavior so the motor and gearbox selections could be made. The 
parts were then machined further for less binding when the piston slid (the circularity of 
the culture chambers was improved, since the extruded blue tubing was not sufficiently 
round) and material was removed from parts to reduce assembled and filled system 
weight. The first bioreactor that was loaded with porcine tissue and used experimentally 
can be seen in Figure AI.4. This bioreactor was subject to the bearing lockup and 
resulting sheared part problems described in Chapter 3. This was the final prototype 
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design before the bioreactor design was deemed suitable for experimental cultures (the 
final design can be seen in Figure 3.1). 
Figure A 1.2: Motor-driven brass rack and pinion was used to achieve linear motion. This 
system investigated the effect of enclosing the piston in a culture chamber. 
Figure A 1.3: Prototype full assembly for fit testing and final drive confirmation. 
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Figure A 1.4: First completed version of the custom bioreactor that was used for organ 
culture. This system frequently became unstable, leading to bearing lockup that inspired 
the current design to account for alignment shaft deflection and increase the effective 
bearing length/diameter relationship. 
A.2 Bending Tester Prototype and Evolution 
The prototype bending tester was initially hand driven by a Newport 
micropositioner, this system was designed with Rice undergraduate Alex Brewer (Figure 
Al.S). The method for use was to pull an experimental sample a set deflection and 
measure the total resulting deformation of the flexure bar. This was the method employed 
by Gloeckner et al.[126] Since valve tissues are viscoelastic and strain rate dependent, it 
was determined that automation of the system was performed with a stepper motor to 
gain better control of the strain rate (Figure A 1.6). The physical design of the motorized 
revision was performed with another Rice Undergraduate, Steve Xu. 
Figure A 1.5: Prototype bending tester that was hand driven. 
Figure A 1.6: Bending tester with stepper motor to allow strain rate control and greater 
precision of displacement. 
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This system was initially used with a Leica dissection illuminator and microscope CCD, 
however this did not yield high enough frame rate or even enough lighting for repeatable 
automatic marker tracking on samples (Figure A1.7). Superior image tracking was 
realized by using conventional photography flood lamps and a consumer digital single 
192 
lens reflex camera capable of shooting high-speed high definition video (l280x720 pixels 
with 60 frames per second). The final iteration of the designed bending tester can be seen 
in Figure 4.2. 
Figure A1.7: Initial bending tester experimental setup, with Leica dissection scope 
illumination, Leica CCO, and stepper amplifier and controller visible. 
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Appendix II: Additional Hydrogel Network 
Information 
A2.1 Synthesis Verification 
lH-NMR was performed to verify that methacrylation of heparin was successful 
and therefore that it would be covalently linked to the PEGDA used in studies in Chapter 
5. Percent methacrylation was calculated as 6.8% by comparing the peaks at 6.2 and 5.8 
ppm to the peaks on the disaccharide repeat unit of heparin (Figure A2.1).[158] 
A2.2 Additional Network Property Information 
Hydrogel network properties (studied in Chapter 5) were represented in Table 5.1. 
Although the data is present in the table, the visual relationships of formulation on 
network properties is difficult to discern from that presentation, so the three main 
parameters have been displayed in Figure A2.2, Figure A2.3, and Figure A2A. 
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Figure A2.2: Molecular weight between crosslinks of acellular hydrogels. In both 
heparinized and non-heparinized gels, with increasing weight fraction, molecular weight 
between crosslinks decreases. In non-heparinized gels, molecular weight between 
crosslinks increases with increasing molecular weight. In heparinized gels, this trend is 
observed from 3400 to 6000 Da, but is not seen at higher molecular weights. Samples 
marked with different letters are significantly different at a=0.05. 
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Mesh Size of Acellular PEGDA Hydrogels 
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Figure A2.3: Mesh size of acellular hydrogels. In both heparinized and non-heparinized 
gels, with increasing weight fraction, mesh size decreases. In non-heparinized gels, mesh 
size increases with increasing molecular weight. Samples marked with different letters 
are significantly different at a=O.05. 
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Figure A2.4: Mass swelling ratio of acellular PEGDA hydrogels functionalized with O.S mM 
Hep-MA. Samples marked with different letters are significantly different at a=O.OS. 
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A2.3 Explanation of Moment Calculation 
Bending moment is calculated as described in Figure A2.S. This moment is used 
in the derived relationship between thickness and stiffness in Section A2.4. If a simply 
supported beam undergoing three point bending is considered, and application of load P 
occurs at point R, the moment about a cross section at point R is PL/4. This is the point of 
maximum moment in the sample, and is calculated by multiplying the reaction force at Q 
(P/2) by the length of the arm (L/2). 
p 
y=c 
Q R s 
L 
p 
Figure A2.5: illustration showing calculation of moment, quadratic line (fit at neutral axis), 
application of load, and maximum moment. 
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Appendix III: Confocal Tissue Strainer 
This appendix features work in which I participated and was a co-author on the 
manuscript; however the work was led by other researchers. A brief description of the my 
primary contributions is given below and a reprint of the manuscript follows. This was 
published as Stephens EH, Durst CA, Swanson JC, Grande-Allen KJ, Ingels NB, Miller 
DC. Functional Coupling of Valvular Interstitial Cells and Collagen Via a2~1 Integrins in 
the Mitral Leaflet. Cellular and Molecular Bioengineering, 2010 Dec; 3(4):428-437 
This research sought to characterize the mechanisms of mitral leaflet force generation by 
investigating actin-mediated VIC force generation coupled to collagen via a2~1 integrins. 
High-resolution confocal microscopy was intended to be used to study this phenomena 
and the study required a device to apply strain and measure load to mitral valve tissue 
while being directly imaged, however this was not available. I then designed a novel 
device to apply strain and measure load to mitral valve leaflets while being directly 
imaged with confocal microscopy. My secondary contribution was to train and assist the 
ftrst author with confocal microscopy and 2nd harmonic imaging of collagen ftber. 
Figures representing the my primary contributions to the manuscript are shown below 
(Figure A3.1 and Figure A3.2) 
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Figure A3.1 : Isometric rendering of custom strain load device. The device fit into a 
motorized Zeiss LSM confocal microscope stage to allow direct imaging of tissue while 
applying strain and measuring load. 
Figure A3.2: Photograph of system in use on a Zeiss LSM confocal microscope. 
Thumbscrew to apply strain can be seen on left of device with load cell acquiring force 
data on right side. 
Cellular and Molecular Bioengineering (© 2010) 
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13 Abstract-Once considered passive flaps, we now understand 
14 that mitral leaflets are dynamic structures with their own 
15 vasculature and innervation that actively remodel and even 
16 generate force in response to their environments. Valvular 
17 interstitial cells (VICs) are contractile and could underlie 
18 mitral leaflet force generation, but the exact mechanisms for 
19 VICs in mitral leaflet force generation are not understood. 
20 This study tested the hypothesis that actin-mediated VIC 
21 force generation coupled to collagen via (J..2f31 integrins is 
22 necessary for force generation in the mitral leaflet. High 
23 magnification fluorescent imaging of freshly excised porcine 
24 mitral leaflets revealed VIC cytoplasm tightly conforming to 
25 collagen fibers, with actin within VIC cytoplasmic processes 
26 appearing to attach to the collagen fibers. Functional studies 
27 of isometric force development demonstrated that while 
28 control samples developed force in response to KCI, either 
29 blocking (J..2f31 integrins or blocking actin polymerization via 
30 cytochalasin abolished KCI-induced force development 
31 (p < 0.001). These results strongly suggest that VIC-collagen 
32 coupling, mediated by (J..2f31 integrins, is necessary for KCl-
33 induced force generation in the mitral leaflet. This functional 
34 coupling between collagen and VICs via (J..2f31 integrins may 
35 playa role for in vivo mitral valve function. 
36 Keywords-Extracellular matrix, Force generation, Cell con-
37 traction, Integrin , Cytochalasin, Actin, Heart valve, Second 
38 harmonic generation, Confocal microscopy. 
4$ INTRODUCTION 
42 While mitral valves were once regarded as passive 
43 flaps , a growing body of evidence continues to revise this 
Address correspondence to D. Craig Miller, Department of 
Cardiothoracic Surgery, Falk Cardiovascular Research Center, 300 
Pasteur Drive, Stanford, CA 94305-5247, USA . Electronic mail : 
dcm @stanford.edu 
notion. Mitral leaflets have their own vascula- 44 
ture, 2,13,31,-l2 innervation ,.~ · IO . I3 . ':::I< .. 1x remodel in response 45 
to various stresses,r',1 U'),40 and recent studies suggest 46 
that there are mUltiple contractile systems within the 47 
leaflets. 2~ Ex vivo studies have demonstrated that mitral 48 
leaflets generate force in response to vasoactive 49 
agents .I (),:\1' Valvular interstitial cells (VIes) are a 50 
dynamic, active component within leaflets that enable 51 
valves to remodel and mitral leaflet VIes are known to 52 
contract in response to vasoactive agents. I r) Given the 53 
contractile properties of VIes and evidence that the 54 
same vasoactive agents that cause mitral VIe contrac- 55 
tion also result in force generation in mitral leaflets, lo,:lR 56 
it appears that mitral VIe contraction could be one 57 
component of mitral leaflet force generation. However, 58 
the means by which mitral VIC contraction is trans- 59 
fer red into mitral force generation has not been studied. 60 
Transmission electron micrographs of mitral leaflets 61 
show VIes closely associated with collagen fibers, II> 62 
suggesting an interaction between VIes and collagen in 63 
the leaflet, perhaps even acting together as a functional 64 
unit. Given that integrins are the primary proteins 65 
attaching cells to the surrounding matrix ,·lH a potential 66 
interaction between VIes and collagen likely occurs 67 
through one of the integrins. Of the known collagen 68 
binding integrins, only rJ.2fJl and rJ.llfJl show higher 69 
affinity for type I collagen (the predominant collagen 70 
in heart valves <J) than type IV. I Based on fibroblast- 71 
col1agen gel contraction I'::: and fibroblast collagen fiber 72 
transport:H1 studies, we hypothesized that rJ.2fJl integrins 73 
may be a mechanism by which VIes attach to collagen 74 
within the mitral valve leaflet. Given the critical role 75 
that rJ.2fJl integrins play in fibroblast--{;ollagen interac- 76 
tions, 12,30 their demonstrated presence on mitral 77 
VIes, 2,6 and the tools available to probe rJ.2fJl integrin 78 
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79 function , this study chose to investigate lJ.2/31 integrins. 
80 While a variety of integrins have been shown to be 
81 present on enzymatically isolated mitral VICs, includ-
82 ing lJ.2/31 2/) . ~~ 7 the potential functional role of integrins in 
83 valves, however, has not been studied. 
84 Based on the hypothesized roles of cellular con-
85 traction and lJ.2/31 integrins in this proposed VIC-
interaction, such as may have occurred with a fluo- 129 
rescent probe conjugated collagen antibody. Images 130 
were taken with the 20x objective lens, while higher 131 
magnification images used 25 x, 40 x, 63 x , and 100 x 132 
oil immersion objective lenses. Images were processed 133 
using Zeiss LSM Image Browser software (Zeiss). 134 
86 collagen mechanotransduction within the mitral valve, 
87 the aim of this study was to test the specific hypothesis Custom-Built Strain-Load Device 135 
88 that actin-mediated VIC contraction coupled to col-
89 lagen via lJ.2/31 integrins was necessary for force gen-
90 eration in mitral leaflets. 
Using computer assisted design software (Solid- 136 
Works, Dassault Systemes, Lowell , MA), a strain-load 137 
device (Fig. I) was built to fit, spring-loaded, into a 138 
motorized Zeiss Leica 510 LSM confocal microscope 139 
91 MATERIALS AND METHODS stage replacing the standard microscope slide holder. 140 The device was fabricated from 6061 aluminum that 141 
92 Immunofluorescence 
93 Porcine hearts (Yosemite Meat, Modesto, CA) were 
94 obtained within I h of animal slaughter and trans-
was anodized for corrosion resistance. Tissue samples 142 
were placed in a 4-well cover glass chamber (LabTek II, 143 
Nalgene Nunc International, Naperville, IL) and 144 
sutured to plastic mesh attached to wire struts. These 145 
95 ported in cold saline (0.9% sodium chloride, Hospira, wire struts were secured with set screws in blocks on 146 
96 Lake Forest, IL). The central bare area (central region 
97 devoid of chordal attachments) of each mitral anterior 
either side of the wells. The blocks slid freely in one 147 
dimension in recessed channels. The 4-well cover 148 
98 leaflet was dissected within 4 h of animal slaughter 
99 and stained to visualize VIC cytoplasm, nucleus, and 
glass chamber was suspended above the microscope 149 
objective using a small metal lip. An adjustable screw, 150 
100 F-actin. VIC cytoplasm was stained using calcein AM coupled with the freely-sliding left block, allowed 151 
101 (Invitrogen Molecular Probes, Eugene, OR) and VIC manipUlation of strain on the tissue. A miniature ten- 152 
102 nuclei were stained using Syt085 (Invitrogen Molecu- sion load cell (Omega, Stamford, CT) was fit in-line 153 
103 lar Probes). Cytoplasmic F-actin was stained using with the sutured tissue. The load cell was powered using 154 
104 AlexaFluor 488 phalloidin (Invitrogen Molecular a 12 V battery that delivered 10 V DC to the load cell 155 
105 Probes) in tissues fixed in 10% formalin for 30 min and through the use of a voltage divider. Output from the 156 
106 permeabilized with 0.5% Triton-X 100 (Sigma-Aldrich, load cell was captured by a USB data acquisition kit 157 
107 St. Louis, MO). Tissue was only fixed for actin staining; (USB 6008, National Instruments , Austin, TX) and 158 
108 all other staining and force generation experiments uti- recorded using a custom-designed virtual instrument 159 
109 lized fresh tissues without fixation or permeabilization. (Lab View Signal Express, National Instruments). 160 
110 Confocal Microscopy Force Generation Studies 161 
III A Zeiss Leica 510 LSM confocal microscope (Zeiss, Small (-1 cm x 5 mm) circumferential strips of the 162 
112 Oberkochen, Germany) with a Mira tunable Ti:Sa central, bare area of the anterior mitral leaflet were 163 
113 laser (Coherent, Santa Clara, CA) was used to visual- sutured into the custom-designed strain-load device fit 164 
114 ize the fluorescent probes and the second-harmonic upon the microscope stage, as described above . After 165 
115 generated collagen signal (excitation at 820 nm, max- suturing the tissue in place, the tissue was allowed to 166 
116 imum emission at 410 nm). Specifically, calcein was equilibrate in Kreb's solution for at least 20 min 167 
117 visualized using a 488 nm Ar laser and 500-530 nm (136.9 mM NaCl, 11.9 mM NaHC03, 2.7 mM KCl , 168 
118 band pass (BP) filter, Syto85 was visualized using a 0.4 mM NaH2P04, 2.5 mM MgCI2, 2.5 mM CaCh, 169 
119 543 nm HeNe laser and 565- 615 BP filter, and AI- 11.1 mM glucose, 0.04 mM disodium EDT A, pH 7.4). 170 
120 exaFluor 488 phalloidin was visualized using a 488 nm Potassium chloride (95 mM) was added to control 171 
121 Ar laser and 500-530 nm BP filter. Second-harmonic samples (n = 10) and the load-cell output recorded 172 
122 generated collagen signal was obtained using an using the custom-designed software described above. 173 
123 820 nm wavelength on the tunable Ti:Sa laser and To investigate the roles of lJ.2/31 integrins and actin in 174 
124 emission captured using a 390-465 nm BP filter, simi- VIC-mediated leaflet contraction, VIC cytoplasmic 175 
125 lar to previously reported techniques. J 7 A key advan- and nuclear staining was performed as described 176 
126 tage of using second harmonic generation in these above, and tissues were incubated with either 10 ,ug/mL 177 
127 studies is that it allowed visualization of collagen lJ.2/31 monoclonal blocking antibody (Chemicon4(,) 178 
128 without interfering with the potential VIC-collagen for 2 h (n = 5) or 25 ,uM cytochalasin (which prevents 179 
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tissue sample 
FIGURE 1. Custom-built strain-load device. (a) Diagram 
illustrating strain-load device built to fit into a motorized 
confocal stage. Adjustable screw is shown at left; this screw, 
coupled with a block (labeled "A") that could freely slide in 
cut-out channel, allowed manipulation of strain on tissue as 
indicated by red arrow. Chamber glass, which held tissue 
sample in buffer, appears ghosted in on this diagram. The 
chamber glass was held above objective by virtue of a small 
metal lip. Placement of tissue sample within the set-up is 
indicated by the beige rectangle and load cell is labeled. (b) 
Photo illustrating custom-built strain-load device diagrammed 
in (a) set in place on confocal stage. Edges of strain load 
device are outlined in red, tissue sample and load cell are 
labeled. Microscope objectives are located under the black 
stage (hidden from view) and microscope eye piece is evident 
in foreground of photo. Signal output from load cell is carried 
by silver cable to electronics not pictured. (c) Close-up photo 
of in situ strain-load device. Note valve tissue sutured to 
plastic mesh between green wire struts. Microscope objective 
can be seen beneath cover glass. Tissue sample and load cell 
are labeled. Inset: view of tissue sample from above (micro-
scope head piece removed) demonstrating tissue sutured in 
place within the chamber. Microscope objective can be seen 
below. 
filamentous actin polymerization) (Sigma-Aldrich) for 
I h (n = 4) before the addition of 95 mM KCI. All 
experiments were performed at room temperature. 
180 
181 
182 
Statistics 183 
Statistical comparisons between groups were made 184 
with one-way ANOVAs using SigmaStat software 185 
(SPSS, Chicago, IL). For data sets that were not nor- 186 
mally distributed, ANOVA on ranks was performed. 187 
Post-hoc pair-wise comparisons were performed using 188 
Dunn's method. The level of significance was set at 189 
p = 0.05. Data is represented as mean ± SEM. 190 
RESULTS 191 
VICs Aligned and Integrated with Collagen Fibers 192 
Fluorescent imaging of VICs revealed that VIC cell 193 
bodies were highly aligned in parallel with collagen 194 
fibers (Fig. 2). VIC cytoplasm and nuclei were elon- 195 
gated , with their long axis coinciding with that of the 196 
collagen fibers . High magnification images demon- 197 
strated the VIC cytoplasm tightly conforming to the 198 
undulating contour of the crimped collagen fibers 199 
(Fig. 3). Fluorescent imaging of VIC cytoskeletal actin 200 
revealed VIC actin similarly aligned wi th collagen 201 
fibers, and actin within VIC cytoplasmic processes 202 
appeared to attach to collagen fibers (Fig. 4). VICs 203 
in (X2f31 integrin-blocked samples tended to show less 204 
alignment relative to collagen fibers compared to 205 
control samples taken from the same region of the 206 
same leaflet (Fig. 5). Alignment of collagen fibers , as 207 
well as alignment of VICs with each other, also tended 208 
to appear less in integrin-blocked samples. 209 
Blocking (X2f31 Integrins or Actin Polymerization 210 
Prevented Force Generation 211 
Consistent with previous studies,4.7.1C..24 . .I2 • .I~,45.47 the 212 
addition of 95 mM KCl resulted in force generation 213 
(Fig. 6) in the circumferential strip of mitral valve 214 
tissue. Blocking of either (X2f31 integrins or actin poly- 215 
merization (via cytochalasin) was sufficient to prevent 216 
force generation in response to 95 mM KCI (control: 217 
3.30 ± 0.23 mN, integrin-blocked: 0.04 ± 0.09 mN, 218 
cytochalasin 0.20 ± 0.06 mN, p < 0.001 , Fig. 6). 219 
DISCUSSION 220 
The imaging results of this study, taken together 221 
with the leaflet force data , support the hypothesis that 222 
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FIGURE 2. (a) Image demonstrating VIC alignment with respect to collagen fibers. Blue (upper left panel) indicates the VIC 
cytoplasm, green (upper right panel) indicates collagen fibers, red (lower left panel) indicates VIC nuclei, and lower right panel is 
the merged image of the 3 other panels. The yellow arrow in the upper right panel indicates the orientation of collagen ridges, and 
correlates to the yellow arrow in the schematic in part B. The white arrow in the upper right panel indicates the orientation of 
collagen fibers, and is analogous to the white arrow in the schematic of part b (Note: in all remaining figures collagen fiber 
alignment is indicated by a white arrow). Scale bar indicates 50 pm. (b) Schematic illustrating how undulating collagen fibers at this 
magnification appear as lines perpendicular to the direction of collagen fibers. White portions of undulating fibers above green 
plane represent portions of fibers in focus. The yellow arrow indicates the ridges visualized in the upper right panel of part a (and 
corresponds to the yellow arrow in part a), whereas the white arrow indicates the orientation of collagen fibers. Note: in all 
remaining figures, collagen fiber alignment is indicated by a white arrow. 
223 VIC-collagen coupling, mediated by !'i.2fJ I integrins, 
224 underlies leaflet force generation. Confocal microscopy 
225 imaging provided a structural foundation for a pro-
226 posed VIC-collagen functional unit. Functional studies, 
utilizing KCI to elicit VIC contraction, built on this foun- 227 
dation, and demonstrated the necessary components of 228 
this functional unit fbr mitral valve force generation: VIC 229 
actin polymerization, collagen fibers , and !'i.2fJl integrins. 230 
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FIGURE 3. Image demonstrating VICs nestled into the 
curves of the collagen fibers. Green indicates collagen fibers, 
blue indicates VIC cytoplasm, and pink indicates VIC nuclei. 
White arrow indicates the direction of collagen fibers. Scale 
bar indicates 10 I'm. 
FIGURE 4. Left panel demonstrates alignment of VIC actin 
with collagen fibers at lower magnification. Green indicates 
collagen fibers, blue indicates VIC actin, and pink indicates 
VIC nuclei. Scale bar indicates 50 I'm. Right panel demon-
strates VIC actin processes "grasping" collagen fibers at 
higher magnification. Scale bar indicates 10 I'm. White arrow 
in both portions of the figure indicates orientation of collagen 
fibers. 
Structural Interaction Between VICs , Integrins, 231 
and Collagen Fibers 232 
The second harmonic-generated collagen signal 233 
allowed visualization of the structural relationship 234 
between collagen fibers and viable VICs in freshly 235 
excised leaflets without altering their spatial arrange- 236 
ment with tissue fixation and processing, or disrupting 237 
potential interactions between VICs and collagen 238 
fibers , as can occur with antibodies or other probes . 239 
This method of visualizing viable cells in freshly 240 
excised tissues is in contrast to the limited number of 241 
previous studies in which transmission electron 242 
microscopy demonstrated VICs abutting collagen 243 
fibers. '6,2 ' While these previous studies were important 244 
to our understanding of VICs within the valve matrix, 245 
such imaging modalities have significant limitations 246 
related to specimen preparation, which make inter- 247 
pretation of their results in the context of in vivo leaf- 248 
lets difficult. 249 
Of particular note was the parallel alignment of 250 
VICs relative to collagen fibers . While leaflet anisot- 251 
ropy has largely been attributed to collagen fiber 252 
alignment in the past":;5 the observed alignment of 253 
VICs in conjunction with the functional findings of this 254 
study and studies demonstrating that VIC contraction 255 
caused greater circumferential as opposed to radial 256 
force generation in aortic CUSpS,24 suggests that VIC 257 
alignment may contribute to the anisotropic material 258 
properties of valves. 259 
VIC cytoplasm was not only observed to closely 260 
follow the contours of the crimped collagen fibers , in 26 I 
what could be considered a space-filling manner, but 262 
apparent direct attachments were observed between 263 
cytoplasmic processes and collagen fibers , suggesting a 264 
structural link between VICs and collagen fibers . 265 
Imaging in this study also suggested a potential func- 266 
tional role for these (1-213, integrins: attaching VICs to 267 
adjacent collagen fibers. When (J.2P, integrins were 268 
blocked, VICs were less aligned with collagen fibers as 269 
compared with VICs in control samples taken from the 270 
same leaflet region . 271 
VIC-Integrin-Collagen Functional Unit 272 
This study demonstrated that blocking (J.2P, inte- 273 
grins abolished leaflet force development; this result 274 
suggests that VICs are functionally coupled with col- 275 
lagen via (J.2P, integrins allowing the force generated by 276 
VIC contraction to be transmitted to collagen, and 277 
thereby the mitral leaflet. Similarly, when actin poly- 278 
merization was blocked via cytochalasin , I 7,1 H leaflet 279 
force generation did not occur. This result suggests 280 
that leaflet force is developed by actin-dependent VIC 281 
contraction. Therefore, when either the actin portion 282 
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Control Sample Integrin-Blocked Sample 
FIGURE 5. VICs after blocking alpha2 beta1 integrins tended to show less alignment with collagen fibers. Left panel demonstrates 
control sample, right panel demonstrates sample from adjacent region of the same leaflet in which alpha2 beta1 integrins were 
blocked. The upper panels are merged images in which green indicates collagen fibers, blue indicates VIC cytoplasm, and pink 
indicates VIC nuclei. Lower images are identical to merged images above, but illustrate cytoplasm staining alone to better visualize 
VIC alignment relative to collagen fiber orientation (indicated by white arrows), demonstrating less alignment of VICs in alpha2 
beta1 integrin-blocked samples relative to collagen fibers. Scale bar indicates 20 pm. 
283 of the functional unit or the integrin portion of the intracellular signaling can also act to alter the extra- 296 
284 functional unit is blocked, force is not generated in the cellular conformation of the integrins (inside-out sig- 297 
285 leaflet. naling) via cytoplasmic proteins such as F AK (focal 298 
adhesion kinase), ILK (integrin-linked kinase) , filamin , 299 
286 Integrin Signaling and Mechanotransduction talin, kindlins, and migfilin.
1 With respect to the [31 300 
integrin subunit specifically, four proteins are known 301 
287 Composed of transmembrane IX and [3 heterodimers, to mediate attachment of [31 integrin to the actin 302 
288 integrins act as connectors from the cell's outside cytoskeleton: IX-actinin, talin, filamin , and ILK.5 303 
289 world to its cytoskeleton, usually actin. I Integrin sig- Additionally, Rack I, caveolin, and NW ASp have been 304 
290 naling is complex, including both outside-in and shown to bind to its cytoplasmic tail. 5,41 Upon integrin 305 
291 inside-out signaling effecting short-term and long-term binding Cdc42 and Rac are activated ,-':\ which leads to 306 
292 (i .e., gene expression) changes. I Upon ligand binding actin polymerization and Rho activation . I S Integrin 307 
293 integrins undergo a conformational change that binding also leads to tyrosine phosphorylation of 308 
294 includes its cytoplasmic domains and initiates intra- many proteins and modulation of protein tyrosine 309 
295 cellular signaling events (outside-in signaling).21 But phosphatases, which among other roles regulate Rho 310 
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Force Generated by Mitral Valve Anterior Leaflets Under 
Various Treatments 
• ContrOl 
Integlin block 
III Cylochaiils,n 
FIGURE 6. Force generated by mitral valve anterior leaflets 
exposed to various treatments in response to 95 mM KCI after 
10 min. Overall comparison between groups by one-way 
ANOVA: p< 0.001; pair-wise comparison (Dunn's method): 
* p < 0.05 vs. control. Error bars indicate standard error of the 
mean. 
activity. I ) Among the kinases activated with integrin 
binding are FAK and src, whose substrates include 
Rac and Cdc42. ' 5 In terms of actin assembly, upon 
integrin binding Arp2/3 is recruited to vinculin, which 
in turn is recruited to integrins via talin; the association 
of Arp2/3 and vinculin is regulated by phosphatidyli-
nositol-3-kinase and Rac. I .. 1 Other key regulators of 
Arp2/3 include the WASP family of proteins, which in 
turn are regulated by proteins such as Nck, Cdc42, and 
ptdIns( 4,5)P2• I :5 Specifically in response to a contractile 
stimulus, N-WASp activates Arp2/3, a process that 
also involves Cdc42 and CrkII .... 4 During contraction 
paxillin binds F AK and both are phosphorylated; 
paxillin phorphorylation may regulate downstream 
signaling via CrkII.4 :~ 
VIC-Integrin-Collagen Force Generation-Relevance 
to Valve Function 
The primary goal of this study was to demonstrate 
this VIC-integrin-collagen functional unit, however a 
natural question that arises from this work is how this 
unit and the forces it generates could impact valve 
function. Clearly the forces we measured are much 
lower than the forces externally applied to the valve 
in vivo, but evidence suggests that VIC contraction 
could impact valve function , principally by altering the 
valve's material properties, i.e., stiffness. Merryman 
et al.2IJ demonstrated that VIC contraction increased 
aortic cusp flexural stiffness by 48% and elimination 
of VIC basal tone caused a 2-4 fold decrease in flex-
ural stiffness. Thus, the VIC-integrin-collagen unit 
described here could serve to help align as well as 
stiffen the collagen matrix, and vary this stiffness to 
meet changing demands. Other work suggests that 
VICs could be involved in collagen fiber alignment and 344 
VIC contraction could be important in valve function 345 
in cases of low strain.36 Given that collagen fibers are 346 
important tensile, load bearing elements in the valve 347 
and their material properties are highly dependent on 348 
fiber alignment, VIC regulation of collagen alignment 349 
could have important functional consequences. Studies 350 
in aortic cusps have also shown regional variation in 351 
force generation;24 therefore VIC contraction could be 352 
important for regional stress distribution and/or 353 
modulating shape. Chester et al . ~ demonstrated that 354 
circulating vasoactive agents in an ex vivo setting led to 355 
aortic valve incompetence, suggesting that vasoactive 356 
agents and potentially VIC contraction within this 357 
functional unit could impact valve performance. 358 
Implications 359 
This study confirms and builds upon a proposed 360 
model of the mitral valve (MV) that included 3 con- 361 
tractile elements including cardiac muscle, smooth 362 
muscle, and VICs to explain the dynamic MV stiffness 363 
changes that occur in vivo. 23 The results of this study 364 
confirm that VICs are a contractile element in the MV, 365 
and add to this proposed model by demonstrating how 366 
VICs generate force in concert with collagen via inte- 367 
grin coupling. 368 
A number of factors could affect the proposed VIC- 369 
integrin-collagen unit and potentially valve function in 370 
pathophysiological conditions. For example, changes 371 
in collagen fiber cross-linking and packing, as well as 372 
collagen turnover , could affect the ability of VICs to 373 
bind to collagen and transduce force. Circulating fac- 374 
tors, including cytokines, inflammatory mediators, 375 
vasoactive agents, and pharmaceutical agents, could 376 
affect both the contractile and adhesive capabilities of 377 
VICs. Changes in VIC cell phenotype, as occur via 378 
alterations in the mechanoenvironment and chemical 379 
mediators, would also likely affect the ability of VICs 380 
to produce and transduce force. Lastly, sympa thetic 381 
and parasympathetic innervation could affect this 382 
functional unit either directly or through paracrine 383 
mechanisms. 384 
In fact, valve diseases demonstrate alterations in 385 
these factors. Changes in MV collagen content, colla- 386 
gen turnover, and matrix metalloproteinase expression 387 
have been documented in diseases such as dilated 388 
cardiomyopathy and functional mitral regurgita- 389 
tion. 19,W,40 VICs in a number of valve diseases, such as 390 
myxomatous mitral valve disease, also demonstrate a 391 
more myofibroblastic cell phenotype including greater 392 
smooth muscle C( actin expression,-,4 which directly 393 
relates to force generation in myofibroblasts .2o Chan- 394 
ges in myocardial integrin expression and activation 395 
have been demonstrated in cardiac diseases , ;) and may 396 
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397 be altered in pathological valves as well. Therefore, the will our definition of valve diseases and therapeutic 450 
398 proposed functional unit may be impacted by, or even approaches to them. 451 
399 contribute to valve pathologies, although considerable 452 
400 work in this area is needed. 
40 I The results of this study may also have implications 
402 for the design of a tissue engineered heart valve ACKNOWLEDGMENTS 453 
403 (TEHV). Creating a TEHV complete with living VICs 
404 may be necessary not only for the TEHV to success-
405 fully adapt (via matrix remodeling) to changes in valve 
406 stresses, for example as the patient grows, or as cardiac 
407 pressures change with age, but living VICs within a 
408 TEHV will be important at a more fundamental level 
409 to provide these VIC-collagen functional units and 
410 their contributions to tonus, anisotropy, and stiffness 
411 modulation. 
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Appendix IV: Computational Fluid Model of ELSIE Bioreactor 
This appendix features work in which the I and was a co-author on the manuscript; 
however the work was led by other researchers. A brief description of the my primary 
contributions is given below and a reprint of the manuscript follows. This was published 
as Barzilla JE, McKenny AS, Cowan AE, Durst, CA, Grande-Allen KJ. Design and 
Validation ofa Novel Splashing Bioreactor System for Use in Mitral Valve Organ 
Culture. Annals of Biomedical Engineering, 2010 Nov; 38(11):3280-3294. 
It was decided during the fmal stages of manuscript preparation that a characterization of 
the in vitro dynamic mechanical environment and corresponding tissue strains would 
substantially enhance the impact of the work. I then joined the project to create a 
computational fluid dynamics model to simulate the fluid flow and resulting shear forces 
as a result of the dynamic culture regimen. Figures representing the my primary 
contributions are shown below (Figure A4.1 and Figure A4.2) 
212 
Figure A4.1 : Plot of shear stress on the surface of the leaflet. Shear stress was averaged 
over the shown surface of the leaflet. Shear stress at system orientation: (a) 0° (straight 
up and down), (b) 45° , (c) 90° (horizontal), (d) 135°. 
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Figure A4.2: Vector plot of fluid velocity in the mid-plane of the culture chamber. Fluid 
velocity peaks at -4 cmls near the area of chordal attachment to the leaflet. Eddies can be 
observed near the free edge. Velocity vectors at system orientation: (a) 0°, (b) 45°, (c) 90°, 
(d) 135°. 
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Abstract-Previous research in our lab suggested that heart 
valve tissues cultured without mechanical stimulation do not 
retain their in vivo microstructure, i.e., cell density decreased 
within the deep tissue layers and increased at the periphery. In 
this study, a splashing rotating bioreactor was designed to 
apply mechanical stimulation to a mitral valve leaflet seg-
ment. Porcine valve segments (n = 9-10 per group) were 
cultured in the bioreactor for 2 weeks (dynamic culture), 
negative controls were cultured without mechanical stimula-
tion (static culture), and baseline controls were fresh uncul-
tured samples. Overall changes in cellularity and extracellular 
matrix (ECM) structure were assessed by H&E and Movat 
pentachrome stains. Tissues were also immunostained for 
multiple ECM components and turnover mediators. After 
2 weeks of culture, proliferating cells were distributed 
throughout the tissue in segments cultured in the bioreactor, 
in contrast to segments cultured without mechanical stimu-
lation. Most ECM components, especially collagen types I 
and III, better maintained normal expression patterns and 
magnitudes (as found in baseline controls) over 2 weeks of 
dynamic organ culture compared to static culture. Lack of 
mechanical stimulation changed several aspects of the tissue 
microstructure, including the cell distribution and ECM 
locations. In conclusion, mechanical stimulation by the 
bioreactor maintained tissue integrity, which will enable 
future in vitro investigation of mitral valve remodeling. 
Keyword_Extracellular matrix, Collagen, Proteoglycans, 
Matrix metalloproteinases, Lysyl oxidase, Prolyl-4-hydroxy-
lase, Heat shock protein 47. 
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INTRODUCTION 
The successful creation of an in vitro experimental 
model of the mitral valve would provide a powerful tool 
for investigating the underlying mechanisms behind 
and possible treatments for mitral valve disease. 
Although animal models have been used with great 
success in studying many forms of cardiovascular dis-
ease, these surgeries are invasive and costly. In addi-
tion, a large number of animals would be required to 
study multiple early timepoints. Alternatives to surgical 
methods, such as molecular imaging to monitor valve 
remodeling, are being explored. 1.1 Cell studies offer a 
less expensive alternative to animal studies; many 
recent studies of valvular biology and remodeling have 
employed cultures of valvular cells maintained in 
monolayers:,5,37,4o This widely accepted protocol, 
however, does not allow investigators to investigate the 
basis for changes to the layered structure of the native 
valve, which can be greatly altered in valve disease. II 
Additionally, a monolayer culture imposes a drastic 
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change in environmental stimuli for the cells, and thus 
may not accurately elicit the in vivo response. 
To avoid the shortcomings of animal and cell 
models, we have chosen to investigate organ cultures, 
which maintain the valvular cells within the native 
physical structure of the tissue. Ideally, the organ 
cultures would be grown in conditions engineered to 
mimic the native environment. Organ cultures have 
successfully been established for a variety of tissues, 
including vascular intima,15 canine leptomeninges,2<! 
mouse gallbladder epithelium/Ii brain hippocampal 
slices,:' I and human lacrimal gland tissue.1J In human 
and mammalian heart valve tissues, short-term 
(6 days) organ cultures have been used to investigate 
wound healing responses. 19- 21 
Heart valve tissues are particularly appropriate for 
organ culture research because the cells within adult 
valves are nourished primarily through diffusive 
transport of oxygen and nutrients (as opposed to 
through vascularization4). It was therefore believed 
that designing a valvular organ culture system might 
be much simpler than designing systems for more 
complicated fully vascularized tissues. Previous work 
in our laboratory used a simple static system for organ 
culture (after Lester et al. 19- 21 ) to demonstrate that the 
cells within the cultured valve tissues remained alive 
during long-term culture periods (up to 7 weeks).1 The 
aforementioned work also suggested, however, that 
static culture techniques alone did not maintain cell 
location. Fewer endothelial cells were noted on the 
cultured tissue. Although valvular interstitial cells were 
still present and viable after 7 weeks, fewer cells were 
located deep within the tissue, suggesting migration of 
these cells to the periphery to obtain nutrients. I 
Since heart valves are continuously exposed in vivo 
to a variety of mechanical stresses from both myo-
cardial motion and blood flow, it was further supposed 
that an in vitro system incorporating similar mechani-
cal forces could maintain the valve structure. A num-
ber of bioreactor designs including flow loops, 12, 15 
cyclic pressure,2X,42 and cyclic flexures-s,26 systems are 
available for organ culture and tissue engineering 
applications. Many of these designs have specialized in 
the culture of semi-lunar (aortic and pulmonary) 
valves for a short period of time (approximately 48 h). 
Although these bioreactor systems have been success-
ful for their intended function, this study was focused 
on the culture of atrioventricular (mitral and tricuspid) 
yalve leaflets and their associated chordae tendinae. 
This study was also designed for a longer timeframe 
(approximately 2 weeks). 
To that end, a bioreactor was designed to provide 
cyclic, dynamic mechanical stimulation to an 9rgan 
culture via sub-physiological fluid movement against 
the valve surfaces. These data were compared to 
porcine mitral and tricuspid valves cultured without 
mechanical stimulation to qualify valve remodeling 
over a period of several weeks. We hypothesized 
that the perfusion and gentle stretch provided by the 
dynamic un-quantified mechanical environment of the 
splashing bioreactor would be sufficient to maintain 
tissue structure and prevent cell migration. The suc-
cessful validation of this system will allow future use of 
this bioreactor in both organ culture and tissue engi-
neering applications. 
METHODS 
Pilot Long-Term Static Culture Study 
To determine the phenotypic effects of organ cul-
turing without mechanical stimulation on heart valve 
tissue, organ cultures were established20 for periods of 
time ranging from 0 to 8 weeks. Porcine tricuspid 
valves were used to prepare the valvular organ cultures 
in this study; porcine valves are widely used and 
accepted as anatomic lX,32 and biological models37 for 
human valves. Valves (n = 5) were obtained from a 
commercial abattoir, and the tricuspid valves were 
dissected from the hearts within 24 h of removal from 
the body. 
After removal of chordae tendinae and cardiac 
muscle tissue, the valve leaflets were dissected into 
100 mm2 blocks, yielding 5-10 blocks per individual 
valve. At each stage of culture establishment, care was 
taken to prevent physical disruption of the endothelial 
tissue layers. The organ culture blocks were then 
transferred into a sterile flow hood, gently rinsed in 
sterile phosphate-buffered saline (PBS), and placed 
into individual wells of 24-well tissue culture plates 
containing Medium 199 with modified HEPES buffer 
(Sigma, St. Louis, MO, USA) supplemented with 15% 
fetal bovine serum, 100 U/mL penicillin, lOOllg/mL 
streptomycin, and 0.25 Ilg/mL amphotericin B (all 
reagents from Invitrogen, Carlsbad, CA, USA). The 
organ cultures were maintained in a humidified incu-
bator at 37 °C with 5% CO2 for up to 8 weeks. Culture 
medium was changed every 2-3 days. The resulting 
organ cultured blocks were removed before and after 
establishment of culture, and subsequently at weekly 
intervals for analysis. 
At the specified time points, tissue blocks 
were removed from culture, fixed in Histochoice ™ 
(Amresco, Solon, OH, USA), and embedded in paraf-
fin. Tissue sections were stained with H&E and Movat 
pentachrome to identify the cell nuclei and extracellular 
matrix (ECM) components. Changes in the location of 
endothelial cells and in collagen (COLL) synthesis were 
evaluated immunohistochemically using antibodies 
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against von Willebrand Factor (vWF, Sigma) and the 
enzyme prolyl-4-hydroxylase (P4H, Chemicon, 
Temecula, CA, USA), respectively. The sample was 
first rehydrated using graded dilutions of Flex 
(Richard-Allen Scientific, Kalamazoo, MI, USA). 
Antigen decloaking was performed using a citrate 
buffer, and the sample was exposed to a 10% solution 
of goat serum at room temperature for I h to limit 
indiscriminate binding of the secondary antibody. After 
removing the goat serum, the appropriate primary 
antibody was applied and incubated at 37°C for 1 h. 
Negative controls for each sample were exposed to the 
secondary antibody only. The primary antibody was 
then removed and the sample exposed to the biotinyl-
ated secondary goat anti-mouse antibody (Jackson 
ImmunoResearch, West Grove, PA, USA) at room 
temperature for 1 h. The samples were then exposed to 
an avidin- biotin complex for 30 min and tagged using a 
3,3'-diaminobenzidine kit for 10 min (both from Vector 
Labs, Burlingame, CA, USA). All samples were coun-
terstained with hematoxylin to localize cells within the 
tissue. 
Bioreactor Design 
The bioreactor chamber design consisted of three 
polycarbonate segments (McMaster-Carr, Chicago, 
~L , USA), each 2" in diameter (Fig. I a). The segments 
were clamped together via four 4"-long, Y4"-28 par-
tially threaded screws and nuts spaced 90° around the 
circumference of the bioreactor. The two ends of each 
segment each had three 1/16" neoprene washers 
(McMaster-Carr) mounted using cyanoacrylate glue. 
The washers were wrapped with Teflon® tape upon 
chamber construction to prevent leaks. The main body 
of segment A was 1.5" tall and had a Y/' hole in the 
center to accommodate fluid flow. The top of A was 1" 
height and threaded to fit the vented filter cap from a 
25-cm2 tissue culture flask (BD Biosciences, San Jose, 
CA, USA) in order to allow gas exchange in the bio-
reactor. Segment B was 5/8" height and had a Y/' hole 
in the center. Polyester mesh squares (Sefar America 
Inc. , Depew, NY, USA) approximately 0.5 x 1 mm2 
were glued between the neoprene washers to provide a 
mounting location for the mitral valve. Segment C was 
1.25" height, and a Y/' hole was cut through the top I" 
for fluid flow . The bottom Y4" of the segment was 
solid. 
Repeatable fluid motion was provided by rotating 
the bioreactor chambers using a Labnet Mini 
LabRoller™ (lSC Bioexpress, Kaysville, UT, USA). 
This rotator fit two bioreactors on a pallet, secured 
with two 3/ 16" cable ties (Fig. Ib). The rotator, which 
was selected based on its small size and incubator 
compatibility, had only one available speed setting, 
FIGURE 1. (a) Splashing bioreactor chamber. The chamber 
is comprised of three hollow segments (A)-(C) into which the 
valve segment is mounted. The media inside the chamber 
provide nutrients to the tissue. Valve attachment sites (inside 
chamber) are also indicated. ANN, annulus; CH, chordae. 
(b) Bioreactor on rotator. The pallet rotates 3600 , forcing 
media over the valve surfaces. 
rotating a full 360° at an approximate speed of 
0.33 revolutions/so This motion caused the media to 
splash across both valve surfaces, imparting a combi-
nation of normal and shear force to the valve; com-
pression force from in vivo coaptation of the valve 
leaflet free edges would be absent (Fig. 2). Based on 
previously published values of heart rate and tissue 
deformation in normal in vivo animal models,l fI"lll it 
was assumed that tissue velocities and developed shear 
stresses in the bioreactor would be sub-physiological. 
A 4,5-mL culture medium was used to fill the chamber; 
although this volume of media only partially bathed 
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the tissue when the chamber was not rotating, this 
volume allowed greater forces to be imparted onto the 
valve surface than would have been possible if the 
chamber had been completely filled. 
Maximum tensile strains in the leaflet and the 
chordae were estimated separately due to the differ-
ences in the ECM structure of the two tissue types. 
Stress was first calculated from the normal force of the 
fluid on the submerged tissue, as given by the specific 
weight of the fluid and the tissue geometry. Strain was 
then calculated using the pre-transition stiffness of the 
tissue, which was estimated to be five times greater for 
chordae than leaflet. 17,:n As a result, the maximum 
tensile strain for leaflet (0.65%) was five times greater 
that of chordae (0.13%). 
Maximum bending strains within regions of local 
curvature were estimated for both the leaflet and 
chordae by the ratio of one-half leaflet thickness to 
o 45 90 135 
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FIGURE 2. Rotation of splashing bioreactor through 360° 
motion. As the chamber rotates, the culture medium flows 
past the tissue surface, imparting normal and shear forces to 
the surface and causing deformation of the organ culture. 
radius of curvature. This calculation was independent 
of material or geometry and was therefore applicable 
to both valve portions . Leaflet thickness was assumed 
to be I mm. Radius of curvature was calculated from 
the chord length and arc length of the locally curved 
regions . To determine these lengths, it was assumed 
that the leaflet segment was straight across either one-
half, two-thirds, three-fourths, or four-fifths of the 
annular to chordal attachment distance and the 
remainder of the leaflet segment was curved . These 
geometric conditions were estimated to generate max-
imal bending strains ranging from 4%, when the whole 
leaflet--chordal segment was bent in one smooth arc, to 
25% when only one-fifth of the entire leaflet--chordal 
segment length was. bent (Fig. 2). 
In addition, a basic computational model was used 
to investigate the shear forces and fluid velocities 
imparted to the tissue by this system. ANSYS Work-
bench (ANSYS Inc., Canonsburg, PA, USA) was used 
to run a computational fluid dynamics model of fluid 
flow across an idealized leaflet using the CFX code. 
Inlet flow rate (2.97 mL/s) was chosen from the fluid 
volume and rotation speed of the system. The flow was 
modeled as an inlet flow from the bottom surface of 
the lumen toward the top at four points through half 
of a system rotation (0°, 45°, 90°, 135° rota tion) . 
Calculations were performed using a shear-stress 
transport model , which improves accuracy in the 
boundary region thereby increasing accuracy of wall 
shear stress calculations. This method employs a k- w 
model at the wall and then blends it with a k-f-
model. 2·~ Tissue wall shear stress was visualized on all 
surfaces of the leaflet, and the shear on the surface of 
the leaflet was determined by using a contour plot 
(Fig. 3). Shear stress was observed to be consistent 
FIGURE 3. Plot of shear stress on the surface of the leaflet. Shear stress was averaged over the shown surface of the leaflet. 
Shear stress at system orientation: (a) 0° (straight up and down), (b) 45°, (c) 90° (horizontal), (d) 135°. 
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FIGURE 4. Vector plot of fluid velocity in the mid-plane of the culture chamber. Fluid velocity peaks at -4 cmls near the area of 
chordal attachment to the leaflet. Eddies can be observed near the free edge. Velocity vectors at system orientation: (a) 0°, (b) 45°, 
(c) 90°, (d) 135°. 
over the bulk of the leaflet surface and was observed to 
be 0.010- 0.020 Pa at all orientations. In addition, fluid 
velocities were investigated at the center plane of the 
culture chamber and visualized with a vector field 
(Fig. 4), showing turbulence around the leaflet free 
edge. 
Developing a bioreactor system that could be ster-
ilized prior to assembly, and assembled and run in a 
sterile manner, was a major consideration during the 
design process. Prior to attachment of the valve seg-
ment in the bioreactor, the bioreactor was disassem-
bled and the individual segments washed using a 1: 128 
dilution of CiDecon (Decon Labs, King of Prussia, 
PA, USA) disinfectant. The segments were then 
sprayed with a 70% ethanol solution, with special 
attention paid to the inside surfaces, and exposed to 
ultraviolet light in a sterile biological hood for 
30-60 min. The bioreactor pieces remained in the 
sterile hood until assembly. Sterility testing of the 
bioreactor was performed by allowing media to remain 
in the stationary chamber for I week . Initial tests were 
performed without valve tissue, and later tests included 
a mitral valve segment mounted in the bioreactor 
chamber. When the media were changed, a sample of 
the old media was placed into a 6-well plate and 
returned to the incubator. A sample of the fluid was 
also applied to an agar plate and allowed to incubate 
for 3 days. In addition, media were spot-checked 
for contamination during test runs with the valves 
by drawing media samples, incubating the media in a 
6-well plate for 2- 3 days , and examining the media 
using an inverted microscope. 
Design Validation 
Porcine mitral valves (Fisher Ham & Meat, Hous-
ton, TX , USA) from approximately 6-month-old ani-
mals were used to validate the ability of the designed 
bioreactor to maintain the normal condition of the 
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FIGURE 5. Valve insertion. (a) A 5-mm radial valve segment 
is removed from the AL. (b) The segment is then mounted at 
the ANN and CH, taking care to leave the tissue slack. The free 
edge is unattached. (c) Top view of valve in bioreactor. AL, 
anterior leaflet; ANN, annulus; CH, chordae; PL, posterior 
leaflet. 
valve microstructure and cell distribution . Valves were 
dissected from the heart wi thin 6-10 h postmortem 
and rinsed in sterile PBS containing 5% antibiotic/ 
antimycotic solution (Mediatech Inc. , Herndon, VA, 
USA) to remove bacteria. Two 5-mm wide radial 
segments (one surrounding each strut chordae, Fig. 5a) 
were then removed from the anterior leaflets (n = 19 
total). When preparing the tissue segments, the entire 
length of the leaflet (annulus to free edge) and strut 
chordae were used. Due to the similarity in the age of 
the animals from which the hearts were harvested , 
valve tissue segment sizes were generally consistent. 
The first segment from each valve was cultured, 
under either static or dynamic conditions, for 2 weeks. 
Static cultures (negative control , n = 10) were placed 
in a T-25 tissue culture flask. As with the pilot study, 
static cultures were not subjected to any mechanical 
stimulation . Dynamic cultures (n = 9) were mounted 
in the bioreactor (Figs. 5b and 5c); anchoring on both 
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ends of the tissue was fixed, and did not contract as it 
would in the in vivo system. The valve segment was 
~arefully mounted within the bioreactor in such a way 
that it was kept slack in order to model diastole, with 
the assumption that tension on the tissue culture dur-
ing systole would be lower than on the in vivo tissue 
due to the lower in vitro fluid speed and lack of 
mechanical stimulation from the ventricular wall. In 
both test cases, the tissue was bathed in organ culture 
media (DMEM/Ham's F12, Mediatech Inc.; 10% 
bovine growth serum, HyClone Waltham, MA, USA; 
1 % HEPES buffer, Mediatech Inc.) containing 5% 
antibiotic/antimycotic solution for the first 24 h after 
dissection, after which it was replaced by media with 
1 % antibiotic/antimycotic solution. The second seg-
ment from each valve was designated a baseline control 
sample. All tissues were fixed in Histochoice™ after 
2 weeks (cultured samples) or immediately after dis-
section (baseline control samples). After fixation, all 
tissue samples were dehydrated to xylene, paraffin 
embedded, sectioned into 5 J.lm slices, and mounted on 
slides. 
As in the pilot study, samples in the validation study 
were stained with H&E and Movat pentachrome. 
Immunohistochemical staining was employed to local-
ize the proteoglycans (PGs) versican (VC, Seikagaku, 
Associates of Cape Cod, East Falmouth, MA, USA), 
decorin (DCN), and biglycan (BGL), as well as collagen 
types I and 3 (COLL I /COLL3), within the valve layers. 
Unless otherwise indicated, antibodies were generously 
provided by Dr. Larry Fisher (NIDCR, Bethesda, MD, 
USA).9 In addition to these ECM components, the 
ECM synthesis mediators P4H (Millipore, Billerica, 
MA, USA), lysyl oxidase (LOX, Imgenex, San Diego, 
CA, USA), and heat shock protein 47 (HSP47, Abcam, 
Cambridge, MA, USA) were also localized. HSP47 is a 
molecular chaperone associated with COLL synthesis, 
whereas LOX is involved in COLL and elastin cross-
linking. Immunohistochemical staining for matrix 
metalloproteinases (MMPs) I, 2, 9 (all from Assay 
Designs, Ann Arbor, MI, USA), and 13 (Millipore) 
identified sites of enzymatic matrix degradation. 
Staining for tissue inhibitor of MMP I (TIMP-l, Assay 
Designs) stain was also performed. An antibody sensitive 
to proliferating cell nuclear antigen (PCNA, Abcam) 
determined the location of proliferating cells within the 
tissue. The immunohistochemical method for PGs was 
identical to that of the P4H method described above, 
except for sample pretreatment with Chondroitinase 
ABC (Seikagaku, Tokyo, Japan) in lieu of antigen 
decloaking to expose the core protein binding site. No 
antigen retrieval step was required for the COLLI, 
COLL3, or MMPI3 primary antibodies. Sections were 
then treated with biotinylated secondary antibodies 
derived from goat (anti-rabbit or anti-mouse as 
appropriate, Jackson ImmunoResearch) prior to chro-
mogenic staining. 
All stained samples were imaged using a Microtek 
ArtixScan 4000tf slide scanner (Microtek Interna-
tional, Carson, CA, USA). Images were then blinded 
and graded for staining intensity on a scale of 0-4: 
O-no stain; I-weak stain in < 50% of the area of 
interest; 2-weak stain in > 50% or strong stain in 
< 10%; 3-strong stain in < 50%; and 4-strong stain 
in > 50%. This semi-quantitative method has been 
used previously in our lab with a variability of 
< 15%." In order to determine the effect of the 
mechanical stimulation throughout the tissue, staining 
intensities were assessed in all three valve leaflet layers: 
the elastin-rich atrialis, located at the atrial surface; the 
middle spongiosa layer, comprised of PGs and gly-
cosaminoglycans (GAGs); and the collagenous fibrosa, 
located near the ventricular surface. Staining intensity 
was also measured in the strut chordae. Co-localization 
of the different ECM components and turnover 
mediators within the valve layers was performed via 
comparison of the immunohistochemically stained 
samples to the Movat-stained samples. PCNA and 
H&E-stained samples were examined qualitatively to 
assess changes in cellular density within the different 
valve layers. 
Statistical Analysis 
Since each anterior valve leaflet had two strut 
chordae (Fig. Sa), each valve yielded two samples for 
testing. For each valve obtained during the validation 
study, one segment was designated a baseline control, 
and the second segment was cultured for 2 weeks in 
either the no mechanical stimulation (static) or cyclic 
mechanical stimulation (dynamic) condition; therefore, 
each test group had its own matched control. In every 
valve layer, staining intensity of each ECM component 
and turnover mediator of the cultured segment was 
normalized to that of the baseline control segment. A 
staining intensity within 20% of the baseline (nor-
malized values of 1.0 ± 0.2) was considered to be 
maintenance of the component during the treatment 
period. Normalized staining intensities of the dynamic 
organ culture were compared to those of the static 
controls using a Student's t-test, with statistical sig-
nificance defined as p < 0.05. 
RESULTS 
Pilot Long-Term Static Culture Study 
Several general trends were identified in the Movat-
stained atrioventricular valve samples cultured under 
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static conditions over several weeks. First, COLL 
became more diffusely distributed in all samples. 
Toward the end of the culture period , COLL either 
dominated the cross section or shared dominance with 
elastin (Fig. 6a). The alcian blue stain marking the 
initially distinct PG layer became less well defined, then 
developed to a diffuse bluish haze within the COLL, 
and was virtually undetectable in the final week of the 
cultures (Fig. 6b). Finally, elastin content increased in 
some samples, although the final distribution of the 
elastin varied greatly between valve samples (Fig. 6c). 
All tissue blocks taken at initial culture had an even 
distribution of cells on the interior, and a thin layer of 
endothelial cells on the outer surface (Fig. 7). Care was 
taking during tissue sectioning to limit damage to the 
endothelium, and staining performed prior to organ 
culture indicated that this layer was intact. In future 
studies, scanning electron microscopy could also be 
performed to confirm tissue integrity. In the first of 
three identified cell distribution patterns in the static 
cultures (Fig. 8), a clumping pattern was observed, in 
which cells became more abundant in certain areas of 
the valve, often less dense regions containing PGs, and 
less abundant in the more dense COLL-rich regions. 
Next, a depletory effect was seen, in which few cells 
could be detected. Finally, there was an accumulation 
of cells on the surface of many organ cultures. This 
accumulation, which was especially pronounced in the 
first 2 weeks of culture, was located mainly on the 
ventricular surface of the valve and in areas containing 
sharp protrusions or indentations that acutely and 
locally disrupted the endothelial layer or well-
organized valve microstructure. 
Cells staining for P4H were initially evenly distrib-
uted throughout the interior of the valve, but by the 
conclusion of culture, strong marker expression in the 
leaflet interior coincided with the accumulations of 
COLL shown in the Movat's pentachrome stain (data 
not shown). P4H also showed strong expression in the 
exterior cell accumulations. The results of the pilot 
study were used as a basis of comparison for the bio-
reactor validation studies. 
Validation of Bioreactor Effectiveness 
After the bioreactor was designed and built, it was 
tested to verify that it could maintain a sterile envi-
ronment and that the mechanical stimulation would 
maintain ECM structure and cell viability. Sterility 
tests showed that the environment within the bioreac-
tor remained free from contamination during the 
2-week test period (data not shown). 
The static culture results regarding the distribution 
of cells and the valvular-layered structure corroborated 
those of the pilot study. PCNA immunostaining indi-
cated that, without mechanical stimulation, fewer 
proliferating cells were located deep within the tissue, 
although prolifera ting cells were found near the tissue 
(a) Collagen (Yellow) (b) PO & GAG (Blue) (e) Elastin (Black) 
FIGURE 6. Movat pentachrome-stained sections of porcine organ-cultured valve tissue blocks (original magnification 10x). The 
ventricular surfaces are on the right and the atrial surfaces are on the left. (a) COll content (yellow) clearly dispersed from the 
normal structure and began to dominate the valves, usually becoming the only remaining matrix protein by the conclusion of 
culture. (b) PG and GAG contents (blue-green) gradually disappeared, becoming just a diffuse haze in the mixture. (c) Elastin 
(black) became less localized and occasionally dominated the cross section, often together with COlL. Arrow indicates increase in 
culture duration. 
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FIGURE 7. Valve section stained with vWF (top) and the 
corresponding negative stain (bottom) of fresh tissue imme-
diately after sectioning into culture segments. Dark brown 
stain along the surfaces in the vWF section indicated the 
presence of an intact endothelial layer prior to organ culture. 
surface. H&E staining showed the same trend (data 
not shown). After 2 weeks of static culture, the layered 
structure of the valve was also compromised. Although 
the Movat image showed maintenance of the atrialis, 
the fibrosa and spongiosa became less defined, with an 
increase in COLL content in the normally PG-rich free 
edge spongiosa. 
The bioreactor appeared to counteract these static 
culture trends; after 2 weeks of culture, cell concen-
trations in the middle and periphery appeared com-
parable to those in control tissue, as indicated by both 
H&E and PCNA staining. Positive immunostaining 
for PCNA (Fig. 9) also suggested that these cells 
retained their ability to proliferate during the culture 
period . In addition, tissue samples cultured in the 
bioreactor displayed a similar ECM structure to that 
of the control samples; the collagenous fibrosa and 
elastin-rich atrial is layers of the leaflet center were 
clearly delineated in the Movat images (Fig. 9). The 
PGs in the spongiosa of the free edge were also 
maintained (data not shown). 
The use of matched baseline controls for both the 
static and dynamic culture groups allowed the staining 
intensities of the ECM components and the turnover 
mediators to be normalized for comparison of differ-
ences after 2 weeks of culture. A normalized value of 1 
indicated that there was no change in the component 
after culture, while a value < 1 indicated reduced 
expression and a value > 1 indicated greater expres-
sion. Overall, the splashing bioreactor was successful 
at maintaining most tested ECM components and 
turnover mediators (Table I) as shown by maintenance 
of expression levels within 20% of baseline (normal-
ized staining intensity of 1.0 ± 0.2) . As shown in 
Figs. 10 and 1 I, static culture generally reduced 
expression of these factors relative to baseline controls, 
whereas dynamic culture resulted in more clustering of 
normalized expression values around 1.0. In fact , more 
normalized values were within 10% of baseline for 
dynamic culture (28 out of 52 factors) than they were 
with static culture (22 out of 52 factors). The most 
distinctive results for each layer are noted below. 
In the chordae, dynamic stimulation encouraged 
negligible changes in component expression when 
compared to static culture conditions (Fig. J I a) . 
Normal chordae consist of a COLL core surrounded 
by an elastin sheath. In the test samples, COLL I 
content was reduced in the static culture samples and 
maintained in the dynamic culture samples (0.65 ± 
0.21 static vs. 1.1 ± 0.27 dynamic, p < 0.01) . Con-
versely, COLL3 expression was elevated in the static 
samples and maintained in the dynamic samples 
(1.5 ± 0.82 static vs. 1.1 ± 0.14 dynamic) . While VC 
expression (which was quite low in static culture 
samples) tended to improve with dynamic stimulation 
(0.53 ± 0.14 static vs. 0.87 ± 0.54 dynamic) , DCN 
expression remained constant among the three groups 
(control , static, and dynamic). Expression of MMPl , 
MMP2, and TIMP I among the three culture groups 
was also approximately equal. HSP47 , MMP9, and 
MMP13 results were too varied to be conclusive. 
Dynamic culture caused expression of P4H , LOX, and 
BGN that was higher than the main tenance range 
(1.25 ± 0.42, 1.29 ± 0.46, and 1.39 ± 0.41 , respec-
tively) ; in static culture conditions P4H and BGN were 
maintained (1.15 ± ,0.46 and 0.92 ± 0.32, respectively) 
but LOX was reduced (0.69 ± 0.50). 
The fibrosa of the normal mitral valve is also mostly 
comprised of COLLI and COLL3. Normalized 
COLLI expression was approximately 1.0 for both the 
static and dynamic cases (0.94 ± 0.45 static vs. 
0.97 ± 0.25 dynamic), and COLL3 expression was 
elevated for both cases (1.6 ± 0.67 static vs. 1.3 ± 0.41 
dynamic). BGL and P4H contents were similar among 
the three sample groups, whereas expression of 
MMPI , MMP9, LOX, and HSP47 was closer to 
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FIGURE 8. Hematoxylin and eosin-stained sections of porcine organ-cultured valve tissue blocks (original magnification 10x). 
The ventricular surfaces are on the right and the atrial surfaces are on the left. When compared to the control (a), valve tissue 
cultured without mechanical stimulation experienced (b) cell depletion pattern, (c) cell accumulation on the ventricular surface, 
and (d) cell clumping/migration from more dense tissue to less dense, more hydrated tissue. 
baseline in dynamic samples (normalized expressions 
of 1.07, 1.06, 0.96, and 1.11 , respectively) when com-
pared to static samples, in which expression levels were 
consistently reduced (0.63 , 0.69, 0.8, and 0.76). In 
general , use of dynamic mechanical stimulation 
appeared to cluster normalized component expression 
around 1.0 (Fig. '11 b) . Exceptions were VC (sta tic 
0.8 ± 0.31 , dynamic 0.70 ± 0.25), COLL3 (static 
1.59 ± 0.68, dynamic 1.32 ± 0.41), MMP2 (static 0.58 ± 
0.39, dynamic 2.6 ± 0.89), and MMP13 (static 1.33 ± 
0.52, dynamic 2.6 ± 1.6). 
In normal valve tissue, the atrialis is mostly com-
prised of elastin. Although immunostaining for elastin 
was not performed, Movat images (Fig. 9) show that 
the elastin layer is maintained after 2 weeks of dynamic 
culture. While normalized COLL I expression was 
reduced in static culture, it was maintained within 
normal values with dynamic culture (0.75 ± 0.25 static 
vs. 0.98 ± 0.27 dynamic, p = 0.03) . Although nor-
malized COLL3 expression was slightly greater with 
dynamic culture than static culture (0.88 ± 0.25 static 
vs. 1.2 ± 0.37, p = 0.06), baseline production of this 
ECM component was maintained in both cases . 
Expression of a ll PGs remained constant compared to 
baseline with both static and dynamic cultures, as did 
COLL3, MMPI , MMP2, MMP9, and LOX content; 
this tendency of both treatments to maintain a trialis 
composition is illustrated in Fig. II c. TIMPI expres-
sion was too varied between samples (0.68 ± 0.32 
static vs. 0.74 ± 0.45 dynamic) to draw a conclusion. 
Dynamic stimulation caused the expression of two 
factors away from the maintenance range: HSP47 
(static 1.32 ± 1.08, dynamic 0.77 ± 0.26) and MMPl3 
(static 1.16 ± 0.44, dynamic 1.6 ± 0.57) . 
The spongiosa of a healthy mitral valve mostly 
contains DCN, VC, and BGL. As shown in Fig. ) Id, 
dynamic stimulation did not induce a marked overall 
improvement of component expression over static 
treatment; selected improvements, however, are high-
lighted below. Normalized expression of DCN and VC 
were normal in both the static and dynamic treatments 
(DCN: 0.92 ± 0.30 static vs. 0.95 ± 0.33 dynamic and 
VC: 0.91 ± 0.27 static vs. 0.98 ± 0.14 dynamic) , 
whereas BGL expression was reduced in both culture 
groups (0.82 ± 0.43 static vs . 0.79 ± 0.28 dynamic) . 
Normalized expression of MMP9 (0 .55 ± 0.31 sta tic 
vs . 1.2 ± 0.72, p = 0.01) and TIMPI (0.79 ± 0.46 vs. 
1.3 ± 0.65, p = 0.04) in the spongiosa was both 
greater with dynamic culture and reduced with sta tic 
culture. MMP2, MMP9, and HSP47 expression were 
constant between the dynamic culture samples and 
baseline controls. Their resulting normalized stain 
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FIGURE 9. Comparison of a mitral valve center before (a, c) 
and after (b, d) 2 weeks of dynamic organ culture. When 
compared to the uncultured fresh control (a), Movat staining 
shows maintenance of atrialis (top black) and fibrosa (yellow) 
layers after 2 weeks of culture (b). PCNA stain in the fresh 
control (c) and the cultured (d) tissues shows the presence of 
proliferating cells (in brown) throughout the tissue. Atrial 
surface at top. Magnification = 5x (a, b) or 20x (c, d). 
TABLE 1. Change in abundance of ECM component! 
precursor after culture. 
BGL 
DCN 
VC 
COLL1 
COLL3 
P4H 
MMP1 
MMP2 
MMP9 
MMP13 
TIMP1 
LOX 
HSP47 
Atrialis 
-1-
-1-
-I-
t /-
-/-
-Ii 
-1-
- /-
-1-
-Ii 
t /t 
-I-
i /-
Spongiosa 
-/-
- /-
-1-
t /t 
t /t 
-1-
-It 
-I-
t /-
-1-
-Ii 
-/-
t /-
Fibrosa 
-/-
-Ii 
-It 
-1-
i /i 
-I-
t /-
t /i 
t /-
i /i 
-/t 
-/-
-1-
Chordae 
-ii 
-/-
t /-
t /-
i /-
-Ii 
-1-
-I-
i /-
-1-
-1-
t /i 
i /-
Symbols before or after slash mark indicate changes in specified 
component after 2 weeks of static/dynamic culture relative to fresh 
tissue. 
- No change in normalized content expression (1.0 ± 0.2); 
i, increase in normalized content expression; t, decrease in 
normalized content expression. 
intensity, which was approximately 1.0, was greater 
than and an improvement over that of the static 
samples. Normalized staining intensity was approxi-
mately 1.0 for MMPI3, P4H, and LOX in both static 
and dynamic samples. Dynamic culture caused a 
reduction in the normalized staining intensity of three 
factors in the spongiosa to outside the maintenance 
range: COLLI (static 0.73 ± 0.32, dynamic 0.71 ± 
0.28), MMP2 (static '0.s8 ± 0.39, dynamic 0.53 ± 0.27), 
and MMPI (static 1.16 ± 0.61 , dynamic 0.54 ± 0.57) . 
DISCUSSION 
This study demonstrated that the splashing biore-
actor provided mechanical stimulation necessary to 
preserve normal mitral valve-layered structure and 
ECM composition. In samples cultured without 
mechanical stimulation , proliferating cells deep within 
the tissue were depleted, and the layered structure 
noted in the nonnal valve became less defined with 
increased culture time. Fluid movement against tissue 
surfaces initiated by rotation of the bioreactor cham-
ber provided perfusion and gentle tension, maintaining 
tissue integrity. This cyclic fluid motion was verified as 
sufficient to maintain valve structure for the 2-week 
period of interest by assessing stain intensity of PGs, 
COLL, and ECM turnover mediators before and after 
culture. This novel bioreactor, though simple in design 
and construction, could become a powerful tool for 
both tissue engineering and organ culture applications . 
In the pilot study, we found that several major 
microstructural alterations occur when native heart 
valve tissue is placed in simple floating organ culture 
for several weeks. First, there was a dramatic upregu-
lation ofCOLL and dissipation ofPGs and GAGs. An 
increased abundance of COLL in the longer duration 
valve organ cultures could be caused by many cellular 
phenotypic changes, such as the upregulation of COLL 
producing enzymes and the downregulation of COLL 
degrading enzymes such as MMPs. A specific pheno-
typic analysis of the cells in the valve showed stronger 
P4H expression corresponding to areas of higher 
COLL content. We speculated that this apparent 
COLL upregulation and the rapid disorganization of 
the COLL layers could be attributed to the absence of 
mechanical stretch-induced perfusion of the tissues 
with our organ culture system. The dissipation of PGs 
could also be caused by the disorganization of the 
tissue, allowing the water-binding PGs and GAGs to 
leach out over time. 
In addition to ECM changes, cells within the static 
cultured valves appeared to either migrate or dissipate 
with time, corroborating earlier static organ culture 
studies. I There were also large buildups of surface 
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FIGURE 10. Histogram showing normalized component expression throughout the mitral valve. To generate the above histo-
gram, the expression levels for all examined components (each of which was normalized to Its matched fresh control) for alliayersl 
chordae of the mitral valve samples were categorized Into increments of 0.1. Samples cultured under static (white) and dynamic 
(black) conditions were compared using this histogram to gain a picture of the overall status of ECM within the cultured valves. In 
general, dynamic culture conditions contributed to component maintenance as defined by 1.0 ± 0.2 (100 ± 20%), after 2 weeks of 
culture. Not shown: normalized expression of MMP13 (2.3) and MMP2 (2.6) In fibrosa of dynamically cultured valves. 
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FIGURE 11. Histogram showing normalized component expression in the mitral valve chordae (a), fibrosa (b), atrialis (c). and 
spongiosa (d) to permit comparison of the samples cultured under static (white) and dynamic (black) conditions. These histograms 
were generated In the same manner as that described In the legend to Fig. 10. In general. dynamic culture conditions contributed to 
component maintenance as defined by 1.0 ± 0.2 (100 ± 20%) after 2 weeks of culture; the components considered to be main-
tained are described in the text and shown In Table 1 by the "-" symbol. ECM components and syntheslslturnover mediators not 
maintained by dynamic culture are Indicated above bars, and are also Indicated In Table 1 by the up or down arrows. Not shown: 
normalized expression of MMP13 (2.3) and MMP2 (2.6) In fibrosa of dynamically cultured valves. Abbreviations are as given In text 
except for HSP47, heat shock protein 47; Cl1, collagen type 1; Cl3, collagen type 3; TMP. tissue Inhibitor of metalloproteases. 
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cells, especially on the ventricular surface. Over several 
weeks, the cells graduaJIy became less abundant in the 
denser fibrosa layer and more abundant in the less 
dense spongiosa layer. Migration of cells within the 
organ cultured tissue blocks may have been a means 
to compensate for deficiencies in diffusive nutrient 
transport. In normal adult heart valves, ceJIs 
throughout the leaflets are nourished by diffusion of 
oxygen and nutrients as opposed to a vascular supply.4 
Normal diffusion, however, is likely facilitated through 
the cyclic-stretch-induced perfusion of the tissues, 
which was not present in the static organ culture 
system. 
A splashing bioreactor was therefore designed for 
perfusing and applying gentle stretch to a valve organ 
culture. Prior to using the bioreactor as a system for 
in vitro testing of valvular disease mechanisms, how-
ever, the cyclic mechanical stimulation provided by the 
fluid motion had to be verified as sufficient for main-
taining both the layered valve structure and cell via-
bility. The shear stress and velocity profile of flow was 
determined computationaJIy, and the observed shear 
stress was 0.017 Pa. Furthermore, the velocity profile 
showed turbulence around the free edge of the leaflet. 
Functional evaluation of the biomechanical signals 
provided by this system was evident from the mainte-
nance of tissue structure. This was illustrated by 
overall maintenance in elastin, PG, and COLL 
expression shown by immunohistostaining and histol-
ogy (Movat) in dynamicaJIy cultured tissue. The lack 
of change in staining intensity of the ECM turnover 
mediators also indicated limited turnover of the ECM 
during the culture time. Proliferating ceJIs were found 
throughout both the fresh and dynamicaJIy cultured 
tissues, indicating that the bioreactor was also suc-
cessful in maintaining ceJI viability within the valve 
layers. These results showed that the mechanical 
stimulation provided by the splashing bioreactor was 
sufficient to maintain the valve layered structure and 
cell viability characteristics that were lost with static 
organ culture methods. 
Valve cultured under static conditions tended to 
display excessive COLL production, and a successful 
bioreactor would maintain normal COLL composi-
tion. P4H has a role in the early non-helical phase of 
COLL synthesis;,4 BGL assists in regulation of fibril 
diameter,10 and LOX catalyses the cross-links in the 
COLL fibers.":- Increased normalized expression of 
these three components indicated additional COLL 
remodeling within the chordae with mechanical stim-
ulation. OveraJI COLL content in the chordae, how-
ever, did not change; dynamic culture expression of 
COLLI and COLL3 was almost equivalent to baseline 
in this highly coJIagenous tissue. Regulation of COLL 
remodeling was also noted within the valve leaflet. 
Considering the general increases in normalized 
expression of MMPI3 (which degrades COLL) as weJI 
as COLL I and COLL3, these data suggest that 
mechanical stimulation upregulated COLL production 
in the atrialis, maintaining COLL content via the 
appropriate turnover mediators. The increase in nor-
malized COLL3 expression, which is also upregulated 
in myxomatous valves,' lends particular weight to this 
remodeling interpretation. It is also interesting to note 
that although MMPl3 is responsible for cleaving 
COLLI 27,41 there was no significant decrease in 
COLLI staining intensity corresponding to increased 
MMPl3 staining intensity in the fibrosa; this result 
suggests that after 2 weeks there was only limited 
COLL remodeling in the fibrosa of dynamic culture 
samples. Since MMPl3 is associated with COLL 
turnover,41 this may have been an attempt to limit the 
excess COLL deposition noted in the earlier study. 
TIMPI is an inhibitor of most MMPS27 ,41; its decrease 
in the fibrosa was possibly responsible for the increase 
in MMP expression. 
Although the mechanical stimulation appeared to 
alter PG and COLL expression in the rest of the 
mitral valve, normalized BGL, COLLI, and COLL3 
remained lower than normal in the spongiosa in both 
the static and dynamic culture conditions. Lack of 
dynamic culture-based improvement in BGL and 
COLL content in the spongiosa was potentially due 
to the lack of coaptation in the leaflet-free edge; 
while the bioreactor supplied mechanical stimulation 
from fluid flow, the tissue did not make contact 
with the opposing posterior leaflet as occurs in vivo. 
Elevated TIMPI expression suggested that remodel-
ing of the tissue might transpire given a longer culture 
time. 
There were some apparent discrepancies between 
the COLL results in the two static culture studies (the 
pilot study and the static culture controls for the bio-
reactor validation study). The mitral valve tissue cul-
tured statically in the bioreactor validation study 
demonstrated less staining for COLLI (the most 
abundant COLL in normal valves) than baseline after 
2 weeks of static culture, whereas the tissue from the 
pilot study showed more total COLL with increased 
culture time, as evidenced by the Movat safran yellow-
stained regions (Fig. 6). One possible explanation is 
that the pilot study employed tricuspid valve tissue; the 
two valves may have had different responses to the 
culture environment. The greater accumulation of 
COLL in the pilot study could also be attributed to the 
longer culture time (up to 8 weeks). In addition, the 
Movat stain used in the pilot study could not be 
used to distinguish between the different COLL 
types present in the valve. In the validation study, 
both COLLI and COLL3 were measured via 
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immunostaining, and results suggested that an increase 
in COLL may have been due to COLL3 upregulation. 
COLL3 has been shown previously to be greater than 
normal in patients with myxomatous" and rheumatic22 
heart valve disease and has been presumed to indicate 
valve pathological remodeling; the increase in COLL3 
noted in this study suggests an ongoing repair process 
within the tissue. 
The exact role of the mechanical stimulation pro-
vided by the splashing bioreactor in maintaining ECM 
components and precursors should be explored in a 
future study. It is possible that the fluid motion directly 
impacted mechanical signaling in the tissue. The role of 
the fluid motion could be further clarified by providing 
mechanical stimulation in another manner, such as 
mounting the valve tissue in tension instead of the re-
laxed state used above, or by employing a different 
speed of rotation or a different rotation pattern (i.e., 
rocking vs. continuous). Another possibility is that the 
splashing of the culture media indirectly improved 
nutrient diffusion, which should be assessed in future 
work by comparing glucose, L-glutamine, ammonia, 
and lactate content in cell culture medium throughout 
the culture period. It is also highly likely that the 
rotating movement of the bioreactor improves trans-
port of oxygen across the gas-fluid interface, thereby 
increasing the levels of dissolved oxygen in the med-
ium. This improvement in oxygen levels would be 
beneficial to the valve as it would prevent hypoxia, 
which can occur when dissolved oxygen levels fall be-
low 20%.:" Therefore, in the future it will be important 
to compare the dissolved oxygen content in the culture 
media between static and dynamic culture conditions. 
This bioreactor design validation study was novel 
compared to those used to validate previous heart 
valve tissue engineering bioreactor designs,\<) using a 
longer time course for the study as well as qualitative 
and quantitative tissue analysis methods. Previous 
heart valve bioreactor studies have often focused on 
demonstrating upregulation of ECM components or 
precursors after 48 h.1 '.'?X.J,! Conversely, this study 
employed a longer culture time, which is more useful 
for modeling a long-term pathology or for examining 
the effects of an extended tissue culture period. Fur-
thermore, most heart valve tissue engineering biore-
actor studies have used biochemical methods or 
qualitative immunohistochemical and histological 
analyses of the overall valve to assess ECM model-
ing. c6.42 The current research is one of few bioreactor 
studies 15.2S that focused on changes of specific ECM 
components and synthesis mediators within the indi-
vidual layers, which is important due to their different 
structure and function. While the results from this 
study cannot be directly compared to those of the 
previous bioreactor studies, when the results are 
combined, a more complete picture of valvular 
remodeling can be drawn. 
Limitations of this project include the subjectivity of 
the semi-quantitative immunohistochemical analysis. 
To eliminate potential bias, all samples were blinded 
prior to analysis. Repeatability was assessed by a 
second analysis of the tissues. This method has been 
previously documented to have a variability of 
< 15%,11 and this study had a similar level of preci-
sion. It is also possible that cell migration noted in the 
static culture studies was due to a wound response 
during the initial sample preparation as opposed to 
nutrient access. 20 To mitigate the effect of this prepa-
ration artifact on the data, samples sectioned for 
staining were located deep within the tissue, away from 
the original cut. Another limitation was that the tissue 
was only examined at the study endpoint. In the future, 
an increased study duration with multiple timepoints 
could track the activity and consequences of ECM 
turnover mediators that were not preserved, such as 
MMP2 in the fibrosa. The ECM itself may remodel 
due to the effects of these mediators. 
CONCLUSION 
The development and validation of organ culture 
systems makes available powerful tools to study 
physiological systems and pathological mechanisms 
in vitro that would otherwise be nearly impossible to 
observe. This study describes the design of a novel 
bioreactor with a splashing motion that is intended to 
cause light stretch and perfusion of the mitral valve 
tissue to maintain tissue structure. Validation is an 
important step; maintenance of both ECM structure 
and cell concentration within the different layers of the 
tissue indicated successful organ culture when the 
bioreactor was used, whereas valve tissue cultured 
without mechanical stimulation displayed loss of the 
layered structure, cell loss deep within the tissue, 
altered COLL content, and reduced PG content. With 
this successful design, this bioreactor can be used to 
study the early mechanisms of valvular heart disease. 
Alternately, the design could be modified for use 
toward the tissue engineering of heart valves with the 
introduction of a treated scaffold material and donor 
cells? The size of the entire system could also be scaled 
up to accommodate an entire valve, which would more 
faithfully reproduce the coaptation of the leaflet-free 
edges. In the future, this straightforward system can be 
used in a myriad of applications to promote further 
investigation of heart valve biology, pathology, and 
therapies. 
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Appendix V: Mitral Valve Function on Substrates 
with Varying Stiffness 
This appendix features work in which I participated and was a co-author on the 
manuscript; however the work was led by other researchers. A brief description of the my 
primary contributions is given below and a reprint of the manuscript follows. This was 
published as Stephens EH, Durst CA, West JL, Grande-Allen KJ. Mitral Valvular 
Interstitial Cell Responses to Substrate Stiffness Depend on Age and Anatomic Region. 
Acta Biomaterialia, 2011 Jan; 7(1):75-82. 
This manuscript described the characterization of valve cell behavior to substrate 
stiffness while probing the anatomic region and age from which the valve cells were 
derived. I assisted with and performed the synthesis and characterization of PEGDA, 
PEG-RGDS, and Hep-MA. Additionally, I assisted with the interpretation of data 
regarding biofunctional moiety incorporation into gels. 
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1. Introduction 
ABSTRACT 
The material properties of heart valves depend on the subject's age, the state of the disease and the com-
plex valvular microarchitecture. Furthermore, valvular interstitial cells (VICs) are mechanosensitive, and 
their synthesis of extracellular matrix not only determines the valve's material properties but also pro-
vides an adhesive substrate for VICs. However, the interrelationship between substrate stiffness and 
VIC phenotype and synthetic properties is poorly understood. Given that the local mechanical environ-
ment (substrate stiffness) surrounding VICs differs among different age groups and different anatomic 
regions of the valve, it was hypothesized that there may be an age- and valve-region-specific response 
of VlCs to substrate stiffness. Therefore, 6-week-, 6-month- and 6-year-old porcine VICs from the center 
of the mitral valve anterior leaflet (MVAC) and posterior leaflet (PML) were seeded onto poly(ethylene) 
glycol hydrogels of different stiffnesses and stained for markers of VIC activation (smooth muscle 
alpha-actin (SMaA)) and collagen synthesis (heat shock protein-47 (HSP47), prolyl 4-hydroxylase 
(P4H)). Six-week-old MVAC demonstrated decreased SMaA, P4H and HSP47 on stiffer gels, while 6-
week-old PML only demonstrated decreased HSP47. Six-month-old MVAC demonstrated no difference 
between substrates, while 6-month-old PML demonstrated decreased SMaA, P4H and HSP47. Six-year-
old MVAC demonstrated decreased P4H and HSP47, while 6-year-old PML demonstrated decreased 
P4H and increased HSP47. In conclusion, the age-specific and valve-region-specific responses of VICs 
to substrate stiffness link VIC phenotype to the leaflet regional matrix in which the VICs reside. These 
data provide furthe r rationale for investigating the role of substrate stiffness in VIC remodeling within 
diseased and tissue engineered valves. 
© 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved. 
Valve disease afflicts a substantial portion of the population: 
1-2% of 26- to 84-year-olds are afflicted by mitral valve disorders 
[1]. Valve disease incurs significant morbidity and mortality, 
requiring over 100,000 surgeries in the USA each year [2]. In many 
of these disease states the mechanical properties of these valves 
are altered, often contributing to the poor valve function requiring 
surgical intervention. Valvular interstitial cells (VICs) are the dy-
namic, living component of heart valves responsible for synthesiz-
ing and maintaining the valve matrix composition, which in turn 
determines the valve's material behavior. VICs and valves are 
known to be responsive to changes in their mechanical environ-
ment [3-5J. However, the interplay between matrix-driven mate-
rial' properties such as stiffness and the phenotype and synthetic 
behavior of VICs, particularly in the mitral valve (MV), has largely 
been overlooked. Recent work has demonstrated age-related sig-
nificant changes in valve composition [6-8J and material proper-
ties [9J: other studies have shown substantial heterogeneity in 
material behavior among the different anatomic regions of the 
MV [10]. Given that different aged VlCs and VlCs from different 
regions of the MV reside in valve tissues with distinct stiffnesses 
[9]. it was hypothesized that there may be an age- and valve-re-
gion-specific response of VICs to substrate stiffness. 
In order to test this hypothesis, separate groups of VICs from 
three distinct age groups and from two different regions of the 
MV were cultured on poly(ethylene) glycol (PEG) hydrogels of 
two different stiffnesses. After 48 h, the resulting VIC expression 
of cell phenotype and collagen synthesis markers was assessed 
using immunocytochemistry (ICC). 
PEG hydrogels were chosen for this experiment based on their 
promise as a potential platform for the design of scaffolds for 
tissue-engineered heart valves. PEG hydrogels are extremely 
hydrophilic, providing prevention against protein adsorption, a 
critical step in the immunogenicity and degradation of biopros-
thetics [11]. They are also highly permeable, allowing the exchange 
of nutrients and waste materials [12J. Their stiffness can be regu-
lated by changing the molecular weight and concentration of PEG 
[13 J. However, one of the factors that makes these gels particularly • Corresponding author. Tel.: +1 713 348 3704 ; fax : +1 713 348 5877. E-mail address: grande@rice.edu (K.J, Grande-Allen). 
1742-7061/$ - see front matter © 2010 Acta Materialia Inc. Published by Elsevier Ltd . All rights reserved. 
doi: 1 0.1 016/j.actbio.2010.07.001 
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attractive is the ability to customize them by conjugating to the 
PEG backbone various peptides, including cell ligands and growth 
factors, as well as incorporating enzyme-degradable sequences 
allowing tunability of the degradation rate of the hydrogel. This de-
signer biofunctionality makes PEG hydrogels advantageous for the 
tissue engineering of heart valves. In the present study PEG hydro-
gels were conjugated with an Arg-Gly-Asp-Ser (RGDS) peptide, 
enabling VIC attachment to the hydrogel, and methacrylated hep-
arin, which is necessary for normal VIC morphology [14,15). These 
functionalized PEG hydrogels of two different stiffnesses were 
formulated to keep the concentration of biological cues constant, 
thus isolating the effect of stiffness on VIC phenotype. 
2. Materials and methods 
2.1. Synthesis of PEG hydrogel components 
PEG-diacrylate (PEG-DA) of 3400 Da MW was synthesized from 
PEG (Sigma-Aldrich, st. Louis, MO) as previously described [13). IH 
nuclear magnetic resonance (NMR) analysis revealed >95% acryla-
tion. Methacrylated heparin was synthesized as described previ-
ously (14). Briefly, a 10 mg ml-I solution of heparin (Sigma-
Aldrich) dissolved in ultrapure water was reacted with 40 molar ex-
cess methacrylic anhydride (Sigma-Aldrich). The pH of the solution 
was adjusted to 7.5 using 4 M NaOH and stirred for 24 h. Methacry-
lated heparin was then precipitated using cold 95% ethanol. The pre-
cipitate was then filtered, dried and dialyzed against ultrapure water 
using a 1000 Da MWCO membrane (Spectrum Laboratories, Rancho 
Dominguez, CA). The product was then lyophilized. IH NMR analysis 
revealed 5% methacrylation per disaccharide. 
The RGDS peptide (Bachem, Bubendorf, Switzerland) was at-
tached to hetero-bifunctional PEG (PEG-SCM; Laysan Bio, Arab, 
AL) by reacting the peptide with hetero-bifunctional PEG and cat-
alyst diisopropylamine (Sigma-Aldrich) in dimethyl sulfoxide 
(DMSO; 1.2 M RGDS:l.0 M PEG-SCM:2.0 M disopropylamine) for 
24 h. The product was then dialyzed against ultrapure water using 
a 1000 Da MWCO membrane (Spectrum Laboratories) and lyophi-
lized. The Trp-Arg-Gly-Asp-Ser (WRGDS) peptide (GenScript, Pis-
cataway, N]) was similarly attached to hetero-bifunctional PEG. 
Evafll;ation of PEG-RGDS by gel permeation chromatography re-
vealed 81 % conjugation. 
2.2. Polymerization of /Unctionalized PEG hydrogels 
PEG hydrogels were synthesized by dissolving the appropriate 
amounts of PEG-RGDS, methacrylated heparin and PEG-DA in 
phosphate-buffered saline. A volume of 10 III ml- I 2,2-dime-
thoxy-2-phenyl-acetophenone (300 mg ml- I in I-vinyl-2-pyrroli-
done) was added and the solution was poured between two 
sterile glass slides separated by a 0.4 mm spacer and exposed to 
ultraviolet light for 2 min (365 nm, 10 mW cm-2). Hydrogels were 
then removed from the mold and soaked in phosphate-buffered 
saline with 2% antibiotic (Mediatech, Herndon, VA) for at least 
24 h allowing the hydrogels to swell to equilibrium. Hydrogel 
thickness was optically measured using a Leica DFC 320 CCD cam-
era (Wetzlar, Germany) and ImagePro acquisition software (Media 
Cybernetics, Bethesda, MD). Hydrogel thicknesses were deter-
mined from the acquired images using Image] software (NIH, 
Bethesda, MD). 
2.3. Optimization of /Unctionalized PEG hydrogels 
Optimization studies were performed to determine the concen-
trations of PEG-RGDS and methacrylated heparin in the pre-poly-
mer solution necessary to yield equivalent amounts of these 
bioactive ligands in the swollen, polymerized gels of the two differ-
ent weight-volume fractions of PEG-DA. The concentration of 
methacrylated heparin in polymerized, swollen gels was deter-
mined using an uronic acid assay, as described by Blumenkrantz 
and Asboe-Hansen [16] after gels were hydrolyzed by reacting 
them with 0.1 N NaOH for 34 h at 37 0(, These studies determined 
that 9.0 mg ml-I of methacrylated heparin in the pre-polymer 
hydrogel solution for the 5% weight-volume PEG-DA hydrogel 
and 10.6 mg ml-I of methacrylated heparin in the solution for 
the 15% weight-volume PEG-DA hydrogel yielded equivalent con-
centrations of methacrylated heparin in the polymerized, swollen 
gels of the different PEG-DA weight-volume fractions (Fig. 1). Opti-
mization studies utilizing tryptophan (which was detected by its 
absorbance at 280 nm using a spectrophotometer (SpectraMax 
M2, Molecular Devices, Sunnyavale, CA» in the RGDS peptide 
(WRGDS, conjugated to PEG using the same reaction as for RGDS; 
gel permeation chromatography revealed 83% conjugation), deter-
mined that 7.49 mg ml-I of PEG-RGDS in the pre-polymer solu-
tions for both weight-volume PEG-DA hydrogels yielded 
equivalent final concentrations of PEG-RGDS in the swollen, poly-
merized gels (Fig. 2). 
2.4. Determination of elastic modulus of /Unctionalized PEG hydrogels 
Strips ofthe two weight-volume fraction PEG hydrogels (5 mm 
in width) were uniaxially tensile tested using an EnduraTec ELF 
3200 (Bose, Eden Prairie, MN). The strain rate was 10 mm S-I 
and load-elongation data were recorded until failure occurred. Dis-
placement was converted to strain based on the initial hydrogel 
length between grips. The elastic modulus was determined as the 
slope of the least-squares linear fit to the stress-strain curve. 
2.5. Cell culture and cell seeding onto PEG 
Mitral valves were dissected from hearts from 6-week-, 
6-month- and 6-year-old pigs obtained from an abattoir (the 
6-week- and 6-month-olds from Fisher Ham and Meat, Spring, TX; 
the 6-year old from Animal Technologies, Tyler, TX). Based on previ-
ous studies demonstrating that the mitral valve anterior center 
(MVAC) is stiffer than the posterior leaflet [10], VICs were isolated 
from the MVAC (representing a stiffer valve region) and the PML 
(representing a less stiff valve region) from the same mitral valves 
according to previously published protocols [17]; cells were cul-
tured in medium containing 1 0% bovine growth serum (HyClone, lo-
gan, UT) and 2% antibiotic/antimycotic (Mediatech). The medium 
was changed every 2-3 days and cells were passaged after reaching 
Concentration of Methacrylated Heparin In Gels 
e ~00r---------------~~~~~~~~~~~ I 5000 
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[Metheeryletect Hep.,ln] In p,.-Polymer Solution (Ilg/ml) 
FIg. 1. Concentration ofmethacl1'lated heparin In the two different weight-volume 
fraction PEG swollen gels as determined by uronic acid assay. Four PEG hydrogel 
samples of each weight-volume fraction were tested. Error bars on all graphs 
indicate standard error of the mean. 
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Fig. 2. Optimization of PEG-WRGDS in the two different weight-volume fraction 
PEG swollen gels by varying the concentration of PEG-WRGDS in the pre-polymer 
solutions. The concentration of PEG-WRGDS was determined by absorption at 
280 nm. 
80-90% confluence. Experiments were performed on cells from pas-
sages 5-6. Cells were seeded onto functionalized PEG hydrogels at a 
cell density of 6000 cells cm-2 and maintained in 10% serum med-
ium with 2% antibiotic/antimycotic. 
2.6. Immunocytochemistry 
Based on previous reports demonstrating phenotypic changes 
in fibroblasts and VICs after 24-48 h [14,18), in the present study 
VICs were cultured on gels for 48 h and then fixed by incubation 
in 10% formaldehyde in PBS for 30 min at room temperature. Sam-
ples of dimensions 4 mm x 6 mm were cut from cell-seeded gels 
and transferred to the wells of an 8-well coverglass chamber (Lab-
Tek 11, Nalge Nunc International, Naperville, IL) for ICC staining and 
subsequent imaging. ICC was performed for markers of collagen 
synthesis prolyl 4-hydroxylase (P4H; Chemicon, Temecula, CA) 
and heat shock protein 47 (HSP47; Assay Designs, Ann Arbor, 
MI), as well as markers related to valve cell phenotype vimentin 
(Dakocytomation, Denmark) and the marker of VIC activation 
[19[ smooth muscle alpha-actin (SMaA; Dakocytomation), with 
AlexaFluor 488 secondary antibodies (Invitrogen Molecular Probes, 
Eugene, OR). Stained gels were imaged using LSM 5 LIVE 5 DuoScan 
(Zeiss, Oberkochen, Germany) and staining intensity and cell mor-
phology (area and circularity) were quantified using Image] soft-
ware. For determination of staining intensity, cells were outlined 
and the intensity within each cell was quantified (0-255) relative 
to any background intensity. Multiple images (3-5) were analyzed 
for each marker for each VIC population cultured on the different 
gels. 
2.7. Statistical analysis 
Multifactorial analysis of variance (ANOVA) was performed 
using SigmaS tat (SPSS, Chicago, IL). When the data for a given char-
acteristic was normally distributed (as determined by the soft-
ware), the program continued with an ANOVA. When the data 
set was not normally distributed, the data was rank transformed 
before the ANOVA was performed. In both cases the level of signif-
icance was set at 0.05. 
3. Results 
3.1. Stiffness of different weight-volume fraction functionalized PEG 
hydrogels 
Uniaxial testing revealed that functionalized 5% weight-volume 
PEG gels had a mean modulus of 34.5 kPa, while functionalized 
15% weight-volume PEG gels had a mean modulus of 323.3 kPa 
(Fig. 3). 
3.2. SMaA expression of VIes on gels of different stiffnesses 
Not all VICs stained positively for SMaA, as expected. Analysis of 
the fraction ofVICs expressing SMaA (SMaA+ VICs) on the different 
gels revealed a trend towards decreased SMaA+ VICs on the 15% 
gels compared to the 5% in the 6-week-old MVAC VICs (Fig. 4, 
P = 0.1), but there was no difference between gels for 6-week-old 
PML VICs. Six-month- and 6-year-old MVAC VICs did not display 
a difference in the fraction of SMaA+ VICs between gels, but 6-
month- and 6-year-old PML VICs showed a trend toward decreased 
SMaA + VICs on the 15% gels relative to the 5% gels (p = 0.06). Anal-
ysis of the intensity of SMaA stain in SMaA+ VICs on the different 
gels revealed a trend towards decreased intensity in SMaA+ VICs 
for 6-week-old MVAC VICs (Fig. 5, P = 0.087) but no difference for 
6-week-old PML VICs. Six-month-old MVAC demonstrated no 
change in SMaA intensity in MVAC VICs but decreased SMaA inten-
sity in PML VICs (p < 0.05). No difference in SMaA intensity be-
tween gels was evident for 6-year-old MVAC VICs or 6-year-old 
PML VICs. 
3.3. P4H expression of VICs on gels of different stiffnesses 
Analysis of P4H, which was expressed by all VICs, demonstrated 
decreased intensity in 6-week-old MVAC VICs on the 15% gels rel-
ative to the 5% gels (p < 0.05) but no difference between gels for 6-
week-old PML VICs. Six-month-old MVAC VICs demonstrated no 
difference in P4H intensity between gels, but 6-month-old PML 
VICs demonstrated decreased intensity on the 15% gels relative 
to the 5% gels (Fig. 6, P < 0.05). Six-year-old MVAC and PML VICs 
both demonstrated decreased P4H intensity on the 15% gels rela-
tive to the 5% gels (MVAC p < 0.05, PML P < 0.085 (trend)). 
Elastic Modulus of Functionalized PEG 
Hydrogels 
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Fig. 3. Stiffness of the two weight-volume fraction functionalized PEG gels as 
determined by the elastic modulus during uniaxial tensile testing. Four PEG 
hydrogel samples of each weight-volume fraction were tested. 
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3.4. HSP47 expression of VICs on gels of different stiffnesses 
Analysis of HSP47. which was expressed by all VICs. demon-
strated decreased intensity in both 6-week-old MVAC and PML 
VICs on the 15% gels relative to the 5% gels (Fig. 7. both p < 0.05). 
Six-month-old MVAC VICs demonstrated no difference in HSP47 
intensity between gels. but 6-month-old PML VICs demonstrated 
decreased HSP47 intensity on the 15% gels relative to the 5% gels 
(p < 0.05). Six-year-old MVAC demonstrated no difference in 
HSP47 intensity between gels. but 6-year-old PML VICs demon-
strated increased HSP47 intensity on the 15% gels relative to the 
5% gels (p < 0.05). 
3.5. VIC Morphology on gels of different stiffnesses 
For both MVAC and PML VICs of each age and on each gel. two 
populations of VICs were noted: one with a spindle-shaped cell 
morphology and a second with a cuboidal cell morphology 
(Fig. 8). Analysis of staining intensity of cuboidal and spindle-
shaped subpopulations revealed that. for given age- and valve-re-
gion VICs that responded to substrate stiffness. both subpopula-
tions demonstrated a response (data not shown). Cell 
morphology analysis of vimentin-stained VICs revealed a de-
creased cell area of 6-month-old PML VlCs on the 15% gels relative 
to the 5% gels (p < 0.02). No difference was noted in circularity be-
tween VICs on PEG hydrogels of different stiffnesses. 
4. Discussion 
In this study. mitral VICs grown on functionalized PEG hydrogels 
demonstrated both age- and valve-region-specific (MVAC vs. PML) 
responses to substrate stiffness. These results underscore the range 
of unique phenotypes found in valvular cells and provide compelling 
motivation for further studies of heart valve mechanobiology. 
4.1. Previous studies of VICs and substrate stiffness 
While the response of cells to substrate stiffness has been stud-
ied extensively in cell types from many other tissues (see the 
excellent review by Nemir and West [20]). very limited investiga-
tion has been performed on the response of VICs to substrate stiff-
ness. Furthermore. even though the material properties of MVs are 
known to be altered in diseased states [21.22J and are distinct in 
different MV regions [10]. no studies published to date have exam-
ined the response of MV VICs to substrate stiffness. Additionally. 
no studies have investigated a potential age-specific response of 
VICs to substrate stiffness despite a growing awareness that valve 
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6wk 
6mo 
6 yo 
Fig. 8. Images of vimentin-stained VICs from each age group demonstrating two 
distinct VIC morphologic subpopulations: spindle-shaped cells (see the white arrow 
in the 6-week-old image) and cuboidal cells (see the yellow asterisk in the 6-week-
old image). These distinct subpopulations were evident for VICs isolated from both 
MVAC and PML and on PEG gels of both stiffnesses. Shown here are MVAC VICs on 
15% PEG gels. Scale bars indicate 50 mm. 
matrix. material properties and VIC phenotype change with age [6-
9]. 
Work on fibroblasts from different tissues examining cell phe-
notype and morphology changes in response to substrate stiffness 
has documented increased actin fibers in response to increased 
substrate stiffness [20]. appearance of stress fibers on stiffnesses 
of' ; 0 kPa and above [18]. and an increase in cell spreading that 
was maximum on substrate stiffnesses of 8-10 kPa [18.23). How-
ever. all of these studies were performed within a range of sub-
strate stiffnesses that was much lower (Le. 1-100 kPa [20)) than 
the stiffnesses used in the present study. While the in vivo stiffness 
of the MVAC continues to be debated [24.25]. and the in vivo stiff-
ness of the PML remains to be determined. these stiffnesses are 
certainly considerably greater than the 1-10 kPa range of substrate 
stiffness commonly utilized in fibroblast experiments. The two gel 
stiffnesses used in this study were chosen to be in the same general 
range that could be consistent with the in vivo stiffnesses of the 
MVAC and PML. yet were different enough to potentially elicit 
age- and valve-region-specific VIC responses. 
Three previous studies aimed at identifying factors in aortic 
valve (AV) calcification have analyzed the effect of substrate stiff-
ness on mineralization and activation of porcine AV VICs. One work 
[26] compared the calcification potential of AV VICs seeded at con-
fluence (allowing cell-to-cell interaction) on PEG hydrogels (com-
pressive modulus of"" 1 00 kPa) functionalized with fibronectin or 
fibrin to AV VICs cultured on unmodified tissue culture polystyrene 
(TCPS. a much stiffer substrate) and TCPS coated with fibrin and 
fibronectin [26]. One of their key findings was that the response 
of VICs to substrate stiffness depended on the matrix coating the 
substrate [26]. Another study showed that porcine AV VICs cul-
tured on collagen gels of different stiffnesses did not display any 
difference in calcification potential in normal medium. but in cal-
cification medium AV VICs developed different types of calcific 
nodules depending on the collagen gel stiffness [27]. In an earlier 
study [28]. SMaA expression in AV VICs was increased on stiffer 
collagen gels; however. in this study VICs were simultaneously ex-
posed to different concentrations of collagen fibers and this may 
have confounded the interpretation of their results [28]. 
4.2. Age- and va/ve-region-specijic responses of VIes to substrate 
stiffness 
In the present study both age- and valve-region-specific re-
sponses of VICs to different substrate stiffnesses were evident. 
Based on ex vivo experiments of material properties of different 
aged porcine MVs and different regions within the porcine MV 
(MVAC vs. PML [10)). one would expect the 6-week-old VICs to 
be accustomed to a less stiff substrate relative to the 6-month-
and 6-year-old VICs. Similarly. given studies demonstrating that 
MVAC tissues are stiffer than PML tissues [10]. one would expect 
MVAC VICs to be accustomed to a stiffer substrate than PML VICs. 
Unfortunately. the actual in vivo stiffness of the MVAC remains un-
clear. with only a few reports citing vastly differing values [24.25]; 
no reports exist citing values for the in vivo stiffnesses of different 
aged MVAC and PML. Potentially. the results from this study could 
be explained by differences in "optimal" stiffness for each VIC pop-
ulation assessed. Just as "optimal" stiffnesses have been demon-
strated for stem cell lineage specification and the expression of 
associated cellular markers [29]. in VICs expression of myofibro-
blast phenotype and collagen synthesis markers may reach a max-
imum at a certain stiffness. and this stiffness could be unique for 
each VIC population. Based on the mechanical testing studies cited 
above. potentially the "optimal" stiffness for 6-week-old PML 
would be less than those for 6-month-old PML and 6-week-old 
MVAC. Where the stiffnesses of the 5% and 15% gels fall relative 
to one another upon this hypothetical marker expression-stiffness 
curve for a particular VIC population could explain whether differ-
ences in marker expression were observed between the VIC popu-
lation seeded on the 5% and 15% gels (Fig. 9). Clearly. substantial 
future work is needed to investigate this hypothesis further. 
including a larger number and range of substrate stiffnesses. Nev-
ertheless. the results from this study demonstrate that there are 
age- and valve-region-specific responses of VICs to substrate 
stiffness. 
In terms of specific protein expression. SMaA expression and 
proportion of SMaA+ cells generally paralleled changes in collagen 
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A. VIC 1 
B. VIC 2 
5% gel 15% gel 
I 
Subslra te sti ffness 
Marker 
expression on 
5% > 15% 
Marker 
expression on 
5%:: 15% 
Fig. 9. Schematic illustrating how differences or lack of differences in marker 
expression between 5% and 15% gels may relate to a hypothetical marker 
expression- substrate stiffness continuum that is distinct for each VIC population 
(i.e. age and valve region ). The stiffnesses of the 5% and 15% gels fall on the marker 
expression-substrate stiffness curve in A such that marker expression on 5% gels is 
greater than on 15% gels. whereas the 5% and 15% gels fall on the marker 
expression-substrate stiffness curve in B such that marker expression on the 5% 
gels and 15% gels are equal. 
synthesis markers in 6-week-old and 6-month-old MVAC and PML 
VICs. However, in 6-year-old VICs changes were evident in markers 
of collagen synthesis despite no detectable change in SMaA inten-
sity. Benton et al. [26] similarly found some uncoupling between 
stiffness-mediated changes in SMaA expression and calcification 
potential of AV VICs. While the results for HSP47 largely paralleled 
those of P4H, in 6-year-old PML VICs P4H expression was de-
creased on 15% gels relative to 5% gels, while HSP47 was increased. 
Other studies, however, confirm the potential for independent reg-
ulation of HSP47 and other markers of collagen synthesis (such as 
P4H) by mechanically stressed tendon cells [30] and fibroblasts 
treated with transforming growth factor-beta [31]. Certain en-
zymes, such as Iysyl hydroxylase 2, have also demonstrated differ-
ential regulation of HSP47 and P4H in dermal fibroblasts [32]. 
Therefore, it appears reasonable for HSP47 to show distinct 
changes in response to substrate stiffness relative to P4H. 
A~ anticipated, based on inherent differences between VICs 
from AV compared to MV [33,34], the SMaA results in this study 
are different from those of AV VICs reported by Pho et al. [28]. 
Additional distinctions between these two studies, such as cell 
seeding density, different adhesive substrates and range of sub-
strate stiffnesses [28], may also have contributed to the different 
results. Work by Engler et al. [29] has demonstrated that for stem 
cells there exists a stiffness at which there is a maximum in myo-
fibroblast marker expression, and above this stiffness myofibro-
blast marker expression actually decreases, which would be 
consistent with the findings of this study. Differences in the results 
between the Pho et al. study [28] and the present study may also 
be due to the matrix components used in the substrates of different 
stiffnesses. 
4.3. VIC subpopu/ations 
Distinct VIC subpopulations, including the spindle-shaped and 
cuboidal cell morphologies evident in this study, have been previ-
ously documented [35,36]. The spindle-shaped cells demonstrate 
qualities similar to fibroblasts, while those with cuboidal morphol-
ogy are similar to myofibroblasts and are associated with valve 
remodeling and various valve pathologies [19,35- 37 J. These sub-
populations also demonstrate differences in adhesion to different 
substrates and matrix components, such as fibronectin [38,39 ]. In 
the present study, when a difference in marker expression in VICs 
between the gels of different stiffnesses was evident. both subpop-
ulations appeared to display this difference. Recent advances in the 
isolation of these subpopulations could allow a more in-depth 
investigation of these subpopulations with respect to substrate 
stiffness [39]. 
4.4. Implications 
These distinct responses of VICs from different-aged MVs and 
different MV regions have important implications for our under-
standing of valve mechanobiology and motivate further study in 
the context of various diseased states. In light of the fact that these 
different VIC populations (from different aged valves and from dif-
ferent regions) reside in matrices of different stiffnesses, these re-
sults suggest that the in vivo mechanical environment in which 
VICs reside has a profound, fundamental impact on the responsive-
ness ofVICs to their external environment (Le. their baseline intra-
cellular signaling framework), even in the ex vivo setting. In the 
context of normal aging, these distinct responses could relate to 
the ability of the valve to remodel appropriately in response to 
age-related changes in hemodynamics. With respect to normal 
physiology, the region-specific differences may relate to the differ-
ent loading patterns that these regions experience. The age-specific 
differences could relate to the predilection of certain valve diseases 
to occur at certain ages, and the valve-region-specific responses 
could relate to the propensity of certain valve diseases to preferen-
tially affect specific regions of the MV. Knowledge of cell-substrate 
interactions also has relevance for valve tissue engineering; the de-
sign of a tissue-engineered heart valve scaffold should consider 
how its stiffness affects the phenotype and matrix synthesis of 
whatever cells will be seeded within or recruited into the scaffold. 
The results from this study suggest that the scaffold stiffness may 
need to be carefully tuned depending on the cell type used. 
4.5. Limitations and future studies 
While the results of this study provide fundamental knowledge 
regarding how MV VICs respond to substrate stiffness, substantial 
work still needs to be done in this area and certain study limita-
tions should be noted. While the concentrations of biological cues 
presented to these cells (RGDS and methacrylated heparin) were 
carefully orchestrated to' be the same between the two substrates, 
there may be differences in how different aged VICs and VICs from 
different valve regions respond to the same concentration of these 
biological cues (for example, if cultured on tissue culture plastic). 
Future studies investigating this further, examining how these 
short-term changes relate to longer term changes and downstream 
processes, and perhaps assessing differences in how these cells 
interact with their substrate (Le. expression of integrins), would 
add insight in this area. Additionally, the mechanism(s) by which 
these cells respond differently to their substrate warrants investi-
gation. For instance, while PEG is highly hydrophilic and does not 
adsorb proteins, heparin is known to bind growth factors [40]. 
Therefore, differences in the amounts or types of growth factors 
produced by these different VICs in response to different substrates 
could then be sequestered by heparin in the gels and propagate 
changes in the VIC phenotype. Future investigation into inherent 
differences between these VIC populations could also lend insight 
into the results found in this study. Ultimately, a larger range of 
substrate stiffnesses, including stiffnesses that match those in 
235 
E.H. Stephens et al. / Acta Biomaterialia 7 (2011) 75-82 81 
which these different VICs reside in vivo, could allow the determi-
nation of an "optimal" substrate stiffness for each VIC population. 
However, this has been difficult given the limited, conflicting re-
ports regarding the in vivo stiffnesses of the MVAC [24,25] and 
the lack of any in vivo studies of the PML The goal of this set of 
experiments was to first determine whether there were age- and 
valve-region-specific responses to substrate stiffness. An exciting 
topic for future studies is the role of substrate stiffness in the path-
ogenesis of mitral valve diseases, such as myxomatous degenera-
tion, and how age-specific and region-specific responses of VlCs 
to substrate stiffness might relate to the incidence of myxomatous 
changes in particular age groups and valve regions. It should be 
noted that the time point of 48 h was chosen as it allowed suffi-
cient time for cell adhesion, interaction with the matrix and phe-
notypic changes, while being short enough so as to not be 
confounded by potential differences in cell proliferation between 
the different VIC populations. However, it will be important in 
the future to examine how these short-term changes relate to 
downstream processes and longer term changes. 
5. Conclusions 
In this study, the response of MV VlCs to substrate stiffness has 
been investigated for the first time. VIC populations taken from dif-
ferent regions of the same MV and VICs of different ages cultured 
on PEG hydrogels of different stiffnesses demonstrated age- and 
valve-region-specific responses to substrate stiffness. These find-
ings should be taken into consideration in the design of an age-spe-
cific tissue-engineered heart valve and in future investigations of 
heart valve mechanobiology. 
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Appendix A. Figures with essential colour discrimination 
Certain figures in this article, particularly Figures 8 and 9, are dif-
ficult to interpret in black and white. The full colour images can be 
found in the on-line version, at 10.1 016/j.actbio.201 0.07.001. 
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Appendix VI: Mathematical Models for 
Mechanical Testing of Leaflets 
This appendix features work in which the I participated and was a co-author on the 
manuscript; however the work was led by other researchers. A brief description of the my 
primary contributions is given below and a reprint of the manuscript follows. This was 
published as Stephens EH, de Jonge N, McNeill MP, Durst CA, Grande-Allen KJ. Age-
Related Changes in Material Behavior of Porcine Mitral and Aortic Valves and 
Correlation to Matrix Composition. Tissue Engineering Part A, 2010 Mar; 16(3):867-78. 
These studies aimed to characterize valvular material properties as a function of age. I 
trained the other authors on and assisted with uniaxial tensile testing. Additionally, I 
helped interpret the viscoelastic data, identified the utility of Fung's quasilinear 
viscoelastic model (QLV) for this approach and applied a Maxwell-Weichert model with 
three elements to describe the biphasic stress relaxation behavior. 
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Age-Related Changes in Material Behavior of Porcine 
Mitral and Aortic Valves and Correlation 
to Matrix Composition 
Elizabeth H. Stephens, 8.S.,1 Nicky de Jonge, M.Sc} Meaghan P. McNeill, 8.S} 
Christopher A. Durst, 8.S.,1 and K. Jane Grande-Allen, PhD.1 
Recent studies showing significant changes in valvular matrix composition with age offer design criteria for age-
specific tissue-engineered heart valves. However, knowledge regarding aging-related changes in valvular ma-
terial properties is limited. Therefore, 6-week, 6-month, and 6-year-old porcine aortic valves (A V) and mitral 
valves (MV) were subjected to uniaxial tensile testing. In addition to standard material parameters, the radius of 
transition curvature (RTC) was measured to assess the acuteness of the transition region of the tension-strain 
curve. Radially, the MV had greater stiffness and a smaller RTC compared with the A V. Circumferentially, the 
center of the MV anterior leaflet (MV AC) had the highest stiffness (MV AC > A V> MV free edge [MVF]), greater 
stress relaxation (MVAC > MVF / AV), lowest extensibility (MV AC < AV < MVF), and smaller RTC compared 
with MVF (A V < MV AC < MVF). A V and MV radial strips had a larger RTC compared with circumferential 
strips. Aging elevated stiffness for MV and A V radial and circumferential strips, elevated stress relaxation in A V 
and MVF circumferential strips, and increased RTC for MV radial and MVF circumferential strips. In conclusion, 
there are significant age-related differences in the material properties of heart valves, which parallel differences 
in tissue composition and structure, likely impact valve function, and highlight the need for age-specific design 
goals for tissue-engineered heart valves. 
Introduction 
A LTHOUGH HEART VALVE composition and microstructure 
are known to change with aging, 1-6 and a number of 
valve diseases show increased incidence with aging/'s the 
effects of aging on valvular material properties remain lar-
gely unknown, with the exception of one study of radial 
failure strain of aortic valves (AVS).9 It is likely that valve 
material behavior varies with age given age-related changes 
in valve composition, including increased collagen content1,2 
and crosslinking,2,4 as well as changes in the abundance and 
turnover of specific extracellular matrix (ECM) compo-
nents.3,10,1l Potential age-related changes in the material be-
havior of valves likely contribute to proper physiologic 
function, as cardiac hemodynamics change during the nor-
mal aging process.12 Ultimately, a properly designed tissue-
engineered heart valve (TEHV) would similarly need specific 
material properties that allow it to withstand these different 
hemodynamics depending on the patient age. 
Valves are considered to be quasi-viscoelastic,13,14 highly 
anisotropic tissuesl5-20 that demonstrate stress relaxa-
tionI4,17,2()-24 but low hysteresisl3,14 and no creep.14,23 Tensile 
testing of valves results in a characteristic load-elongation 
curve with a low slope pre-transition region in which the 
collagen fibers are crimped and the elastic fibers are bearing 
load, followed by a transition region during which loading is 
transferred to the collagen fibers, and then a post-transition 
region whose high slope reflects load bearing by the collagen 
fibers. 21,22,25 Valve anisotropy, in which valves are stiffer and 
less extensible in the circumferential direction compared 
with the radial direction,I5-20 is attributed to collagen fiber 
alignment in the circumferential direction.15.26 Stiffness also 
varies regionally within the mitral valve (MY) (Le., between 
the anterior center [MV AC) and the free edge [MYF]),15 as 
does ECM composition in these regions.27 
Therefore, the primary objective of this study was to as-
sess age-related differences in the material properties of 
porcine MY and A V and to consider these differences in the 
context of valve microstructure and ECM composition. In 
addition to standard material parameters, we developed a 
novel parameter termed "radius of transition curvature" 
(RTC) to quantify the acuteness of the transition from the 
'Department of Bioengineering, Rice University, Houston, Texas. 
2Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands. 
Jnepartments of Mathematics and Biology, Baylor University, Waco, Texas. 
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TABLE 1. 
Circumferential strips 
MV AV 
MVAC MVF NC LC 
6-week old 6 5 7 7 
'6-month old 5 5 4 5 
6-year old 9 11 6 6 
SAMPLE SET 
RC Total MV 
6 25 7 
4 18 6 
8 31 6 
Radial strips 
AV 
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NC LC RC Total 
8 7 6 28 
5 4 3 18 
8 9 9 32 
MY, mitral valve; A V, aortic valve; NC, noncoronary; MY AC, MY between the anterior center; and MYF, MY between the free edge; LC, 
left coronary; RC, right coronary. 
pre-transition to post-transition region of the tension-strain 
curve. 
Materials and Methods 
Tissue sample procurement 
Based on comparable anatomy between porcine and hu-
man valves,28-30 valves from 6-week, 6-month, and 6-year-
old pigs were used (corresponding to child, young adult, and 
older adult ages in hurnansll ). Porcine hearts were obtained 
from abattoirs (from Fisher Ham and Meat [Spring, TX] for 
6-week-old and 6-month-old pigs; from Animal Technologies 
[Tyler, TX] for 6-year-old pigs) and measured to normalize 
leaflet thickness to heart size (maximum circumference and 
longitudinal length from the origin of the pulmonary artery 
to heart apex). MVs and AVs were dissected from the hearts, 
chordae were removed from the MV, and circumferential 
and radial strips of 5 mm diameter were cut from both MY 
and AV (Table 1). Given known differences between the 
material properties of the MVAC (defined as the central re-
gion without chordal attachments) and MVF,15 circumfer-
'ential strips were taken from both of these regions (Fig. lA). 
MV radial strips sparmed the entire leaflet height from 
armulus to free edge. Tissues were stored in phosphate-
buffered saline (PBS) at 4°C until testing and tissues were 
tested within 4 days of harvesting (based on studies showing 
material properties of valves do not change in that time pe-
riod31 ,32). 
Mechanical testing 
The thickness of the tissue was measured at four locations 
using a displacement gauge (Mitutoyo, Kawasaki, Japan). 
FIG. 1. (A) Orientation of tissue strips cut 
from the mitral valve (MY) (indicated by 
dashed boxes). Curved solid line indicates 
the border between the center (MVAC) 
and free edge (MVF) of the mitral value 
(MV) anterior leaflet. Rad, radial; circ, cir-
cumferential. (B) Diagram illustrating the 
placement of glued balsa/valve tissue 
sample construct within grips of material 
testing system. 
Tissue samples were glued to balsa wood with cyanoacrylate 
and clamped within an EnduraTec ELF 3200 (Bose, Mirme-
tonka, MN) such that the edge of the balsa wood aligned 
with the end of the grips (Fig. IB). The balsa wood improved 
traction of the tissue within the grips, thereby preventing 
slippage during testing. Mechanical testing was performed 
in a 37°C PBS bath as described previously.33 Briefly, me-
chanical testing began with the tissue in an unloaded state 
and consisted of 25 cycles of preconditioning at 1 Hz fol-
lowed by one load-elongation cycle (0.5 Hz) . The tissue was 
then allowed to rest for 15 s before another three cycles of 
preconditioning and a stress relaxation test (duration 100 s). 
Data analysis 
Gauge length, defined as the length at which the tissue 
first starts bearing load, was calculated by fitting a cubic 
function to the pre-transition region of the load-elongation 
curve and then determining the tissue length corresponding 
to the local minimum, similar to the method used by Carew 
and Vesely.34 Recorded displacement values were then di-
vided by gauge length to calculate strains and load con-
verted to tension by dividing by tissue width. The slope of 
the post-transition portion of the tension-strain curve (post-
transition "stiffness") was calculated by first fitting a straight 
line to the maximum load and the preceding four points. 
Additional preceding points were added and the slope of the 
linear least-squares fit line was recalculated until its value 
changed by more than 1%. The pre-transition stiffness was 
determined as the slope of the linear least-squares fit be-
tween zero strain to one half of "end-transition" strain 
(where the end-transition point was the closest point to the 
origin that was used in the post-transition slope calculation). 
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Extensibility was defined as the intersection of the linear 
least-squares fit of the post-transition region with the x-axis 
(strain). The stress relaxation data were fit to the following 
two-phase decay equation: 
y = yo + Aoe -Kr.st X + A 1 e - Kslow X 
The Kfast and Ks10w values were calculated iteratively using 
Graphpad Prism (GraphPad Software, La Jolla, CA). The 
percentage relaxation (%SR) was calculated as the difference 
between the initial load and the load remaining at 100 s as a 
percentage of the initial load. The yo value refers to the pla-
teau stress in the tissue (where t is approaching 100 s). Ao and 
A1 are best-fit values from a nonlinear regression referring to 
the span of the fast and slow portions of the curve. The RTC 
was calculated by first dividing the y-axis of the tension-
strain curve by 100 N/ m to make both axes dimensionless 
and then rotating the tension-strain curve clockwise so that 
pre-transition and post-transition lines were at equal angles 
from the vertical (which converted the vertex of the transi-
tion region to a global minimum). A hyperbola was then fit 
to the points in the transition region (from 0 to l.5 x end-
transition strain) and the RTC was calculated as the inverse 
of the second derivative of this global minimum. 
Histology and immunohistochemistry 
To evaluate the valvular material behavior in context of 
the ECM composition, representative tissue strips equivalent 
tb those used for mechanical testing were fixed in 10% for-
malin overnight, dehydrated, paraffin embedded, and sec-
tioned for histological examination. Movat penta chrome was 
used to visualize the different ECM components and leaflet 
layers. Immunohistochemistry was also performed as pre-
viously described11,35 to identify and localize the proteogly-
cans (PGs) decorin, biglycan, and versican (decorin [LF122] 
and biglycan [LFI04] from Dr. Larry Fisher, NIH, Bethesda, 
MD;36 versican [2Bl] from Associates of Cape Cod, East 
Falmouth, MA), the glycosaminoglycan (GAG) hyaluronan 
(HA, using HA-binding protein; Associates of Cape Cod), 
and collagen type III (Col III, which has been shown to 
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change with age,11 LF69; from Dr. Larry Fisher37). Based on 
studies showing that valve cell contractility can affect val-
vular material behavior,38 staining was also performed for 
the myofibroblast marker nonmuscle myosin heavy chain-lIB 
(NMM; Covance, Berkeley, CA) as previously described.39 
Briefly, immunohistochemical staining consisted of antigen 
retrieval (citrate buffer; Biocare Medical, Concord, CA), ex-
cept for PGs in which chondroitinase ABC was used35 (As-
sociates of Cape Cod), followed by quenching of endogenous 
peroxidases. Nonspecific staining was blocked using goat 
serum buffer, followed by application of primary antibody. 
Rinses in PBS were performed before application of the ap-
propriate species-specific secondary antibody. Positive 
staining was visualized using Vectastain Elite ABC and 
diaminobenzidine kits (Vector Laboratories, Burlingame, 
CA), followed by hematoxylin counterstaining. Radially 
oriented strips of the MY and A V, which were previously 
stained in this same manner as described in a previous 
publication,lO,11 were also used to provide context. 
Statistical analysis 
Multifactorial analysis of variance (ANOV A) was per-
formed using SigmaStat (SPSS, Chicago, IL). When the data 
were normally distributed, an ANOV A test was used. When 
the data set was not normally distributed, a rank transform 
was performed before the ANOV A. In both cases the level of 
significance was set at 0.05. 
Results 
Thickness 
All test strips cut from the MY were thicker than in the A V 
(p < 0.001), whether in the circumferential direction (Fig. 2) 
or radial direction. For aU valve strips, thickness increased 
with age (each p < 0.001), as reported previously for human 
valves.4o The normalized thickness of circumferential and 
radial strips (whether normalized to the circumferential or 
longitudinal dimension of the heart) of 6-month aIds was 
greater than for other age groups (p ~ 0.035 for each valve or 
leaflet region; thickness normalized to circumference). 
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FIG. 2. (A) Thickness of circumferential valve strips with age. Results for radial strips were comparable (data not shown). 
(B) Thickness of circumferential valve strips with age normalized to heart size (maximum circumference of heart) . ,.,"Sig-
nificantly different between ages within a given valve region. ct' ~Valve regions significantly different for a given direction 
(radial or circumferential). 
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FIG. 3. Slope of post-transition region of tension-strain curves for (A) circumferential strips and (B) radial strips. *'''Sig-
nificantly different between ages within a given valve region by post hoc ANOV A comparing all ages. a A V and MY 
significantly different for a given direction (radial or circumferential). t A V radial significantly different from A V circum-
ferential; tMV AC circumferential, MVF circumferential, and MV radial strips each significantly different from one another. 
A V, aortic valve; ANOVA, analysis of variance. 
Post-transition and pre-transition stiffnesses 
In the post-transition region of the tension-strain curves, 
MV and A V radial stiffness was less than circumferential 
(p < 0.001), consistent with previously published studies.15-20 
The radial stiffness of MY was greater than for A V 
(p < 0.001; Fig. 3). Among circumferential strips, the stiffness 
of MV AC was greatest, followed by A V, and then MVF 
(p = 0.005). With increasing age, MY and A V radial stiffness 
increased (each p ::; 0.003), as did MVand A V circumferential 
stiffness (each p ::; 0.010). 
In the pre-transition region of the curves, there were no 
significant differences between circumferential and radial 
stiffnesses in either the AV or MY. Amongst MY and AV 
circumferential samples, MVF pre-transition stiffness was 
greater than MV AC, followed by A V (Fig. 4, P < 0.001). With 
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increasing age, the pre-transition stiffness of MV samples 
(both circumferential and radial) and A V radial samples in-
creased (each p < 0.001). 
Stress relaxation 
In the A V, radial sections showed a higher Kfast but a 
lower Ks10w than circumferential strips (Table 2, each 
p < 0.001). In the MV, however, the Kfast and Ks10w of MVAC 
circumferential strips were higher than for MV radial (each 
p < 0.005). Among radially oriented sections, the A V Kfast 
and Ks10w were both greater than for the MY (each p ::; 0.002). 
Among circumferential sections, Kfast of MY AC was greater 
than AV, followed by MYF (p < 0.001), but Ks10w was great-
est in AV (A V > MVAC > MYF, p < 0.001). With increasing 
age, A V circumferential Kfast was reduced (p = 0.006), as was 
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FIG. 4. Slope of the pre-transition region of tension-strain curves for (A) circumferential strips and (B) radial strips. 
*'''Significantly different between ages within a given valve region by post hoc ANOV A comparing all ages. a,j3 A V and MV 
significantly different for a given direction (radial or circumferential). 
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TABLE 2. STRESS RELAXATION TIME CONSTANTS 
Valve Valve region Direction Age Kfast K s10w 
AV Total Rad1,2 6 weeks 0.545 ± 0.025 0.0295 ± 0.0010 
6 months 0.596 ± 0.030 0.0321 ± 0.0013 
6 years 0.543 ± 0.023 0.0312 ± 0.0010 
Circ2,S,6 6 weeks 0.548 ± 0.023a 0.0361 ± 0.0010 
6 months 0.445 ± 0.030a 0.0329 ± 0.0013 
6 years 0.485 ± 0.023 0.0352 ± 0.0010 
Rad1,3 6 weeks 0.493 ± 0.046 0.0270 ± 0.0013 MY Total 
6 months 0.477 ± 0.056 0.0264 ± 0.0015 
6 years 0.463 ± 0.056 0.0240 ± 0.0015 
Circ4,6 6 weeks 0.457 ± 0.069 0.0307 ± 0.0019a MVF 
6 months 0.468 ± 0.069 0.0270 ± 0.0019 
6 years 0.499 ± 0.044 0.0263 ± O.OO12a 
Circ3A,S 6 weeks 0.545 ± 0.052 0.0299 ± 0.0014 MYAC 
6 months 0.566 ± 0.069 0.0330 ± 0.0019 
6 years 0.707 ± 0.046 0.0285 ± 0.0013 
Units for Kfast and K sJow are N/ s. Data represent mean ± standard error of the mean. Samples with the same numeric superscripts indicate 
significant differences between Kfast as well as K sJow values for those samples across ages, except four in which Kfast was only significantly 
different between samples and six in which only K sJow was significantly different between samples. All differences marked represent p < 0.05. 
aSignificant difference between indicated ages within a given valve region/direction. 
Rad, radial; circ, circumferential. 
MYF circumferential Ks10w (p = 0.046). With respect to the 
relative magnitudes of relaxation, %SR was greater for A V 
circumferential than for AV radial (Fig. 5, P < 0.001) and 
greater for MY AC circumferential, followed by MYF cir-
cumferential, then MY radial (p < 0.001). Among circumfer-
ential strips, %SR of MY AC was greater than for either A V or 
MYF (p = 0.014). With increasing age, %SR was increased in 
A V circumferential strips (p = 0.009) and in MVF circum-
ferential sections (p = 0.005). 
Extensibility 
In both the A V and MV, circumferential strips were less 
extensible than radial strips (p < 0.001; Fig. 6). There were no 
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differences between extensibilities of AV and MV strips. In 
both MY and A V radial strips, as well as in MY AC cir-
cumferential strips, extensibility was reduced with age (each 
p :S 0.010). There was no effect of age on the extensibility of 
MYF circumferential strips. Among A V circumferential 
strips, the 6-month-old samples were the least extensible 
(p < 0.001). 
Radius of Transition Curvature (RTC) 
AV circumferential RTC was less than AV radial RTC 
(p < 0.001; Fig. 7) . MY AC circumferential RTC was less than 
MYF circumferential RTC and then MY radial RTC 
(p < 0.001). Among circumferential strips, A V RTC was less 
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FIG. 5. Total percentage of relaxation (SR) for (A) circumferential strips and (B) radial strips. *'''Significantly different 
between ages within a given valve region by post hoc ANOVA comparing all ages. cxValve regions significantly different 
for a given direction (radial or circumferential). t A V radial significantly different from A V circumferential. tMY AC cir-
cumferential, MYF circumferential, and MV radial strips each significantly different from one another. 
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FIG. 6. Extensibility for (A) circumferential strips and (B) radial strips. *,''.#Significantly different between ages within a 
given valve region by post hoc ANOV A comparing all ages. ~ A V radial significantly different from A V circumferential. tMV 
radial strips are significantly different from both MY AC and MVF circumferential strips. 
than MY AC RTC, which was less than MVF RTC (p < 0.001). 
With age, MVF circumferential and MY radial RTC increased 
(p = 0.003 and p = 0.033), but no age-associated changes 
were evident in A V strips. 
Differences between A V leaflets 
In 6-year-old AVs, the noncoronary (NC) leaflet was 
thicker than the left or right coronary leaflets (p = 0.007), as 
previously reported for human valves.40,41 However, there 
was no significant difference in thickness between A V leaf-
lets in the other age groups. For both radially and cir-
cumferentially oriented strips, Kfast of the NC leaflet was 
greater than for the other two leaflets (each p S 0.037). 
However, the circumferential %SR for the NC leaflet was less 
than for the other two leaflets (p = 0.039). RTC of A V NC 
leaflets was less than the coronary leaflets (p = 0.031). 
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Differences in valve matrix composition 
By Movat staining, it was evident that the annulus portion 
of MY radial strips (corresponding to the MVAC) contained 
a higher proportion of the collagen-rich fibrosa layer com-
pared with A V radial strips (Fig. 8). MY AC circumferential 
strips contained a much thicker fibrosa than found in MVF 
(Fig. 9). With age, the fibrosa thickened and collagen content 
increased throughout the valve layers, but this increase was 
particularly evident in the fibrosa layer and in the ven-
tricularis layer, where collagen surrounded elastic fibers. 
Interestingly, there was also a marbling of PG/GAGs (see 
inset in Fig. 8) in the fibrosa of the 6-year-old MY radial 
annulus and MV AC circumferential section, which was not 
evident in the younger ages. Immunohistochemistry re-
vealed that the PGs versican, biglycan, and decorin, as well 
as the GAG HA, were present within this marbling. Cir-
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FIG. 7. Radius of transition curvature: (A) circumferential strips and (B) radial strips. *Significantly different between ages 
within a given valve region by post hoc ANOV A comparing all ages. ct,p A V and MY significantly different for a given direction 
(radial or circumferential). t A V radial significantly different from A V circumferential. tMY AC circumferential, MYF cir-
cumferential, and MY radial strips each significantly different from one another. 
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FIG. 8. Representative Movat-stained tissue sample sections for 6-week-old and 6-year-old radial strips. In Movat 
pentachrome-stained tissue, yellow = aligned collagen, black = elastic fibers, and green/blue = proteoglycans (PGs)/ 
glycosaminoglycans (GAGs). To facilitate comparison between AV and MV, valves were all oriented with the fibrosa at the 
bottom of the image and sized to show the complete leaflet thickness allowing visualization of all leaflet layers. Because of 
differences in leaflet thickness (see Fig. 2), magnifications differ between images. Scale bars equal 200 Ilm. Note that the MV 
radial annulus is almost exclusively fibrosa (corresponding to the MV AC), whereas AV radial annulus shows a considerably 
smaller proportion of the leaflet thickness composed of fibrosa. Also of note is the marbling of PG/GAG with collagen in the 
fibrosa of 6-year-old MV radial annular strips (see close-up view in inset) and MV AC circumferential strips compared with 6-
week-old strips. This marbling may, in part, account for the increase in SR seen with age (see Discussion section). Color 
images available online at www.liebertonline.com/ten. 
cumferential strips also contained more Col III with age (Fig. 
10), as found previously for radial stripS.ll The myofibroblast 
marker NMM was more strongly expressed in 6-year-old 
strips of MV AC than in younger valves. 
Discussion 
This study showed for the first time that there are signif-
icant age-related differences in numerous material properties 
of MV and A V. At each age, the valves were more extensi-
ble and less stiff radially than circumferentially, as is well 
known.15-20 All valves, however, demonstrated age-associated 
increases in post-transition stiffness and most also showed 
increased pre-transition stiffness. In general, extensibility 
was reduced with age, especially radially. Stress relaxation 
parameters also varied with age, particularly circumferen-
tially. The overall shape of the tension-strain curves also 
changed with age, as demonstrated by the novel parameter 
RTC, which generally increased with age in the MV and was 
larger radially than circumferentially. These age-related 
changes in material properties paralleled an increase in col-
lagen content, particularly in the fibrosa and ventricularis 
(which is normally rich in elastic fibers), and a marbling 
appearance of the fibrosa, in which PG/GAGs were inter-
spersed throughout the collagen. Because this study tested 
MV and AV from the same hearts, it was also possible 
to demonstrate differences in material properties between 
MV and AV. 
With increasing age, the leaflets showed greater post-
transition stiffness both radially and circumferentially. This 
finding is consistent with age-related stiffening of other con-
nective tissues such as cartilage42 and tendon,43 which are 
mainly attributed to increased collagen cross linking. 43 Leaflet 
composition explains much of the differences in stiffness 
among sample groups. For example, the preponderance of 
the collagenous fibrosa layer within the MV annulus likely 
contributes to the greater radial stiffness of MV compared 
with AV and the greater circumferential stiffness of MV AC 
compared with MVF. Age-related increases in fibrosa thick-
ness and collagen content shown here for numerous valve 
regions, as well as previously reported increases in collagen 1,2 
and in crosslinkini.4 in aging valves, could explain the in-
creased stiffness with age. A greater proportion of cells in the 
6-year-old MV AC expressed the activated myofibroblast 
phenotype, which has been linked with increased leaflet 
stiffness.38 In addition, collagen crosslinking has been directly 
correlated with the stiffness of circumferential strips of hu-
man A V, although no such correlation was found for radial 
stripS?6 Combined with evidence suggesting that the ven-
tricularis is a key contributor to valvular material behavior in 
the radial direction,22,44 the age-related increase in radial 
stiffness could be due to increased collagen in the ven-
tricularis, as observed in the Movat-stained sections. 
Interestingly, the pre-transition stiffness also signifi-
cantly increased with age. This parameter may be due in 
part to the stiffness of the elastic fibers,45 but is not often 
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6 year-old 
FIG. 9. Representative Movat-stained tissue sample sections for 6-week-old, 6-month-old, and 6-year-old circumferential 
strips. In Movat pentachrome-stained tissue, yellow = aligned collagen, black = elastic fibers, and green/blue = PGs/GAGs. 
To facilitate comparison between A V and MV, valves were all oriented with the fibrosa at the bottom of the image. Images in 
column 1 show high magnification of 6-week-old valves (all images in column 1 are the same magnification). Images in 
columns 2-4 are lower magnification to demonstrate the differences in leaflet thickness (all images in columns 2-4 are the 
same magnification). Scale bars equal 200 !-lm. Compared with MVF, MV AC circumferential sections contain much higher 
proportion of fibrosa. For all valve regions an increase in collagen was noted throughout the valve layers with age, but most 
particularly in the fibrosa and ventricularis. Color images available online at www.liebertonline.com/ten. 
reported15,16,18,46 and has never previously been studied with 
respect to age. The increase in pre-transition stiffness with 
age could reflect the stiffening of aging elastic fibers,43 as 
well as increased collagenous reinforcement of the elastic 
fibers, which was observed in Movat-stained sections. It was 
also noteworthy that the age-related increases in the thick-
ness of the valve leaflets40 were not proportional to the in-
crease in heart size, possibly due to the ventricular 
hypertrophy found in older animalS.47,48 
Accompanying the age-related increase in the post-
transition stiffness was a pronounced reduction in radial ex-
tensibility of older valves. Extensibility assesses the amount of 
tissue that can stretch before the collagen fibers are fully un-
crimped and able to bear load;21 its magnitude reflects both 
collagen fiber crimp and alignment. The finding that extensi-
bility is greater radially than circumferentially confirms pre-
vious reports;16-18,20 this anisotropy permits the leaflets to 
stretch radially during valve closure. These findings are also 
consistent wi th a previous report on an age-rela ted reduction in 
maximal radial stretch of human cryopreserved valves.9 A re-
duction in extensibility with age could be attributed to factors 
that impact collagen uncrimping, such as increased collagen 
crosslinking2,4 or elastic fiber fragmentation,43 which can lead 
to gradual permanent tissue stretch and less-crimped collagen 
fibers. Indeed, in tendon collagen, crimp amplitude decreases 
and crimp wavelength increases with age;49 these extensibility 
changes motivate future study of collagen crimp in aging heart 
valves. Similarly, heart valves subjected to glutaraldehyde 
fixation (crosslinking) under pressure demonstrated reduced 
collagen crimp and extensibility.5o 
The novel finding of an increase in the percentage of cir-
cumferential stress relaxation (in AV and MVF) with age 
could be due to many factors. First, there is more HA with 
age10 as well as marbling of PGs/GAGs in the collagenous 
fibrosa, which would allow more sliding of collagen bundles 
relative to one another. 51 Alternatively, the greater numbers 
of the PGs decorin and biglycan,lO which bind to the surface 
of collagen fibrils,52 could be transferring more load from 
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collagen to other matrix components, resulting in greater 
%SR. Indeed, age-related changes in %SR were most evident 
in the circumferential direction, the predominant collagen 
fiber direction. 53 Reductions in the functionality43 and con-
teneo of elastic fibers could also increase stress relaxation, 
according to studies on pericardium. 54 Lastly, the greater 
abundance of Col III, which dissipates more energy than 
does collagen type 1,55 could have contributed to the greater 
%SR with age. There is some disagreement in the heart valve 
literature regarding anisotropy in stress relaxation.14,17,20,23,24 
Our finding of greater %SR in circumferential strips com-
pared with radial strips corroborates the work by Lee et al., 
who measured the %SR of fresh leaflets over 1000 s using 
uniaxial testing.20 
The viscoelasticity of valve tissues has been examined 
using a wide variety of constitutive models,17,19,33,56--59 but 
the effects of age have not been previously investigated. In 
particular, the quasi-linear viscoelastic (QL V) model devel-
oped by Fung60 has been applied to fresh and fixed valve 
tissues;19,33,56 analysis using this technique, however, is 
computationally intense. In this study, a Maxwell-Weichert 
model with three elements was used to examine biphasic 
decay behavior of the stress relaxation curve.61 ,62 The age-
related decreases in K fast of AV circumferential samples and 
in Ks10w of MYF samples both indicate more viscous behav-
ior, which could relate to the increased abundance of PGs 
and GAGs. lO The Kfast and Ks10w values reported in this study 
also serve as baseline parameters for evaluating mechanical 
properties of TEHVs. While current TEHV studies have fo-
cused primarily on linear material properties, understanding 
the viscoelastic properties will continue to be of significant 
value, especially as more advanced materials are developed. 
FIG. 10. MY AC circumferential sections 
showing increased Col III and NMM 
in 6-year-old sections compared with 
6-month-old sections. Similar differences 
were noted for the staining of Col III for 
other valve regions between the 6-year-
old aged sections and the younger ages. 
Scale bar equals 200 f!m. Insets in NMM 
images are 1.5 x higher magnification for 
improved visualization of cells. Col III, 
collagen type III; NMM, nonmuscIe 
myosin heavy chain-lIB. Color images 
available online at www.liebertonline 
.com/ten. 
The novel parameter RTC, which quantifies the acuteness 
of the transition region of the tension-strain curve, can be 
compared across samples for any soft tissues that display 
bilinear tension-strain or stress-strain curves. Collagen fibers 
that are highly aligned and uniformly crimped will have a 
very acute transfer of load bearing from elastic fibers to the 
straightened collagen fibers, and hence a very small RTC. If 
collagen fibers are not uniformly crimped, their transition to 
load bearing would be more gradual, resulting in a greater 
RTC. A larger RTC would also result from a random fiber 
alignment, in which some fibers would be initially aligned 
with the applied load and begin bearing load at low strains, 
but the remaining collagen bundles would require varying 
amounts of additional\train and/or rotational realignment 
before bearing 10ad.21 Indeed, the angular distribution of 
collagen fibers significantly changes within this transition 
region?l The smaller RTC of MY AC circumferential strips 
compared with MYF likely indicates greater alignment53 and 
homogeneity of collagen fiber crimping in MY AC compared 
with the other valve regions. In the valve, collagen bundles 
are predominantly oriented circumferentially,53 and there-
fore, RTC would be lower circumferentially than radially, as 
found here. The age-related increase in RTC of MVF and MY 
radial strips could be due to greater collagen crosslinking2,4 
and a greater abundance of network-forming Col III. In fu-
ture, it will be important to relate this parameter to changes 
in the soft tissue microstructure during this transition region 
of loading. 
This study is also the first to show differences in material 
properties between NC and coronary A V leaflets, such as 
lower %SR and RTC in the NC leaflet. These differences may 
be due to the lack of coronary blood flow within the NC 
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sinus; simulations of human AVs have shown that NC ex-
periences higher stress63 and greater diastolic pressure 
loading than the other leaflets.64 The NC leaflet also contains 
smaller diameter collagen fiber bundles,65 which may permit 
easier rotation of collagen fibers as they align in the direction 
of loading, and hence contribute to a lower RTC. An addi-
tional subset of valves was frozen at _20DC for 2 months 
before testing; as previously demonstrated by Clark,18 sig-
nificant differences were found between fresh A V and pre-
viously frozen A V (data not shown). 
Conclusion 
In this study, A V and MY from the same porcine hearts 
were subjected to tensile testing. In the analysis of the tensile 
testing data, we developed a novel parameter, RTC, which 
may be useful in quantifying the dynamic stress-strain be-
havior of biological tissues. Overall, our results showed that 
between A V and MY, and within each valve, there are pro-
found heterogeneities and age-related changes that reflect 
the ECM and microstructural composition. In addition, the 
effects of age on the heart valve tissues differ between valves, 
valve regions, and material testing orientations. Given the 
documented similarities between porcine and human valves, 
these results provide further justification (as well as baseline 
data) for the development of age-specific TEHVs. These age-
related changes in valve material properties likely contribute 
to proper physiologic function of valves at different ages. For 
instance, the age-related increase in leaflet stiffness likely 
allows the A V and MY to withstand the increase in cardiac 
pressures and concomitant decrease in aortic compliance 
with age.12 Clearly, considerable work remains in under-
standing the structural and mechanical complexity of heart 
valves, their ECM and cell composition, and the contribu-
tions of these characteristics to valve function. 
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Appendix VII: Custom MA TLAB Code 
1. prodcata_sugar.m 
The following script allows the determination of bending stiffness from samples 
where the digital image correlation (marker tracking) was run on SUG@R. The script 
requires the matrix of marker positions as a function of image to be local. Sample 
parameters such as thickness of the sample and width between the loading posts are 
measured visually. Stiffness, length and diameter of the flexure bar are also input. The 
script then shows a graph of marker positions, sample information like thickness and 
moment of inertia are output. A graph of bending moment versus change in curvature is 
then displayed and the linear fit can be calculated. 
%Script for Processing Data Run on Sugar. Samples should be 
in fol.ders wi.t.h 
% Commented lines near end of script can be used to 
automate fits instead of using curve fitting toolbox 
initial image, grid data, validx and validy (tracked data), 
and filelist. 
%clea.r all.; 
% use speckle tracking algorithms 
% filelist generator; 
% %makegray ; 
% grid_generator ; 
% automate_ima ge; 
%------------
% calculate t h e sample thickness and width, conversion 
factor (pixels ·t o mrn), and moment of inertia 
%if exist( 'FileNameBase' )==0 
[FileNameBase,PathNameBase] = uigetfile( ... 
{ '*.bmp; * .t i fi*.jpgi*.T I F ; * . BMP;*.JPG ' , ' Image files 
(*.bmp, * .tif,* . jpg) f ; '*. * ' , 'All Files (* . *) ' }, 
'Ope n base image thickness calculat i on' ); 
%end 
cd(PathNameBase) 
imtool(FileNameBase); 
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menu(sprintf( 'Click OK when tl-tS, mm, wp (btwn posts), and 
s have been measured. I ), 'Ok' ); 
prompt={ ' Enter the height of the gel (mm) ' }; 
name= 'Input for MoI calculation' ; 
numlines=l; 
defaultanswer={ ' ' }; 
options.Resize= 'on' ; 
answer=inputdlg(prompt,name,numlines,defaultanswer,options) 
wreal=str2num(answer{1}); 
tp=(tl+t2+t3+t4+tS)/S; 
treal=tp/mm; 
inertia=(1/12)*treal~3*wreal; 
wppost=wp/mm; 
sprintf( '\n Sample thickness %.2f mm \n Sample height %.2f 
mm \n Moment of inertia %.2f' , treal, wreal, inertia) 
displacement; 
%-----------
% calculate the curvature 
load( 'filenamelist.mat' ); 
load( 'validx_corr.dat' ); 
load( 'validy_ cor r .dat ' ); 
[q,r]=size(filenamelist); 
%co lors= [ 'b. ' ; , g. ' ; , r. · ; 'm. ' i ' k. ' ] ; 
% x_init= load{ 'grid_x.dat ' }/mm; 
% y_init=load( 'grid_y.dat' )/mm; 
sx=load( 'validx_ corr.dat' )/mm; 
sy=load( 'validy_ corr.dat' )/mm; 
%creates matrix of dots from each image, fits quadratic 
line, calculates 
%change in curvature (delK) 
for i=l:q-l 
x_fin(: ,i)=sx(: ,i); 
y_fin(: ,i)=sy(: ,i); 
coeff(:,i)=polyfit(x_fin(:,i),y_fin(:,i),2); 
yprime(:,i)=polyder(coeff(:,i)); 
ydprime(i)=polyder(yprime(:,i)); 
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%k(:,i)=(polyval(ydprime(i),sx(:,l))} ./«l+(polyval(yprime( 
: , i) , sx ( : , 1 ) ) ) . A 2 ) . A ( 3/2 ) ) ; 
delk(:,i)=polyder((ydprime(:,i)./(1+yprime(:,i).A2).A(3/2)) 
) ; 
y2(:,i)=polyval(coeff(:,i),sx(:,i)); 
SSE(i)=sum((y_fin(:,i)-y2(:,i)).A2); 
SST(i)=sum((y_fin(:,i)-mean(y_fin(:,i))).A2); 
r2(i)=1-(SSE(i)/SST(i)); 
end 
delk=polyder(k); 
sprintf( 'R-squared values for each fit: \n%.2f %.2f 
%.2f %.2f %.2f' ,r2) 
%plots tracked dots/fitted lines to ensure good tracking 
figure(l) 
hold on ; 
%plot(x_init,y_init, 'y.'); 
xlabel( ' x position (mm)' ); 
ylabel( ' y pos i tion (mm) ' ); 
%for l=l:q-l 
%end 
plot(x_fin,y_fin, 'x' ) %,colors(l, :)); 
plot(sx,y2, ' . r ) %,color s(l)); 
%find displacements between r ef rod and bending rod 
% filel i st_generator2; 
% grid generator2; 
% automate_ image2; 
%calculate distance between ref rod and bending rod 
mx_init=load( 'grid_ x2.dat' ); 
my_init=load( 'grid_y2.dat' ); 
mx=load( 'validx2.dat' ); 
my=load( 'validy2.dat' ); 
[a,b]=size(filenamelist); 
spread_init=((mx_init(1)-mx_init(2))A2+(my_init(1)-
my_init(2))A2)A.S; 
for i=l:a-l 
spread(i)=((rnx(1,i)-mx(2,i))"2+(my(1,i)-my(2,i))A2) A.S; 
end 
spread=spread-spread_init; 
spread=spread/mro; 
prompt={ 'Enter the stiffness of the flexure bar 
(MPa)' , 'Enter the flexure bar length (mm)' , 'Enter the 
diameter of the flexu r e bar (mm) ' }; 
name= 'Input for force calculation ' ; 
numlines=l; 
defaultanswer={ ' 164351' , ' 81' , 'O.50B' }; 
options.Resize= 'on' ; 
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answer=inputdlg(prompt,name,numlines,defaultanswer,options) 
E=str2num(answer{1}); 
L=str2num(answer{2}); 
dia=str2num(answer{3}); 
%this momen't of i n e rtia is for a rec-tan gle 
I=pi/4*(dia/2)A4; 
%sreal=s/mmi 
%d=size(x_fin); 
% postl=median ( x_fin(:,1)-wreal/2; 
% post2 =median(x_fin (: ,1) ) +wreal/2 ; 
%calculate force applied by rod in each image 
%p is in newto ns 
P=(spread*3*(E*I))/(L A3); 
% 
% Fx=(P(1:69)/2 ) . *( (y2(d(1), [1:69] )-y2(d(1)-
1, ( 1 : 69 ] ) ) . / ( x _ fin ( d ( 1 ) I [ 1 : 69 ] ) - x __ fin ( d ( 1 ) -1 , [ 1 : 69 ) } ) ) ; 
% Fy=P(1:69)/2; 
% M=Fy*wreal+Fx . *spread(1:69); 
%init=li 
%fin = 80i 
M=P/4*wppost; 
%stiffness=M./(inertia*mean(delk(:,[init:fin]»): 
%oldstiffness=(P*L~3)./(48*inertia*spread); 
figure(2) 
hold on ; 
plot(delk,M, '.' ); 
xlabel( 'change in curvature (mmA_l)' ); 
ylabel( 'Moment (N-mm)' ); 
% stifffit=polyfit( delk(l,[l:fin] ), M,l } ; 
% stiffy=polyv al(stif ff it , delk ( l ,[ l :fin]»); 
% plot(mean(delk ( : I [l : fin ] ) ) , stif f y , J r ') 
% SSE2=sum«(M-stiffy) . ~2); 
% SST2 =sum(((M-mean(M))). ~ 2); 
% r22=1-(SSE2/SST2 ); 
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2. sugarprep.m 
This script is used to prepare bending samples to have SUG@R run the marker tracking. 
On local machine, the gridpoints for the sample, reference rod, and flexure bar are 
created. These can then be uploaded along with the image sequence. 
%local preparation for sample before uploading to sugar 
%generates list of files in a folder 
% creates initial grid points on sample 
% creates initial grid points on flexure bar and reference 
rod 
% save everything in each samples folder 
% using default filenames makes things easier 
filelist_generator; 
grid_generator; 
grid_generator2; 
3. samplell.m 
This is an example script used to start a job in a "-nodisplay" command line version of 
MATLAB to automate tracking on SUG@R. 
% call to matlab on sugar to automate image tracking 
% needs image stack with grid data and filelist in the 
folder with the 
% images 
% helps to separate samples in folders 
% 3000 tiffs at SOOx500 should take -l.S hours with 8 
processor cores 
cd 
/shared.scratch/cdS012/PreppedForAnalysis/Cropped_Images/Sa 
rnple_11 
autornate_irnage_mp_2009b; 
automate_image_mp_2009b2; 
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4. tensproc.m 
This is a script used to process uniaxial tensile testing samples. The bounds of strain 
range where the material is linear needs to be known and put in the respective i and j 
parameters in the script. 
%filelist_generator; 
%automate with this and filenamelist length 
%ensure that strain range in loop is appropriate and linear 
for your samples 
%files need to be incrementally numbered text files with 
displacement (mm) in column 1, load (kN) 
%in column 2, and sample thickness needs to be in a user 
created vector 
%called thick (in mrn) 
% commented functions can be used in place of fitting, 
interactive toolbox 
% can also be used 
filelist_generator_txt; 
if exist( 'f ilenamelist' )==0 
load( 'filenamelist' ) 
filenames to be processed 
end 
numfiles=length(filenamelist); 
% file with the list of 
prompt={ 'Enter the gauge length (mm)' , 'Enter the neck width 
(nun)' }; 
name= 'Input for stress strain calculations' ; 
numlines=l; 
defaultanswer={ '10' , '2' }; 
options.Resize= 'on' ; 
answer=inputdlg(prompt,name,numlines,defaultanswer,options) 
gl=str2num(answer{1}); 
nw=str2num(answer{2}); 
output=zeros(length(filenamelist),4); 
output(:,2)=thick' ; 
for p=l:numfiles 
m=dlmread(filenamelist(p,:»; 
offset=O; 
%thick=m(l ,3); 
strain=(m(:,l»/gl; 
end 
stress=(m(:,2))*lOOO/(nw/lOOO*thick(p)/lOOO); 
strain=round(strain*lOOO)/lOOO; 
i=find(strain==O.2); 
j=find(strain==O.6); 
linfit=polyfit(strain(i:j),stress(i:j),l); 
linfity=polyval(linfit,strain(i:j)); 
correlation=corrcoef(stress(i:j),linfity); 
output(p,l)=p; 
output(p,3)=linfit(1,i); 
output(p,4)=correlation(1,2); 
figure(l) 
plot(output(:,4),output(:,3)) 
figure(2) 
[n,xout]=hist(output(:,4),20); 
bar(xout,n) 
success=xlswrite( 'analyzed_samples .xls ' ,output); 
if success==l; 
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sprintf( 'Data analyzed and file successfully written' ) 
else 
sprintf( 'Data not written, check output matrix for 
information' ) 
end 
% figure(l) 
% plot(strain); 
% lowstrain=[]i 
% lowstrain(:,1 ) =strain(strain<O.25); 
% lowstrain(:,2 )=stress(strain<O.25)i 
% medstrain=[]; 
% z=find(strain<O.5); 
% 
medstrain(:,l)=strain(find(strain>O.25}:z(length(z»))i 
% 
medstrain(:,2)=stress(find(strain>O.25}:z(length(z))); 
% highstrain= r ] ; 
% y=find(strain<l); 
% 
highstrain{:,1)=strain(find(strain>O.5):y(length(y))); 
% 
highstrain( :,2) =stress(find(strain>O.5):y(length(y))); 
~5 subplot ( 3 , 1 , 1 ) 
% plot(lowstrain(:,1),lowstrain(:,2») 
't. hold on; 
% llinfit=polyfit(lowstrain(:,l),lowstrain( :,2),1); 
% llinfity~polyval(llinfit,lowstrain(:,I)); 
% plot(lowstrain(:,l),llinfity, 'r'}; 
% xlabel( 'Strain (%) ') 
% ylabel( 'Stress (Pa)') 
% title( 'Low strain region') 
% subplot(3,1,2) 
% plot(medstrain(!,l),medstrain(:,2)) 
% hold on; 
% mlinfit=polyfit(medstrain(:,1),medstrain(:,2),1); 
% mlinfity=polyval(mlinfit,medstrain(:,l); 
% plot(medstrain(: , l),mlinfity, 'r'); 
% xlabel( 'Strain (%}') 
% ylabel( 'Stress (Pa)') 
% title( 'Mid-strain region') 
% subplot(3,1/3) 
% plot(highstrain(:,1),highstrain(:,2» 
% hold on; 
% hlinfit=polyfit(highstrain(:,1)/highstrain(: , 2),1); 
% hlinfity=polyval(hlinfit,highstrain(:/l)); 
% plot(highstrain(:,l) , hlinfity, 'r'); 
% xlabel( 'Strain (%)') 
% ylabel( 'Stress (Pa)') 
% title( 'High strain region') 
% if abs(mlinfit(1)-11infit(1))<2000 
% avg._ E= (mlinfit(1)+11infit(1» /2 
% end 
~\ l=llinfit( 1) 
% m=mlinfit(l) 
% h=hlinfit(l) 
subplot(2,1,1) 
plot(strain,stress) 
subplot(2,1,2) 
plot (strain (i: j ) / stress (i: j ) , , b. ' ) 
hold an i 
plot(strain(i:j),linfity, 'r' ) 
5. pegpatgen.m 
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This script can be used to generate photomasks with oriented or chopped "fibers", holes, 
or sinusoidal patterns. DPI of the output mask is set and the choices are made via the 
MAT LAB GUI. 
function pegpatgen(); 
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% Prompt user for mask size 
prompt={ 'Enter t he mask wi dth ( i n) ' , ' Enter t h e ma sk height 
(in) " 'Enter the mas k resolution (dpi) ' }; 
name= ' Mask Size' ; 
numlines=l; 
defaultanswer={ I , , , , , , , }; 
options.Resize= 'on' ; 
answer=inputdlg(prompt,name,numlines,defaultanswer,options) 
mask_sizex=str2num(answer{1})*str2num(answer{3}); 
mask_sizey=str2num(answer{2})*str2num(answer{3}); 
dpi=str2num(answer{3}); 
gridtypesel(mask_sizex,mask_sizey,dpi); 
close al l 
%-------------------------------
% 
% Decide which type of mask you want to create 
function gridtypesel(mask_sizex,mask_sizey,dpi); 
gridselection = menu(sprintf( 'Which type of mask do you 
want to use' ), ... 
'Oriented - Fibers' , 'Oriented - Chopped' , ' Random -
Fibers' , 'Random - Chopped' , 'Holes' , 'Sinusoidal 
Fibers' , 'Cancel' ); 
if gridselection==l 
Ibounds=[O.5*dpi,O.75*dpi]; %Length Bounds -- currently 
arbitrary 
wbounds=[O.025*dpi,O.05*dpi]; %width bounds --
currently arb itrary 
coverage=O.5*(mask_sizex*mask_sizey); %50% coverage 
maxsize=lbounds(2)*wbounds(2); 
numfibers=floor(coverage/maxsize); 
lengths=floor(lbounds(1)+(lbounds(2)-
Ibounds(l».*rand(numfibers,l»; 
widths=floor(wbounds(1)+(wbounds(2)-
wbounds(l».*rand(numfibers,l»; 
originx=floor(rand(numfibers,l)*mask_sizex); 
originy=floor(rand(numfibers,l)*mask_sizey); 
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skew=floor(87.5+(92.5-87.5)*rand(numfibers,1)); %fiber 
skew, roughly estimated from sacks abme 1997 
dfiny=floor(length~.*sind(skew)); 
dfinx=floor(lengths.*cosd(skew)); 
finx=dfinx+originx; 
finx(finx<O)=O; 
finx(finx>mask_sizex)=mask_sizex; 
finy=dfiny+originy; 
finy(finy<O)=O; 
finy(finy>mask_sizey)=mask_sizey; 
grid=ones(mask_sizey,mask_sizex); 
figure(l); 
imshow(grid) 
hold on ; 
for i=l:numfibers 
line([originx(i) finx(i)),[originy(i) 
finy(i)], 'LineWidth ' ,widths(i), 'Color' , 'k' ); 
i=i+l; 
end 
end 
pause 
return 
if gridselection==2 
lbounds=[O.1*dpi,O.25*dpi); %length bounds 
wbounds=[O.075*dpi,O.125*dpi); %width bounds 
coverage=O.5*(mask_sizex*mask_sizey); %50% coverage 
maxsize=lbounds(2)*wbounds(2); 
numfibers=floor(coverage/maxsize); 
lengths=floor(lbounds(1)+(lbounds(2)-
lbounds(l)).*rand(numfibers,l)); 
widths=floor(wbounds(1)+(wbounds(2)-
wbounds(l)).*rand(numfibers,l)); 
originx=floor(rand(numfibers,l)*mask_sizex); 
originy=floor(rand(numfibers,l)*mask_sizey); 
skew=floor(87.5+(92.5-87.5)*rand(numfibers,1)); %fiber 
skew 
dfiny=floor(lengths.*sind(skew)); 
dfinx=floor(lengths.*cosd(skew)); 
finx=dfinx+originx; 
finx(finx<O)=O; 
finx(finx>mask_sizex)=mask_sizex; 
finy=dfiny+originy; 
finy(finy<O)=O; 
finy(finy>mask_sizey)=mask_sizey; 
grid=ones(mask_sizey,mask_sizex); 
imshow(grid); 
hold on ; 
for i=l:numfibers 
line([originx(i) finx(i)],[originy(i) 
finy(i)], 'LineWidth' ,widths(i), 'Co lor ' , 'k' ); 
i=i+l; 
end 
end 
pause 
return 
if gridselection==3 
Ibounds=[O.5*dpi,O.75*dpi]; %Length Bounds 
wbounds=[O.025*dpi,O.05*dpi]; %width bounds 
coverage=O.5*(mask_sizex*mask_sizey); %50% coverage 
maxsize=lbounds(2)*wbounds(2); 
numfibers=floor(coverage/maxsize); 
lengths=floor(lbounds(1)+(lbounds(2)-
lbounds(l)).*rand(numfibers,l)); 
widths=floor(wbounds(1)+(wbounds(2)-
wbounds(l)).*rand(numfibers,l)); 
originx=floor(rand~numfibers,l)*mask_sizex); 
originy=floor(rand(numfibers,l)*mask_sizey); 
skew=floor(rand(numfibers,1)*180); %fiber skew 
dfiny=floor(lengths.*sind(skew)); 
dfinx=floor(lengths.*cosd(skew)); 
finx=dfinx+originx; 
finx(finx<O)=O; 
finx(finx>mask_sizex)=mask_sizex; 
finy=dfiny+originy; 
finy(finy<O)=O; 
finy(finy>mask_sizey)=mask_sizey; 
grid=ones(mask_sizey,mask_sizex); 
imshow(grid); 
hold on ; 
for i=l:numfibers 
line([originx(i) finx(i)],[originy(i) 
finy(i)], ' LineWi d t h ' ,widths(i), 'Color ' , 'k ' ); 
i=i+l; 
end 
end 
pause 
return 
if gridselection==4 
lbounds=[O.1*dpi,O.25*dpi]; %length bounds 
wbounds=[O.075*dpi,O.125*dpi]; %width bounds 
coverage=O.5*(mask_sizex*mask_sizey); %50% coverage 
maxsize=lbounds(2)*wbounds(2); 
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numfibers=floor(coverage/maxsize); 
lengths=floor(lbounds(1)+(lbounds(2)-
lbounds(l».*rand(numfibers,l»; 
widths=floor(wbounds(1)+(wbounds(2)-
wbounds(l».*rand(numfibers,l»; 
originx=floor(rand(numfibers,l)*mask_sizex); 
originy=floor(rand(numfibers,l)*mask_sizey); 
skew=floor(rand(numfibers,1)*180); %fi ber skew 
dfiny=floor(lengths.*sind(skew»; 
dfinx=floor(lengths.*cosd(skew»; 
finx=dfinx+originx; 
finx(finx<O)=O; 
finx(finx>mask_sizex)=mask_sizex; 
finy=dfiny+originy; 
finy(finy<O)=O; 
finy(finy>mask_sizey)=mask_sizey; 
grid=ones(mask_sizey,mask_sizex); 
imshow ( gr id) ; 
hold on ; 
for i=l:numfibers 
line([originx(i) finx(i»),[originy(i) 
finy(i»), 'Linewidth' ,widths(i), 'Color' , 'k' ); 
i=i+l; 
end 
end 
pause 
return 
if gridselection==5 %holes 
return 
end 
if gridselection==6 %sinusoidal fibers 
prompt={ 'Enter the period (rom)' , 'Enter the amplitude 
(rom)' , 'Enter the spacing (mm) ' }; 
name= 'Sinusoid Parameters' ; 
numlines=l; 
defaultanswer={ " , " , " }; 
options.Resize= 'on ' ; 
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answer=inputdlg(prompt,name,numlines,defaultanswer,options) 
period=str2num(answer{1})*25.4; 
amplitude=str2num(answer{2})*25.4; 
spacing=str2num(answer{3})*25.4; 
freq=2*pi/period; 
end 
t=O:pi/(lO*freq):mask_sizex; 
sinusoid=amplitude*sin(freq*t); 
numlines=floor(mask_sizey*25.4/(spacing+amplitude)); 
sinmatrix(l,:)=sinusoid; 
tmat(l,:)=t; 
for i=l:numlines-l 
sinmatrix(i+l,:)=sinmatrix(i,:)+spacing; 
tmat(i+l,:)=t; 
end 
figure(l) 
hold on ; 
for i=l:numlines 
plot(t,sinmatrix(i,:)) 
end 
return 
if gridselection==7 
return 
end 
function owpat(mask_sizex,mask_sizey,dpi); 
%lbounds= [0.25*dpi,O.5*dpi]; %Length Bounds 
wbounds=[O.0075*dpi,O.125*dpi]; %width bounds 
coverage=O.5*(mask_sizex*mask_sizey); %50% coverage 
maxsize=lbounds(2)*wbounds(2); 
numfibers=floor(coverage/maxsize); 
lengths=floor(lbounds(1)+(lbounds(2)-
lbounds(l)).*rand(numfibers,l)); 
widths=floor(wbounds(1)+(wbounds(2)-
wbounds(l)).*rand(numfibers,l)); 
originx=floor(rand(numfibers,l)*mask_sizex); 
originy=floor(rand(numfibers,l)*mask_sizey); 
skew=floor(75+(105-75)*rand(numfibers,1)); %fiber skew 
dfiny=floor(lengths.*sind(skew)); 
dfinx=floor(lengths.*cosd(skew)); 
finx=dfinx+originx; 
finx(finx<O)=O; 
finx(finx>mask_sizex)=mask_sizex; 
finy=dfiny+originy; 
finy(finy<O)=O; 
finy(finy>mask_sizey)=mask_sizey; 
grid=ones(mask_sizex,mask_sizey); 
figure(l); 
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imshow(grid) 
hold on ; 
for i=l:numfibers 
line([originx(i) finx(i)],[originy(i) 
finy(i)], 'Linewidth' ,widths(i), 'Color' , 'k' ); 
i=i+l; 
end 
pause; 
function ocpat(mask_sizex,mask_sizey,dpi); 
lbounds=[0.1*dpi,0.25*dpi]; %length bounds 
wbounds=[0.075*dpi,0.125*dpi]; %width bounds 
coverage=0.5*(mask_sizex*mask_sizey); %50% coverage 
maxsize=lbounds(2)*wbounds(2); 
numfibers=floor(coverage/maxsize); 
lengths=floor(lbounds(1)+(lbounds(2)-
lbounds(l».*rand(numfibers,l»; 
widths=floor(wbounds(1)+(wbounds(2)-
wbounds(l».*rand(numfibers,l»; 
originx=floor(rand(numfibers,l)*mask_sizex); 
originy=floor(rand(numfibers,l)*mask_sizey); 
skew=floor(75+(105-75)*rand(numfibers,1»; %fiber skew 
dfiny=floor(lengths.*sind(skew»; 
dfinx=floor(lengths.*cosd(skew»; 
finx=dfinx+originx; 
finx(finx<O)=O; 
finx(finx>mask_sizex)=mask_sizex; 
finy=dfiny+originy; 
finy(finy<O)=O; 
finy(finy>mask_sizey)=mask_sizey; 
grid=ones(mask_sizex,mask_sizey); 
imshow( grid); 
hold on ; 
for i=l:numfibers 
line([originx(i) finx(i)],[originy(i) 
finy(i)], 'LineWidth' ,widths(i), 'Color' , 'k' ); 
i=i+l; 
end 
function ranwpat(mask_sizex,mask_sizey,dpi); 
lbounds=[0.25*dpi,0.5*dpi]; %Length Bounds 
wbounds=[0.075*dpi,0.125*dpi]; %width bounds 
coverage=0.5*(mask_sizex*mask_sizey); %50% coverage 
maxsize=lbounds(2)*wbounds(2); 
numfibers=floor(coverage/maxsize); 
lengths=floor(lbounds(1)+(lbounds(2)-
lbounds(l».*rand(numfibers,l»; 
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widths=floor(wbounds(1)+(wbounds(2)-
wbounds(l)).*rand(numfibers,l)); 
originx=floor(rand(numfibers,l)*mask_sizex); 
originy=floor(rand(numfibers,l)*mask_sizey); 
skew=floor(rand(numfibers,1)*180); %fiber skew 
dfiny=floor(lengths.*sind(skew)); 
dfinx=floor(lengths.*cosd(skew)); 
finx=dfinx+originx; 
finx(finx<O)=O; 
finx(finx>mask_sizex)=mask_sizex; 
finy=dfiny+originy; 
finy(finy<O)=O; 
finy(finy>mask_sizey)=mask_sizey; 
grid=ones(mask_sizex,mask_sizey); 
imshow(grid); 
hold on ; 
for i=l:numfibers 
line([originx(i) finx(i)],[originy(i) 
finy(i)], 'LineWidth' ,widths(i), 'Color' , ' k' ); 
i=i+l; 
end 
function rancpat(mask_sizex,mask_sizey,dpi); 
Ibounds=[O.1*dpi,O.25*dpi]; %length bounds 
wbounds=[O.075*dpi,O.125*dpi]; %width bounds 
coverage=O.5*(mask_sizex*mask_sizey); %50% coverage 
maxsize=lbounds(2)*wbounds(2); 
numfibers=floor(coverage/maxsize); 
lengths=floor(lbounds(1)+(lbounds(2)-
lbounds(l)).*rand(numfibers,l)); 
widths=floor(wbounds(1)+(wbounds(2)-
wbounds(l)).*rand(numfibers,l)); 
originx=floor(rand(numfibers,l)*mask_sizex); 
originy=floor(rand(numfibers,l)*mask_sizey); 
skew=floor(rand(numfibers,1)*180); %fib er skew 
dfiny=floor(lengths.*sind(skew)); 
dfinx=floor(lengths.*cosd(skew)); 
finx=dfinx+originx; 
finx(finx<O)=O; 
finx(finx>mask_sizex)=mask_sizex; 
finy=dfiny+originy; 
finy(finy<O)=Oi 
finy(finy>mask_sizey)=mask_sizeYi 
grid=ones(mask_sizex,mask_sizeY)i 
imshow(grid); 
hold on ; 
for i=l:numfibers 
line([originx(i) finx(i)],[originy(i) 
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finy(i)], 'LineWidth' ,widths(i), 'Color' , 'k' ); 
i=i+l; 
end 
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Appendix VIII: Custom ImageJ Scripts 
1. Macro to Quantify DAB Intensity 
macro "dabquant [d]" { 
dir = getDirectory(limage") 
name = getTitle; 
mainimage=name; 
run("Colour Deconvolution", "vectors=[H DAB]"); 
closeO; 
rename("dabimage") ; 
run(IDuplicate ... ", Ititle=DAB"); 
//run(18-bit") ; 
setAuto Th reshold (" Defau It") ; 
ru n ("Th reshold ... "); 
waitForUser("Set maskl,"Threshold set?"); 
getThreshold(lower,upper) ; 
//setThreshold(O, 160); 
run("Convert to Mask"); 
run("Fili Holes"); 
run("Set Measurements ... ", "area mean min display redirect=dabimage 
decimal=3") ; 
run("Analyze Particles ... ", "size=500-lnfinity circularity=0.00-1.00 show=Outlines 
display exclude include"); 
outlines=getTitle; 
selectWindow( outlines) 
run(ICopy"); 
closeO; 
index = lastlndexOf(name, "."); 
if (index!=-1) name = substring(name, 0, index); 
measurename = name + "-d.xls"; 
measurepath=dir+measurename; 
saveAs(" Measu rements", measu repath); 
run(IClose") ; 
closeO; 
selectWindow(mainimage); 
setPasteMode(IAND") ; 
run(IPaste") ; 
pathoutlines=dir+name + "-d-outlines"; 
saveAs(ltiff", pathoutlines); 
closeO; 
closeO; 
closeO; 
closeO; 
} 
2. Macro to Count Cells Using Hematoxylin 
macro "cell count [C]" { 
dir = getDirectory("image") 
name = getTitle; 
mainimage=name; 
run("Colour Deconvolution", "vectors=[H DAB]"); 
closeO; 
closeO; 
rename("himage") ; 
run("Duplicate ... ", "H"); 
//run("8-bit") ; 
setAuto Threshold(" Default"); 
run("Threshold ... "); 
waitForUser("Set mask","Threshold set?"); 
getThreshold(lower,upper) ; 
//setThreshold(O, 160); 
run("Convert to Mask"); 
run("Close-") ; 
run("Watershed") ; 
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run("Set Measurements ... ", "area mean min display redirect=himage decimal=3"); 
run("Analyze Particles ... ", "size=5-100 circularity=0.00-1.00 show=Outlines 
display exclude include"); 
houtlines=getTitle; 
selectWindow(houtlines) 
run("Copy") ; 
closeO; 
index = lastlndexOf(name, "."); 
if (index!=-1) name = substring(name, 0, index); 
measurename = name + "-h.xls"; 
measurepath=dir+measurename; 
saveAs(" Measu rements", measu repath); 
run("Close") ; 
closeO; 
selectWindow(mainimage); 
setPasteMode("AND") ; 
run("Paste") ; 
pathoutlines=dir+name + "-h-outlines"; 
saveAs("tiff", pathoutlines); 
closeO; 
claseO; 
claseO; 
claseO; 
} 
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